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Neuropathic pain affects 7 – 10% of people and responds poorly to pharmacotherapy. Numbers 
needed to treat for first line drugs range from 4 – 8. Therefore, there is an obvious need for 
improved understanding of the mechanisms of neuropathic pain to inform improved treatments. 
Mechanistic research on neuropathic pain frequently uses a human surrogate model of secondary 
hyperalgesia that is a common feature of neuropathic pain. The value of experimentally inducing 
secondary hyperalgesia is that one can then test the influence of different pharmacological and non-
pharmacological interventions. This may shed some light on the physiological mechanisms within the 
spinal cord, which possibly also translates to the effects of the interventions on other pathways that 
are involved in processing signals that may be related to pain.  
Additionally, pain is known to be influenced by the threat value of the situation. Many South 
Africans live under constant threat: less than a third of South Africans feel safe walking alone at 
night. This constant threat may be perpetuating the pain problem in South Arica. However, the 
mechanism by which threat achieves this influence on pain is unclear. This project is focused on one 
possible mechanistic hypothesis: that threat influences pain by affecting central physiological 
changes within the dorsal horn of the spinal cord. These central changes often present clinically as 
secondary hyperalgesia. A thorough understanding of these mechanisms will inform improved 
treatment strategies.   
Methods  
Phase one: systematic review and meta-analysis 
The aim of this systematic review was to identify, describe, and compare methods that have been 
used to manipulate experimentally induced secondary hyperalgesia in healthy humans. A systematic 
search strategy (conducted on 01 October 2019) was supplemented by reference list checks and 
direct contact with identified laboratories to maximise the identification of data reporting the 
experimental manipulation of experimentally induced secondary hyperalgesia in humans. Studies 
were only included if they were published and in-press or accepted records for which the title, 
abstract, and full-text versions were available in English. Duplicate screening, risk of bias assessment, 
and data extraction procedures were used. Risk of bias was appraised for the following domains: 
selection, performance, detection, attrition, measurement, reporting, and other sources of bias. 
Data were extracted using a standardised data extraction form. This form was piloted and refined 
beforehand. Authors were asked to provide data were necessary. Data were pooled by method of 
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manipulation and outcome (intensity of secondary hyperalgesia, area of secondary hyperalgesia, or 
both).   
Phase two: experimental paradigm 
An experimental study was developed and conducted to investigate the effect of a stimulus threat 
on secondary hyperalgesia. The aim of this study was to investigate the effect of a manipulation of 
the threat value of a stimulus on experimentally induced secondary hyperalgesia in healthy human 
volunteers. All participants underwent a sham skin examination (the threat stimulus) at both the 
experimental and control sites. Through this sham skin examination, participants were informed that 
their skin integrity was fragile at the experimental site and robust at the control site. Secondary 
hyperalgesia was induced with high-frequency electrical stimulation at both the experimental and 
control site. Sensory testing was conducted at the experimental and control site, providing a within-
subject comparison of the intensity and area of secondary hyperalgesia at each site. It was 
hypothesised that greater threat will be associated with (hypothesis 1) greater intensity and 
(hypothesis 2) greater surface area of induced secondary hyperalgesia.  
Results  
Phase one: systematic review  
Twenty-one studies with non-pharmacological manipulations were included. Nine (out of 21) studies 
assessed intensity of secondary hyperalgesia after manipulation. Nicotine deprivation and negative 
expectations about the induction increased the intensity of secondary hyperalgesia. Three studies 
using attentional modulation and cognitive loading reported conflicting results with two studies 
having no effect and the other reporting a decrease in the intensity of secondary hyperalgesia. 
Emotional disclosure decreased the intensity of secondary hyperalgesia at four days and at one 
month after the manipulation. Hot/cold application, and verbal suggestion had no effect on the 
intensity of secondary hyperalgesia.  
Seventeen (out of 21) studies assessed area of secondary hyperalgesia after manipulation. Nicotine 
deprivation and sleep deprivation increased the area of secondary hyperalgesia. Hyperbaric oxygen 
therapy, cognitive behavioural therapy, emotional disclosure, spinal manipulation, transcranial 
direct current stimulation, and placebo analgesia decreased the area of secondary hyperalgesia. 
Interestingly, the effects of emotional disclosure and hyperbaric oxygen therapy were evident one 
month after manipulation. Acupuncture had no significant effect on the area of secondary 
hyperalgesia. Four studies assessed the effect of hot/cold application. Three studies reported no 
effect and one study reported an increase in the area of secondary hyperalgesia after cold 
application.   
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Phase two: experimental study  
The threat manipulation (sham skin examination) was not effective in eliciting increased anxiety and 
threat of tissue damage at the experimental site, despite a thorough piloting procedure being 
conducted to ensure the effectiveness of the threat manipulation. Therefore, one would anticipate 
that intensity and area of secondary hyperalgesia would not be predicted by site allocation. The 
results in this current study confirmed that both intensity and area of secondary hyperalgesia were 
not predicted by site allocation (i.e. which arm received the high-frequency electrical stimulation 
under a condition of threat). 
Although a similar sham skin examination has been used effectively as a threat manipulation before, 
it was not effective in eliciting threat of tissue damage in the participants in this present study. There 
are many theorised possibilities as to why this threat manipulation was not effective: 1) Safety 
requirements for the study, 2) Trust, 3) Safety cues, 4) Competing threats, 5) Sampling bias, and 6) 
South African context. 
Conclusion  
Manipulations primarily influencing peripheral mechanisms (hot/cold application) have little effect 
on the intensity and area of secondary hyperalgesia. Although there are conflicting data, these data 
indicate that non-pharmacological manipulation can manipulate secondary hyperalgesia – a typically 
considered highly physiologically driven outcome.  
The results of the experimental study are inconclusive without an effective threat manipulation.  
Improvements need to be made to the threat manipulation. Further research is required to 
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Chapter 1: Introduction 
Theoretical pain models  
Pain is a complex phenomenon which has baffled philosophers, doctors, and scientists for centuries. 
Over the years, many theories have been proposed to explain how and why humans experience pain 
(Moayedi and Davis, 2013). Descartes’s 1664 Model of pain implies that the severity of pain is 
directly proportional to the magnitude of tissue damage (Moayedi and Davis, 2013). However, there 
are multiple anecdotes that dispute this proposed 1:1 relationship between pain and tissue damage, 
for example soldiers having extensive tissue damage but no pain (Beecher, 1946). Additionally, 
Descartes’s Model does not account for persisting pain after the tissue has healed – phantom limb 
pain, for example, is when people experience pain in the limb that has been amputated (Flor, 2002) 
with the pain often lasting years after the initial tissue damage (i.e. the amputation) has healed 
(Ehde et al., 2000).  
Ideas on physiological processes contributing to pain (i.e. the mechanisms of pain) progressed from 
Descartes’s Model with the publication of the Melzack and Wall (1968) Gate Control Theory. This 
theory introduced the role of the dorsal horn of the spinal cord acting as a relay station, facilitating 
or inhibiting signals between the periphery and the brain. Transmission of these ‘signals’ is referred 
to as nociception, which is the “neural process of encoding noxious stimuli” (Merskey and Bogduk, 
1994). The Gate Control Theory was one of the first pain models to explain that pain is not directly 
proportional to tissue damage and can be influenced by psychological variables (Melzack, 1996). 
However, this model still does not account for persistent pain without tissue damage. 
More recently, the Pain Neuromatrix model was proposed (Melzack, 2001). This model describes 
pain as being a multidimensional experience produced by specific "neurosignatures”: neural activity 
patterns in a widely distributed area of the brain (Melzack, 2001). This model does not rely on 
nociceptive input from the peripheries for pain to be perceived; it accounts for pain without tissue 
damage. In this understanding of pain, nociception from the peripheries is only one aspect which 
may contribute to pain. Other psychological and physical stressors can activate the pain neuromatrix 
and result in pain without any peripheral input. However, the Pain Neuromatrix model has been 
criticised as being unfalsifiable and therefore of limited scientific utility (Griffin and Tsao, 2012). 
Clearly, the mechanisms underlying pain and its persistence are complex. There is a need for an 
improved understanding of these mechanisms to alleviate the burden of persistent pain to the 
individual, their community and society. The burden of persistent pain will be discussed next. 
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Neuropathic is common, poorly understood and poorly managed  
The prevalence of neuropathic pain - “pain caused by a lesion or disease of the somatosensory 
nervous system” (Merskey and Bogduk, 1994) - has been estimated to be between 6.9 – 10% in the 
general population (Van Hecke et al., 2014). However, wide variations in samples, settings, study 
methodology and the quality of studies investigating the prevalence of neuropathic pain make 
pooling of prevalence data difficult (Van Hecke et al., 2014). It has been proposed that reported 
prevalence data underestimates the true burden of neuropathic pain (Van Hecke et al., 2014).  
Importantly, prevalence of a disease does not provide insight into the impact of the disease on the 
individual, their community and society. Therefore, it is important for researchers, clinicians and 
health policy makers to not merely know the prevalence of neuropathic pain but to also understand 
the impact of neuropathic pain. Neuropathic pain substantially impacts people’s quality of life, 
preventing participation in meaningful life roles, disturbing sleep (Gore et al., 2005) and contributing 
to mental health issues such as depression and anxiety (Jain et al., 2011). Furthermore, it burdens 
the health sector and substantially increases countries’ health expenditure (Burke et al., 2017, 
Gierthmühlen and Baron, 2016).  
Neuropathic pain is difficult to treat and often requires multiple therapeutic agents to achieve 
effective pain relief: only 30 – 40% of patients report satisfaction with monotherapy (Cruccu, 2007). 
Despite extensive research into therapeutic agents for neuropathic pain, a systematic review and 
meta-analysis reported that the numbers needed to treat to achieve a 50% reduction in pain severity 
were between 4 – 8 for first line pharmacological agents (Finnerup et al., 2015). Therefore, there is a 
clear need for improved understanding of the mechanisms of neuropathic pain to allow for the 
development of improved treatments directly targeting the pathology. 
One mechanism underlying neuropathic pain may be structural and functional neuroplastic changes 
within the dorsal horn of the spinal cord, referred to as central sensitisation. These neuroplastic 
changes cause enhanced synaptic strength at the dorsal horn of the spinal cord. This enhanced 
synaptic strength is referred to as spinal long-term potentiation (LTP) (Ruscheweyh et al., 2011). 
Spinal LTP is the amplification and prolongation of an afferent signal at the dorsal horn in the spinal 
cord (Nickel et al., 2012). These neuroplastic changes result in increased sensitivity to painful stimuli, 
termed hyperalgesia and increased sensitivity to non-painful stimuli, termed allodynia (Merskey and 
Bogduk, 1994).  
Spinal LTP, and therefore the presence of neuroplastic changes in the dorsal horn, can be assessed 
using three different outcomes: allodynia (increased sensitivity to a normally non-painful stimulus), 
primary hyperalgesia (increased pain to a normally painful stimulus within the area of tissue 
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damage) and secondary hyperalgesia (SH) (increased pain to a normally painful stimulus in the area 
surrounding the tissue damage) (Merskey and Bogduk, 1994). These three outcomes are common 
clinical findings in patients with chronic pain and are therefore frequently assessed in experimental 
pain research.  
Experimental pain research  
Experimental pain research is commonly used to improve researchers’ understanding of pain 
mechanisms and to find improved treatment strategies to relieve pain suffering. In experimental 
pain research specifically investigating the mechanisms of neuropathic pain, neuroplastic changes 
are frequently experimentally induced. Specifically, a human surrogate model of SH – that is, a short-
lived expression of SH that has been induced under controlled conditions in a laboratory – is 
commonly used in mechanistic experimental research on neuropathic pain (Klein et al., 2005).  
There are many methods of experimentally inducing secondary hyperalgesia, including but not 
limited to burn injury (Salomons et al., 2014), high-frequency electrical stimulation (Henrich et al., 
2015), low-frequency electrical stimulation (Klein et al., 2004), and intradermal and topical capsaicin 
(Serra et al., 2004). Furthermore, recent research has shown that SH can be manipulated (i.e. the 
magnitude of SH can be increased or decreased) with pharmacological modalities such as ketamine 
(Andersen et al., 1996), and non-pharmacological modalities such as cognitive behavioural therapy 
(Salomons et al., 2014). One of the aims of this thesis is to investigate the non-pharmacological 
methods used to manipulate experimentally induced SH (discussed in Chapter 2). 
There are many benefits of conducting laboratory-based pain experiments. First, experimental pain 
research is ‘clean’ and controlled, for example sensation and pain ratings would be assessed at 
specific time points with specific equipment. Second, researchers can individually select and 
manipulate different variables such as the nature, localisation, intensity and frequency of the pain 
stimulus (Arendt-Nielsen et al., 2007). Third, a validated and reliable method of sensory testing 
called Quantitative Sensory Testing (Geber et al., 2011) has been developed, allowing for 
standardised assessment of specific outcomes, such as allodynia, and primary and secondary 
hyperalgesia. Standardised assessment of outcomes allows for accurate comparison across the 
literature base. Fourth, experimental pain research allows researchers to selectively add 
psychological manipulations, such as an emotional disclosure intervention (You et al., 2014) or 
cognitive behavioural therapy (Salomons et al., 2014), to investigate how these psychological 
manipulations may influence pain processing and/or pain itself. Lastly, experimental pain research 
with healthy human participants helps to bridge the gap between animal studies and clinical trials. 
4 
 
Commonly, research findings from animal studies are investigated in experimental studies on 
healthy humans before clinical trials are conducted (Arendt-Nielsen et al., 2007).  
Although experimental pain research can be useful for researchers to gain insight into the 
mechanisms of pain, it has some limitations. Pain studies are subject to sampling bias: people who 
volunteer for pain studies may not be representative of the general population (Karos et al., 2018). A 
recent study compared the characteristics of volunteers for a pain-related study to those of 
volunteers for a non-pain related study (Karos et al., 2018). Volunteers for the pain-related study 
displayed higher levels of sensation seeking than volunteers for the non-pain related study. 
Additionally, low fear of pain and older age predicted the likelihood of someone volunteering for a 
pain-related study. Karos et al. (2018) proposed that individuals who display protective behaviours 
may be less likely to participate in pain-related studies. Another limitation of experimental pain 
research is that it often focuses solely on the sensory dimension of pain and naïvely disregards the 
affective dimension of pain. Pain is defined as “an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage, or described in terms of such damage” (Merskey 
and Bogduk, 1994). This definition explains that pain is not merely a biological sensory experience. 
Instead, pain also has an affective-motivational dimension (Price, 2000). The affective-motivational 
dimension encompasses the unpleasantness of pain and the motivational drive to do something 
about it (Talbot et al., 2019). It has been argued that assessing the severity of a pain stimulus with a 
numerical scale does not adequately assess the entire pain experience (Pryseley et al., 2009). A 
recent systematic review concluded that the sensory dimension cannot be selectively modulated by 
cognitive manipulations, but it may be possible to selectively modulate the affective dimension; 
however, evidence for this is weak (Talbot et al., 2019). Additionally, it was argued that it may be 
easier to selectively modulate the affective dimension in an experimental pain study than in a clinical 
setting. This may be due to pain being short-lived, unlikely to cause tissue damage and participants 
are aware that they can withdraw from the study at any time during an experimental pain study, 
thus decreasing the threat value of the situation (Price et al., 1987). It is important for researchers to 
be mindful of these limitations when designing and conducting experimental pain research.       
The benefits and limitations of experimental pain research were taken into consideration when 
designing and conducting the experiment (discussed in Chapter 3) for this thesis. This author was 
interested in gaining further insights into the influence of threat on pain. Specifically, an aim for this 





Threat is associated with increased pain  
Pain is known to be influenced by the threat value of the stimulus (Arntz and Claassens, 2004, Wiech 
et al., 2010a). In experimental research, participants report increased pain if they are informed the 
stimulus will be of high intensity (Moseley and Arntz, 2007). The extent to which a person feels 
threatened that a stimulus can cause tissue damage is subjective (Arntz and Claassens, 2004). 
Overall, threat is known to influence pain. What is less clear is the mechanism by which it achieves 
that influence. This author speculates that the mechanisms by which threat influences SH may be by 
descending facilitation, i.e. upregulation of nociception from the spinal cord to the brain. However, 
there is insufficient evidence to conclude this speculation accurate now. Threat may influence SH 
through a change in descending inhibition, or something entirely supratentorial. 
There is well-established research investigating descending inhibition, that is cortical regions 
inhibiting nociception from the spinal cord, resulting in decreased pain severity (Suzuki et al., 2004). 
This forms a strong basis for many pharmacotherapies for pain, e.g. opioid medications. Cortical 
regions have also been reported to contribute to descending facilitation, i.e. upregulation of 
nociception from the spinal cord to the brain (Porreca et al., 2002, Urban and Gebhart, 1999, Ren 
and Dubner, 2002). Descending facilitation has been thought to contribute to the maintenance of SH 
(Urban and Gebhart, 1999) – a spinal cord driven phenomenon. Included in this thesis (in Chapter 3) 
is an experimental study investigating the effect of threat on experimentally induced secondary 
hyperalgesia. Specifically, this project aims to build on the work by Wiech et al. (2010a) by testing 
the effects of a threat manipulation (using a similar sham skin integrity test) on experimentally 
induced SH in healthy humans. A thorough understanding of how threat may influence spinal 
processing of nociception will allow for improved targeting of novel therapeutic interventions to 
decrease pain. Investigating the effect of threat has not been done within a South African context. 
Insight into the effects of threat on SH within a South African context is important because many 
South Africans live under threatening circumstances and many suffer from chronic pain. Research 
into the association between threat and chronic pain may help with the development of improved 
treatment modalities for chronic pain, specific to people living in threatening environments.  
Contextual setting relevant to South Africa  
The available data suggest that the prevalence of pain in the developing world is similar to that in 
the developed world. Data obtained from countries participating in the World Mental Health Surveys 
report the prevalence of chronic pain being 41.1% in developing countries and 37.3% in developed 
countries (Tsang et al., 2008). Importantly, the prevalence of chronic pain in South Africa was higher 
than the average for developing countries, with approximately half (51.8%) of the population 
reporting chronic pain within the 12 months prior to the survey being conducted. Furthermore, 
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musculoskeletal conditions resulting in pain are commonly reported at clinics in South Africa and can 
often be debilitating (Parker and Jelsma, 2010).  Of those attending two clinics in under-resourced 
areas in Cape Town, South Africa, 36% were seeking care for peripheral and spinal joint pain (Parker 
and Jelsma, 2010). Despite the high prevalence of pain in South Africa, not enough resources are 
being pooled to address this major health concern (Louw et al., 2007). Instead, the focus of many 
researchers and healthcare professionals in South Africa is on infectious diseases due to the huge 
burden they place on the healthcare system (Parker and Jelsma, 2010). Importantly, prevalence data 
do no provide insight into the burden of the disease. For example, a disease could be highly 
prevalent but not be burdensome to the individual, their community and society. This is not the case 
with chronic pain. Chronic pain is burdensome in South Africa. It severely limits function and 
increases disability: back and neck pain is the second greatest cause of years lived with disability in 
Southern Sub-Saharan Africa, second only to HIV (Institute for Health Metrics and Evaluation, 2017). 
Therefore, it is vital that research on the topic of chronic pain is conducted to address this potential 
national health crisis. Research into the mechanisms of chronic pain is required to assist with the 
development of improved treatment modalities.  
Furthermore, many South Africans live under constant threat: less than a third (31.8%) of South 
Africans feel safe walking alone at night (Statistics South Africa, 2019). This constant threat may be 
perpetuating the pain problem in South Arica. However, there is no research investigating the 
relationship between threat and pain in the South African setting. The magnitude of the pain 
problem in South Africa may be due to a limited understanding of pain mechanisms and the 
potential influence of threat such that optimising clinical treatment is difficult (Breivik et al., 2013, 
Briggs et al., 2015). A thorough understanding of these mechanisms will inform improved treatment 




Terminology: neuropathic vs nociplastic 
Neuroplastic changes have recently been termed ‘nociplastic’. Nociplastic pain is defined as “pain 
that arises from altered nociception despite no clear evidence of actual or threatened tissue damage 
causing the activation of peripheral nociceptors or evidence for disease or lesion of the 
somatosensory system causing the pain” (International Association for the Study of Pain, 2017). 
Prior to the development of this new terminology, the term ‘neuropathic’ pain was used to describe 
these neuroplastic changes. Neuropathic pain refers to frank damage to the nervous system 
(Merskey and Bogduk, 1994). This author argues that the ‘nociplastic’ rather than ‘neuropathic’, 
more accurately describes the neuroplastic changes induced in some experimental pain studies. This 
is because: 1) experimental pain studies that use modalities such as high-frequency electrical 
stimulation (a modality used in this study and outlined in Chapter 3 of this thesis) induces 
neuroplastic changes at the dorsal horn of the spinal cord without any tissue damage, and 2) often 
participants in experimental study are healthy and have no evidence for disease or lesion of the 
somatosensory system. However, ‘nociplastic’ has been criticised by the scientific pain community 
for being vague, imprecise and unhelpful for health professionals’ clinical reasoning and for 
experimental pain research (Aydede and Shriver, 2018, Granan, 2017). A limitation with using 
‘nociplastic’ that is specific to this thesis is that the definition outlines “no clear evidence of actual or 
threatened tissue damage”. An aim of this thesis was to investigate effects of a threat manipulation 
on experimentally induced SH (discussed in Chapter 3). This threat manipulation was focused on 
inducing threat of tissue damage. Therefore, nociplastic is an inaccurate term for this study. 
Additionally, since nociplastic is a relatively new term, all published experimental studies inducing 
short-lived neuroplastic changes used the term ‘neuropathic’ when referring to pain elicited by these 
neuroplastic changes. Therefore, for the sake of clarity and succinctness, the term neuropathic pain, 




Overview of thesis chapters 
The remainder of this thesis is presented in three chapters:  
Chapter 2: Systematic review. This systematic review critically appraises the literature base 
investigating non-pharmacological methods used to manipulate experimentally induced secondary 
hyperalgesia. Originally, the protocol for this systematic review included summarising all methods – 
non-pharmacological and pharmacological – used to manipulate experimentally induced secondary 
hyperalgesia. However, for the scope of this thesis, only data pertaining to non-pharmacological 
methods used to manipulate experimentally induced SH will be reported. The reasoning behind this 
decision was two-fold: Firstly, a non-pharmacological manipulation (a threat stimulus) was used to 
manipulate experimentally induced SH in the experimental study presented in Chapter 3 of this 
thesis. Therefore, it was appropriate to focus the systematic review on non-pharmacological 
manipulations. Secondly, a very large number (n = 137) of studies using pharmacological methods to 
manipulate SH was identified in the review search. Two systematic reviews – one using non-
pharmacological manipulations only and one using pharmacological manipulations only – will be 
completed and published separately. However, this thesis focuses on studies using non-
pharmacological manipulations.  
Chapter 3: Experimental study. Chapter 3 presents a laboratory-based experimental study 
investigating the effects of a threat manipulation, as a non-pharmacological method, to manipulate 
experimentally induced SH in healthy human volunteers. 
Chapter 4: Conclusion. This chapter summarises key findings from this project and proposes ideas for 




Chapter 2: Systematic literature review  
Introduction   
Neuropathic pain is prevalent and hinders good quality of life. The prevalence of neuropathic pain 
varies among different population groups: it is estimated to be between 6.9 – 10% in the general 
population1 (Van Hecke et al., 2014), 38% in patients with HIV (Ellis et al., 2010) and as high as 53% 
in patients with spinal cord injuries (Burke et al., 2017). As discussed in Chapter 1, neuropathic pain 
substantially impacts people’s quality of life (Gore et al., 2005, Jain et al., 2011) and burdens the 
health sector and increases countries’ health expenditure (Burke et al., 2017, Gierthmühlen and 
Baron, 2016).  
Neuropathic pain is often misdiagnosed (Dieleman et al., 2008), under-treated (Torrance et al., 2013) 
or not managed with the latest evidence-based treatments (Dworkin et al., 2012). This poor 
management and high prevalence of neuropathic pain has driven a 66% increase in published trials 
between 2005 and 2010 investigating pharmacological treatments for neuropathic pain (Finnerup et 
al., 2010). However, despite this increase in research, neuropathic pain still often responds poorly to 
pharmacotherapy (Torrance et al., 2013). 
There is a growing body of research investigating non-pharmacological treatments for neuropathic 
pain. Non-pharmacological treatments such as cognitive behavioural therapy (Evans et al., 2003), 
physical exercise (Dobson et al., 2014), invasive and non-invasive cortical stimulation (Moisset and 
Lefaucheur, 2019), and graded motor imagery (Bowering et al., 2013) have been reported to 
decrease symptoms of neuropathic pain. However, research into non-pharmacological treatments is 
limited, and often generates conflicting data. More research is required to provide a comprehensive 
evaluation of different non-pharmacological treatments for neuropathic pain.  
There is a clear need for improved pharmacological and non-pharmacological treatment modalities 
to manage neuropathic pain. But first, an improved understanding of the mechanisms of 
neuropathic pain is needed to inform the development of improved treatment modalities.  
Secondary hyperalgesia is a common feature of neuropathic pain and can be induced experimentally 
in a laboratory setting. Mechanistic experimental research on neuropathic pain frequently uses 
human surrogate models of SH - that is, a short-lived expression of SH that has been induced under 
controlled conditions in a laboratory. As discussed in Chapter 1, a variety of methods have been 
used to experimentally induce SH in humans, including but not limited to high-frequency electrical 
 
1 In this systematic review, “general population” included people diagnosed with postherpetic neuralgia, 
Herpes Zoster Virus, painful diabetic peripheral neuropathy, trigeminal neuralgia and/or glossopharyngeal 
neuralgia, as well people with no medical diagnoses.  
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stimulation (van den Broeke and Mouraux, 2014, Pfau et al., 2011), low-frequency electrical 
stimulation (Torta et al., 2019), topical capsaicin application (You et al., 2016), intradermal capsaicin 
injection (Baron et al., 1999) and burn injury (Wahl et al., 2019). The value of experimentally 
inducing SH is that the effect of different pharmacological and non-pharmacological interventions 
can then be explored. Experimentally induced SH can be manipulated (i.e. the magnitude of the SH 
can be increased or decreased) with both pharmacological and non-pharmacological modalities. 
Pharmacological modalities such as ketamine (Andersen et al., 1996) and non-pharmacological 
modalities such as cognitive behavioural therapy (Salomons et al., 2014) have been reported to 
decrease the intensity of secondary hyperalgesia. Non-pharmacological modalities such as negative 
suggestion have been reported to increase the intensity of SH (van den Broeke et al., 2014). A 
thorough examination of the effects of different pharmacological and non-pharmacological 
modalities used to manipulate experimentally induced SH is expected to shed light on the 
mechanisms of neuropathic pain and help with the development of improved treatment modalities. 
As far as this author is aware, there are no published reports of a systematic appraisal of methods 
used to manipulate experimentally induced secondary hyperalgesia. The aim for this study was to 
systematically identify, collate, and describe all the published studies that have applied non-
pharmacological2 manipulations intended to influence experimentally induced SH in healthy human 
participants.  
Aims  
The aim of this review was to systematically identify, collate, and describe all the published studies 
that have applied non-pharmacological manipulations intended to influence experimentally induced 
SH in healthy human participants. In doing so, this author hopes to provide a resource that will 
summarise the literature to date, provide pooled effect size estimates where possible, and identify 
gaps in knowledge and opportunities for further inquiry. Therefore, the primary aim of this 
systematic review was to identify, describe, and compare methods that have been used to 
manipulate experimentally induced SH in healthy humans.  
  
 
2 Systematic review of studies that used pharmacological manipulations was out of the scope of this thesis and 




1. To identify methods used to manipulate secondary hyperalgesia;  
2. Describe each method in terms of procedure, essential equipment required, pain reported 
by participants during induction3 and manipulation of SH and reported harm in studies using 
each method; 
3. Determine the effect of each manipulation on:  
a. The magnitude of static mechanical SH (i.e. intensity of SH) 
b. The surface area affected by static mechanical SH (i.e. area of SH). 
Methods  
A systematic review and meta-analysis were planned and conducted, following the guidelines 
outlined by the Cochrane Collaboration (Higgins and Green, 2011). The protocol was peer-reviewed 
and published in the journal Systematic Reviews (Madden et al., 2019c) (Appendix 1). 
Eligibility criteria  
Types of studies  
Prospective experimental studies were included, that is, studies that attempted to manipulate SH for 
the purpose of studying the effects of the manipulation on experimentally induced SH, and that did 
so in the context of an experiment, such that the SH was not a naturally occurring clinical 
phenomenon. In other words, participants must have begun the study without any SH present. 
Studies must have assessed SH within 120 minutes after induction (so as not to miss the anticipated 
peak of the effect). Published and in-press or accepted records for which title, abstract, and full-text 
versions were available in English were eligible for inclusion. 
Types of study participants 
Only data from healthy human participants were included. No restrictions were placed on the age of 
participants and data from adults were to be treated separately from data from children (< 18 years 
old). However, all included studies enrolled adult participants only.  
  
 
3Pain during induction of SH was not reported in the protocol. Thus, there was a deviation from the protocol 
because this objective was added after the protocol was published to provide more information on the 
induction procedures.  
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Types of interventions 
Data were included from experimental studies that aimed to manipulate SH (defined as “increased 
pain from a stimulus that normally provokes pain” (Merskey and Bogduk, 1994) in an area adjacent 
to the stimulated area). Studies that manipulated SH as one step in a larger study were considered 
eligible, provided that suitable baseline/control data were available to allow for estimation of the 
effect of the manipulation on secondary hyperalgesia. 
Types of outcome measures 
Pain was defined as “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage” (Merskey and Bogduk, 1994). Pain 
must have been measured by subjective self-report. Therefore, studies must have assessed the 
subjective (participant-reported) intensity of pain or sensation to somatosensory stimulation. 
Primary outcome 
The primary outcome was intensity of SH. Studies must have assessed mechanical SH (specifically, 
participants’ self-report to punctate mechanical stimulation) applied to the area surrounding the 
induction site. Further, in order to qualify as “hyperalgesia”, the post-manipulation assessment must 
have been compared to a within-subject control site (e.g. opposite limb on which induction but not 
manipulation was performed) or time point (e.g. after induction but before manipulation or, in the 
case of repeated inductions, to the same induction procedure performed without manipulation) or a 
between-subject control (e.g. group that underwent induction without the manipulation). 
Secondary outcomes 
• Surface area of SH, as measured using reproducible methods (such as a radial lines approach 
(You et al., 2016, Henrich et al., 2015, Andersen et al., 1996). 
• Time course of SH. 
• Pain (except to test stimulation) reported during and after manipulation procedure.  
• Pain (except to test stimulation) reported during and after induction procedure (this was not 
initially a secondary outcome listed in the protocol. It was added to provide more 
information on the induction procedures.). 







The following electronic databases were searched (on 24 June 2019 and rerun on 01 October 2019) 
with a strategy that spans the time from their inception to the date of the search: 
• Biosis (via Web of Science) 




• Cochrane library 
• Web of Science Core (use to search and then use menu on left to filter for Core option and 
Biosis) 
Initially, ScienceDirect was include in the list of databases outlined in the protocol. However, it was 
subsequently omitted after discussion with an experienced librarian at the Health Sciences Library, 
University of Cape Town. The reason for this deviation from the protocol was because all content of 
ScienceDirect is included in Scopus.  
The search strategy was: 
((“human*” OR “women” or “woman” OR “man” OR “men” OR “participant*” OR “volunteer* OR 
individual*”) 
OR 
“normal skin” OR “healthy skin”) 
AND 
(“secondary hyperalgesia” OR “punctate hyperalgesia” OR “pinprick pain” OR “pinprick hyperalgesia” 
OR “mechanical hyperalgesia” OR “mechanical pain” OR “heat hyperalgesia” OR “neurogenic 
hyperalgesia”)) 
with all terms searched for in the title, keywords, or abstract. 





Reference lists of eligible studies were screened to check for other eligible studies not identified by 
electronic searching. Experts in the field, and the corresponding authors of the most recent narrative 
reviews on experimental induction and manipulation of secondary hyperalgesia, were contacted to 
ask for their assistance in identifying any missed studies (including Walter Magerl, Rolf Baron, Jürgen 
Sandkühler, Mark Wallace, Peter Drummond, Emmanuel van den Broeke). The protocol specified 
that unpublished data would be requested from labs that have published extensively on these 
techniques, including data obtained during model develop or optimisation. However, this step was 
deemed to fall outside the scope of the current thesis and therefore is not reported here.  
Data collection and analysis 
Data management  
Originally, the protocol specified the use of the online Systematic Review Facility (http://syrf.org.uk/) 
to manage the review process. However, this platform proved unnecessarily complicated to work 
with: there were difficulties with viewing how many studies were included and excluded at 
title/abstract screening and full-text screening, and the reasons for exclusion were not clearly 
displayed on this platform. Therefore, the authors opted to deviate from the protocol and use the 
Covidence (https://covidence.org/) online software to manage the review process.  
Study selection  
Two reviewers (GJB and PCC)4 independently screened each identified record for eligibility in two 
sequential stages, screening (Stage 1) title and abstracts and (Stage 2) full texts. Initially, three 
reviewers had planned to undertake the screening process independently. However, time 
constraints led to a deviation from the protocol and only two reviewers undertook the screening 
process. A customised eligibility form (Table 1) was used to record decisions in Stage 2. Any 
disagreements about study inclusion were resolved by discussion or by adjudication from a third, 
independent reviewer (VJM)5.  
  
 
4 The two reviewers were Gillian J. Bedwell (this current author) and Prince C. Chikezie. GJB is associated with 
the Department of Health and Rehabilitation Sciences, University of Cape and the Pain Unit, Department of 
Anaesthesia and Perioperative Medicine, Neuroscience Institute, University of Cape Town, D23.30 Groote 
Schuur Hospital, Observatory, Cape Town 7925, South Africa Town, Cape Town, South Africa. PCC is associated 
with School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South 
Africa. 
5 The third, independent reviewer was Victoria J. Madden. VJM supervised this project and is associated with 
the Pain Unit, Department of Anaesthesia and Perioperative Medicine, Neuroscience Institute, and the 
Department of Psychiatry and Mental Health, University of Cape Town, D23.30 Groote Schuur Hospital, 
Observatory, Cape Town 7925, South Africa Town, Cape Town, South Africa 
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Table 1 Inclusion/exclusion criteria and grouping table 
 Inclusion  Exclusion  
Participants  Pain-free, healthy 
humans  




Used an experimental 
procedure with the aim 




(identifiable goal AND 




Review (set aside for cross-
checking) 
OR 




manipulation procedure  
Outcomes  Pain or sensitivity to 
provocation assessed 
subsequent to induction 
AND manipulation  
Acceptable: pain yes or 
no, self-report of 
intensity, quality, pain 
threshold 





or psychophysiology in 
absence of self-report 
Include 
(yes/no) 
Tick in every box above: 
include  
Tick in any box above: 
exclude  
Review (reference lists of 
reviews were screened for 
studies that may have 
been missed by the 
electronic search. Reviews 
were not eligible for 





Risk of bias analysis  
A risk of bias assessment was completed for each study by two reviewers6 (GJB and FS), 
independently. A thorough risk of bias assessment is necessary to assess the quality of the methods 
and identify potential flaws in the data that might contribute to the results being unreliable for the 
purposes of answering the question of the current review (Lundh and Gøtzsche, 2008). Reviewers 
appraised the risk of bias for the domains of selection, performance, detection, attrition, 
measurement, reporting, and other sources of bias. The criteria used to rate the risk of bias were 
based on recommendations from the Cochrane collaboration (Higgins et al., 2011) known quality 
instruments (e.g. the CONSORT (Moher et al., 2010) and STROBE (Vandenbroucke et al., 2007) 
statements as relevant) and on known areas of bias relevant to the study design used (Sanderson et 
al., 2007), and were specified in the risk of bias assessment tool and guide (Appendices 2 and 3 ). 
Reviewers piloted the form on three studies and adapted it prior to formal application to all included 
studies. The focus of the risk of bias assessment was on the risk that the data to be extracted to 
answer the questions of this review could be biased. The appraisals of the two independent 
reviewers were compared and any disagreements resolved through discussion and consensus.  
Data extraction  
Two reviewers (GJB and FS) independently extracted data from each included study, using a 
standardised data extraction form (Appendix 4). The data extraction form was piloted and refined 
using three studies before formal data extraction commenced. Study authors were contacted a 
maximum of three times to obtain required data that were unavailable or unclear from the 
published texts. If no reply was received within six weeks, the data were considered unavailable. If 
the relevant data were not provided within six weeks of the first reply, the data were considered 
unavailable for this review. Any published data that seemed implausible was verified directly with 
the corresponding author where possible.  
Data analysis  
Data were analysed to 1) determine the potency of each manipulation method, 2) pool and compare 
data where possible and sensible, 3) facilitate relative ranking of interventions, and 4) detect 
publication bias. Data from studies that assessed intensity of SH were handled separately from those 
that assessed area of SH.  
  
 
6 The two reviewers conducting the risk of bias assessment and the data extraction were Gillian J. Bedwell (this 
current author) and Felicia Siboza. FS is associated with School of Physiology, Faculty of Health Sciences, 
University of the Witwatersrand, Johannesburg, South Africa.  
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Rescaling of ratings scales  
A wide variety of ratings scales used to assess severity of pain are used in pain research studies. The 
most common ratings scales are the 0 – 10 and the 0 – 100 scales, where 0 = no pain and 10/100 = 
worst pain imaginable. To allow for descriptive comparison across ratings data, all pain ratings from 
0 – 100 ratings scales were rescaled to 0 – 10, by dividing by 10.  
Pooling of data  
Data were pooled where possible and sensible, by grouping by outcome (i.e. intensity and area of 
SH), and subgrouping by class of manipulation. The outcome measure used was the standardised 
mean difference. A random effects model was used to allow for anticipated heterogeneity between 
studies. The RevMan software (Review Manager, 2014), version 5.3, was used to pool data and 
generate forest plots.  
Relative ranking of manipulations   
The protocol outlined that if the quantity and quality of data allowed, the pooled effect sizes (where 
available) would be compared to rank the different manipulations in the order of potency and risk.  
Publication bias  
The protocol outlined that funnel plots would be examined for publication bias.  
Measures of manipulation effects  
The potency of each manipulation was estimated by comparing the post-manipulation outcomes 
with the pre-manipulation outcomes and/or a control site/condition/group to generate a mean 
difference between post-manipulation (or with-manipulation) outcomes and pre-manipulation (or 
without-manipulation) outcomes, where possible. The standardised mean difference was used to 
measure manipulation effects because the standardised mean difference is recommended for 
continuous data where difference scales have been used. If all ratings scales were exactly the same 
among the included studies, the mean difference would have been more appropriate to use (Higgins 
and Green, 2011). 
The protocol outlined subgrouping the studies into manipulations with localised effects, systemic 
effects and time-limited effects for determining the potency of manipulation methods. However, 
after careful consideration this author opted to deviate from the protocol and instead subgroup by 
the hypothesised direction (i.e. increase or decrease) of manipulation effect on 1) intensity and 2) 
area of SH. An aim for the outcome of this review is to provide readers with an improved 
understanding of the mechanisms of SH. Subgrouping by hypothesised direction of manipulation 
effect provides a more comprehensive overview of the effects of the manipulation on intensity and 
area of SH than the previously planned subgroups.  
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Assessment of the quality of body of evidence  
The quality of the body of evidence for each manipulation was assessed using the GRADE criteria 
(Guyatt et al., 2008) and the GRADEpro GDT software (www.gradepro.org). The quality of the body 
of evidence was estimated for each outcome, where more than one study was available for a certain 
manipulation. The assessment was determined based on the following four factors:  
1) Risk of bias, i.e. is there a low risk of bias associated with the study design?  
2) Indirectness, i.e. does the data directly answer the research question?  
3) Inconsistency, i.e. are the results consistent across all studies?  
4) Imprecision, i.e. are all results calculated and reported correctly?  
For each factor, studies are categorised as having ‘no’, ‘serious’ or ‘very serious’ limitations. Factors 
graded as having ‘serious’ limitations results in a downgrade of 1 level for the body of evidence. 
Factors graded as having ‘very serious’ limitations result in a downgrade of 2 levels for the body of 
evidence.  
Results  
Results of search  
An initial literature search (conducted on 24 June 2019) yielded a total of 4809 records, of which 
2251 remained after duplicates were removed. Thirty-one additional studies were identified – 30 
through rerunning the search (01 October 2019) and one through direct communication with 
experts in the field – resulting in a total of 2283 records included in title/abstract screening. The two 
reviewers independently identified 229 studies eligible for full text screening, with Cohen’s Kappa 
statistic (view working out in Appendix 5) revealing moderate agreement (0.47) between the two 
reviewers. After screening the full texts, a total of 153 studies were identified as eligible for inclusion 
in this review, with Cohen’s kappa coefficient (view working out in Appendix 5) revealing moderate 





Due to the large number of included studies, it was decided to sub-group the studies by 
manipulation: 1) pharmacological manipulations of SH and 2) non-pharmacological manipulations of 
SH. This subgrouping had not been planned in the protocol. Acknowledging that both 
pharmacological and non-pharmacological manipulations influence normal physiological functioning, 
we used the mode of administration to define the subgroups. For a study to be classified as having 
used a pharmacological manipulation, participants had to have received a chemical substance via 
ingestion, injection or topical administration. For example, nicotine deprivation in smokers would be 
considered a non-pharmacological manipulation because, although nicotine deprivation would 
influence normal physiological functioning, it does not involve ingestion, injection or topical 
administration of a chemical substance. Conversely, ingestion of a liquid containing a high 
concentration of lipids would be classified as a pharmacological manipulation. 
A large number (n = 137) of pharmacological studies were identified and included in this review. As 
outlined in Chapter 1, this thesis will focus on the studies that used non-pharmacological 
































included in quantitative 
synthesis  
(meta-analysis)  
n=18 articles and n= 21 studies 
Records identified through 
database searching  
n=4809 
Additional records identified 
after rerunning search  
n=30 
Additional records identified from 










Records excluded  
n=73 
Wrong outcome: n=30 
Protocol: n=29 
Full text not available in 
English: n=4 
Wrong study design: n=4 
Duplicate: n=3 
Unpublished: n=1 
No manipulation of 
secondary hyperalgesia: n=1 
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quantitative synthesis  
(meta-analysis)  
n=137 
Records screened  
n=2283 
Records excluded  
n=2055 
Full-text articles assessed 
for eligibility  
n=228 
Studies eligible for inclusion 
n=155 















Included studies  
Types of studies  
Eighteen articles reporting on non-pharmacological manipulations were eligible for this systematic 
review. Two articles reported on more than one study which were eligible for inclusion for this 
review: Torta et al. (2019) reported on three studies, of which two were eligible for inclusion in this 
review and Yucel et al. (2001) reported on three studies, of which all were eligible for inclusion in 
this review. Therefore, the total number of studies included in this review were 21. Table 3 
summarises the characteristics of the studies. The study designs included between-group (n=11) and 
within-subject comparisons (n=9). One study (van den Broeke et al., 2014) used both between-group 
and within-subject comparisons. Six studies using between-group comparisons were crossover 
studies and one study using within-subject comparisons was a crossover study.  
Participants  
A total of 698 participants (396 males, 302 females) were included in the 21 eligible studies. All 
participants were adults (> 18 years old). Age data could not be pooled because studies used a 
variety of statistical summaries for reporting age. Age has been reported individually per study in 
Table 3. Only one study included an obviously biased sample consisting of participants with a history 
of trauma (You et al., 2014). However, this biased sample was purposeful of their study design. 
Types of interventions  
Six different methods were used to induce SH: topical capsaicin (n=7), burn injury (n=6), intradermal 
capsaicin injection (n=4), low-frequency electrical stimulation (n=2),  high-frequency electrical 
stimulation (n=1) and topical high-concentration menthol (n=1). A variety of manipulations were 
used to influence the intensity and/or area of the experimentally induced SH: application of heat or 
cold (n=6); verbal suggestion, negative suggestion, and placebo analgesia (n=3);  hyperbaric oxygen 
therapy (n=2); modulation of attention or cognitive load (n=3); nicotine deprivation (n=1);  
transcranial direct current stimulation (n=1);  spinal manipulation (n=1);  acupuncture (n=1);  
cognitive behavioural therapy (n=1);  sleep disruption (n=1) and emotional disclosure (n=1). Table 4 





Most studies (12 of 21) assessed only the surface area of SH (Matre et al., 2006, Mohammadian et 
al., 2004, Meeker et al., 2019, Pud et al., 2006, Rasmussen et al., 2015, Salomons et al., 2014, Wahl 
et al., 2019, Yucel et al., 2001, Smith et al., 2018, Rebhorn et al., 2012)7. Five studies assessed both 
the intensity and surface area of SH (Baron et al., 1999, Ditre et al., 2018, Helfert et al., 2018, 
Werner et al., 2002, You et al., 2014). Four studies assessed the intensity of SH only (Kóbor et al., 
2009, Torta et al., 2019, van den Broeke et al., 2014)8.  
Adverse events  
No adverse effects were reported in any of the studies. Meeker et al. (2019) assessed the side 
effects of the manipulation (transcranial direct current stimulation) using a standardised 
questionnaire (Fregni et al., 2008). However, the results from this questionnaire were not reported, 
adding to the high risk of reporting bias outlined in the risk of bias assessment section below.  
Rasmussen et al. (2015) and Wahl et al. (2019) reported no adverse events to both induction (burn 
injury) and manipulation (hyperbaric oxygen therapy). As a precaution, Smith et al. (2018) excluded 
participants with a history of adverse reactions to capsaicin (induction method). However, three 
participants withdrew from the study because the pain from topical capsaicin induction was “too 
intense”.  The rest of the included studies (17 of 21) did not assess for adverse events after induction 
and manipulation.  
Rescaling of scales  
To assess change in sensation or pain, most (n = 12 of 21) studies reported using 0 – 10 rating scales 
(Baron et al., 1999, Ditre et al., 2018, Kóbor et al., 2009, Mohammadian et al., 2004, Rasmussen et 
al., 2015, Salomons et al., 2014, Wahl et al., 2019, You et al., 2014, Yucel et al., 2001, van den Broeke 
et al., 2014). Six studies reported using 0 – 100 rating scales with 0 = “no pain” and 100 = a version of 
the phrase worst pain imaginable (Matre et al., 2006, Pud et al., 2006, Rebhorn et al., 2012, Torta et 
al., 2019, Werner et al., 2002, Meeker et al., 2019). The remaining two studies did not report which 
ratings scale was used in their experiment (Helfert et al., 2018) or did not assess pain severity at any 
point in the experiment, therefore, no ratings scale was used (Smith et al., 2018). Table 2 
summarises the ratings scales used for each study, except Helfert et al. (2018) and Smith et al. 
(2018). To allow for comparability across ratings data, all ratings from 0 – 100 ratings scales were 
rescaled to 0 – 10, by dividing by a factor of 10.  
Table 2 Summary of pain and sensation ratings scales used in each study 
Study Scale used Anchors 
 
7 Reminder that Yucel et al., 2001 reported on three studies, all of which were included in this current review.  
8 Reminder that Torta et al., 2019 reported on three studies, of which two were included in this current review. 
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Baron et al. (1999) 
 
0 - 10 Anchors not reported 
Ditre et al. (2018) 0 - 10 0 = “no pain”  
10 = “pain as bad as you can imagine” 
Kóbor et al. (2009) 0 – 10 0 = “no pain”  
10 = “highest tolerable pain”  
Mohammadian et al. (2004) 0 - 10 0 = “no pain”  
10 = “intolerable pain” 
Rasmussen et al. (2015) 0 - 10 0 = “no pain”  
10 = “worst imaginable pain” 
Salomons et al. (2014) 0 - 10 0 = “no pain”  
10 = “most intense pain imaginable” 
Wahl et al. (2019) 0 – 10  0 = “no pain”  
10 = “worst imaginable pain” 
You et al. (2014) 0 – 10  0 = “no pain sensation”  
10 = “most intense pain sensation imaginable” 
Yucel et al. (2001) Experiment 1 0 – 10  0 = “no pain”  
10 = “most intense pain imaginable” 
Yucel et al. (2001) Experiment 2 0 – 10  0 = “no pain”  
10 = “most intense pain imaginable” 
Yucel et al. (2001) Experiment 3 0 – 10  0 = “no pain”  
10 = “most intense pain imaginable” 
van den Broeke et al. (2014) 0 – 10  0 = “no pain”  
10 = “unbearable pain” 
Matre et al. (2006) 0 - 100 0 = “no sensation” 
40 = “pain threshold” 
100 = “worst pain imaginable”. 
Pud et al. (2006) 0 - 100 0 = “no pain at all”  
100 = “the worst pain one can imagine” 
Rebhorn et al. (2012) 
 
0 - 100 Anchors not reported 
Torta et al. (2019) Experiment 1 0 - 100 0 = “no sensation” 
50 = “separating non-painful to painful” 
100 = “the most intense pain imaginable” 
Torta et al. (2019) Experiment 2 0 - 100 0 = “no sensation” 
50 = “separating non-painful to painful”  
100 = “the most intense pain imaginable” 
Werner et al. (2002) 0 - 100 0 = “no pain”  
100 = “the worst imaginable pain” 
Meeker et al. (2019) 
 






Table 3 Summary of included studies, grouped by outcome measurement (intensity of secondary hyperalgesia and area of secondary hyperalgesia) and sub-grouped by manipulation procedure. 
Outcome measurement: intensity of secondary hyperalgesia (n=9) 
Reference Study design Total sample size 
(male; female) 






Manipulation: heat or cold stimulation (n=2) 
Baron et al. (1999) Within-subject 
comparison 
10 (10;0) Not reported  Intradermal capsaicin Whole-body cooling and 
heating with a thermal 
suit. 
250 mN stiff von Frey 
filament.  
Werner et al. (2002) Within-subject 
comparison 
24 (24;0) Not reported  Burn injury  Local cooling  535 mN stiff von Frey 
filament 
Manipulation: nicotine deprivation (n=1) 
Ditre et al. (2018) Between-group 
comparison 
165 (94;71) Mean ± SD 
41.12 ± 12.66  
Topical capsaicin  Nicotine deprivation  300 g von Frey filament 
Manipulation: emotional disclosure (n=1) 
You et al. (2014) Between-group 
comparison 
78 (0;78) Mean ± SD 
With trauma history: 18.7 
(0.6) 
 
Without trauma history: 
18.8 (0.8) 
Topical capsaicin  Disclosure intervention  2.9 N Stiff von Frey filament  
Manipulation: verbal suggestions (n=1) 
Helfert et al. (2018) Crossover and between-
group comparison 
16 (16;0)  Mean (range) 
24 (20 – 29) 
Topical high-concentration 
menthol 
Verbal suggestion  128 mN pinprick stimulator 
Manipulation: modulation of attention or cognitive loading (n=3) 




19 (4:15) Median (range) 
22 (18 – 40) 
Low-frequency electrical 
stimulation  
Cognitive load using 
Eriksen Flanker test  
128 mN pinprick stimulator 




21 (11:10) Median (range) 
26 (19 – 36) 
Low-frequency electrical 
stimulation 
Cognitive load using 
modified version of an N-
back task 
128 mN pinprick stimulator 
Kóbor et al. (2009) Crossover and within-
subject comparison 
16 (11;5) Mean (range) 
22.9 (19 - 25) 
Heat-capsaicin model 
(topical) 
Attentional modulation  180 g and 300 g von Frey 
filament.  
 
Manipulation: negative expectation (n=1) 





30 (11;19) Mean (range) 
23.5 (18 – 59) 
High-frequency electrical 
stimulation 




Outcome measurement: area of secondary hyperalgesia (n=17) 
Manipulation: heat or cold stimulation (n=6) 
Baron et al. (1999) Within-subject 
comparison 
10 (10;0) Not reported  Intradermal capsaicin Whole-body cooling and 
heating with a thermal 
suit. 
"Stimulations were done 
along four linear paths 
arranged radially around 
the capsaicin-sensitised skin 
in steps of 5 mm at intervals 
of 1 sec.” Sensitivity was 
assessed with 250 mN stiff 
von Frey filament.   
Werner et al. (2002) Within-subject 
comparison 
24 (24;0) Not reported  Burn injury  Localised application of 
cold 
8 radial lines at 45° angles. 
Sensitivity was assessed 
with 535 mN stiff von Frey 
filament. 
Yucel et al. (2001) 
Experiment 1 
Within-subject  10 (7;3) Mean ± SD (range) 
25 ± 5.7 (21 – 30) 
 
Topical capsaicin Heat conditioning  “Starting in the periphery 
and along the vector 
towards the center of the 
injury”. Sensitivity was 
assessed using 75.9 g von 
Frey filament 
Yucel et al. (2001) 
Experiment 2 
Within-subject 10 (8;2) Mean ± SD (range) 
25 ± 4.2 (21 – 34) 
intradermal capsaicin 
injection   
Heat conditioning “Starting in the periphery 
and along the vector 
towards the center of the 
injury”. Sensitivity was 
assessed using 75.9 g von 
Frey filament 
Yucel et al. (2001) 
Experiment 3 
Within-subject 10 (7;3) Mean ± SD (range) 
25 ± 3.7 (21 – 34) 
Burn injury  Heat conditioning “Starting in the periphery 
and along the vector 
towards the center of the 
injury”. Sensitivity was 
assessed using 75.9 g von 
Frey filament 
Pud et al. (2006) Within-subject 
comparison 
14 (9;5) Mean (range) 
34.5 (20 – 35) 
Intradermal capsaicin  Localised application of 
cold  
6 radial lines at 60° angles. 
Sensitivity was assessed 
using 60.0 g von Frey 
filament. 
Manipulation: nicotine deprivation (n=1) 
Ditre et al. (2018) Between-group 
comparison 
165 (94;71) Mean ± SD 
41.12 ± 12.66  
Topical capsaicin  Nicotine deprivation  8 radial lines “radiating 
from the centre of the 
application site, forming 
eight concentric von Frey 
rings”. Sensitivity was 




Manipulation: emotional disclosure (n=1) 
You et al. (2014) Between-group 
comparison 
78 (0;78) Mean ± SD 
With trauma history: 18.7 
(0.6) 
 
Without trauma history: 
18.8 (0.8) 
Topical capsaicin  Emotional disclosure   8 radial lines at 45° angles. 
Sensitivity was assessed 
with 2.9 N Stiff von Frey 
filament. 
Manipulation: verbal suggestion (n=1) 
Helfert et al. (2018) Crossover and between-
group comparison 
16 (16;0)  Mean (range) 
24 (20 – 29) 
Topical high-concentration 
menthol 
Verbal suggestion  8 radial lines “arranged 
horizontally and vertically” 
at the site of induction. 
Sensitivity was assessed 
with 128 mN pinprick 
stimulator 
Manipulation: hyperbaric oxygen therapy (n=2) 
Rasmussen et al. (2015) Crossover and between-
group comparison 
17 (17;0) Mean (95% CI) 
27.6 (25.1 – 30.2) 
Burn injury  Hyperbaric oxygen 
therapy 
8 radial lines at 45° angles. 
Sensitivity was assessed 
using 895 mN polyamide 
nonfilament 
Wahl et al. (2019) Crossover and between-
group comparison  
19 (19;0) Median (95% CI) 
26.1 (24.7 – 28.8) 
Burn injury  Hyperbaric oxygen 
therapy 
8 radial lines at 45° angles. 
Sensitivity was assessed 
using 512 mN pinprick 
stimulator.  
Manipulation: placebo analgesia (n=1) 
Matre et al. (2006) Between-group 
comparison 
29 (17;12) Range  
20 - 45 
Burn injury Placebo analgesia  8 radial lines. Sensitivity 
was assessed using 84.4 
g/mm2 (pressure) von Frey 
filament.  
Manipulation: cognitive behavioural therapy (n=1) 
Salomons et al. (2014) Between-group 
comparison 
34 (18;16) Range 21 - 38 Burn injury   Cognitive behavioural 
therapy  
8 radial lines at 45° angles. 
Sensitivity was assessed 
using 256 mN von Frey 
filament. 
Manipulation: transcranial direct current stimulation (n=1) 
Meeker et al. (2019) Crossover and between-
group comparison 
27 (16;11) Mean (range) 
25 (20 – 35) 
Topical capsaicin  Transcranial direct current 
stimulation  
8 radial lines. Sensitivity 
was assessed using 128 mN 
pinprick stimulator. 
Manipulation: spinal manipulation (n=1) 




20 (14;6)  Mean (range) 
27 (21 – 37) 
Topical capsaicin Spinal manipulation  6 radial lines at 60° angles. 
Sensitivity was assessed 
using 20.9 g von Frey 
filament.  
Manipulation: acupuncture (n=1) 
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Rebhorn et al. (2012) Between-group 
comparison 
50 (50; 0) Mean (range) 
24.8 (20 – 30) 
Intradermal capsaicin  Acupuncture Sensitivity was assessed 
using 256 mN von Frey 
filament. Specific methods 
of assessing area were not 
reported. 
 
Manipulation: sleep disruption (n=1) 
Smith et al. (2018) Crossover and between-
group comparison 
79 (33;46) Mean ± SD 
27.18 ± 6.98 
Heat-capsaicin model 
(topical) 
Sleep disruption  8 radial lines. Sensitivity 
was assessed using 5.18 





Table 4 Summary of induction and manipulation methods. Studies have been pooled by manipulation methods. 
Reference Induction of secondary hyperalgesia Manipulation of secondary hyperalgesia 
 
 
















Manipulation: heat or cold stimulation (n=6) 















Not reported Cooling: 12°C, 
Heating: 50°C 
   
Werner et al. 
(2002) 
Burn injury Bilateral 
calf  
7 minutes 47 °C Localised 
application of cold 
30 minutes  8 °C    










1.5 g of 1% 
capsaicin 
cream 
Heat conditioning  2 minutes x 2 1st conditioning: 
39.2 ± 1.3 °C 
 
2nd conditioning: 
39.9 ± 2.8 °C  
   






Forearm  50 µg in a 
volume of 0.2 
ml 
Heat conditioning  2 minutes x 2 1st conditioning: 
40.9 ± 2.3 °C 
 
2nd conditioning: 
41.8 ± 2.9 °C  
   
Yucel et al. 
(2001) 
Experiment3 
Burn injury (and 
pre-heating) 
Forearm 7 minutes 47 °C Heat conditioning  2 minutes x 2 1st conditioning: 
40.1 ± 2.8 °C 
 
2nd conditioning: 
41.9 ± 1.8 °C. 
   




 50 µg/50µl 
capsaicin  
Localised 
application of cold 
Before and 8 
minutes after 
induction 




   
Manipulation: nicotine deprivation (n=1) 
Ditre et al. 
(2018) 










12 – 24 hours 
prior to 
experiment 
 Continued smoking   
Manipulation: emotional disclosure (n=1) 
You et al. (2014) Topical capsaicin Dominate 
volar 
forearm  
30 minutes  6% capsaicin 
solution (3g in 




20 minutes  "Were asked to 
write about the 
most traumatic 
Sham 20 minutes  "Were asked to 







Manipulation: verbal suggestions (n=1) 







20 minutes  1 mL aliquot 










contents of the 
substance used 
for induction 
   
Manipulation: attentional modulation and cognitive loading (n=2) 








2 minutes  2 Hz, pulse 






The task started 
90 seconds 





    








2 minutes  2 Hz, pulse 




Modified version of 
an N-back task 
The task started 
90 seconds 





    













  Low attentional 
load 
  
Manipulation: negative expectation (n=1) 
van den Broeke 






5 x 1 second 










 “After the HFS 
stimulation, 
your 
skin will become 
more sensitive 









   
30 
 
Manipulation: hyperbaric oxygen therapy (n=2) 
Rasmussen et 
al. (2015) 
Burn injury  Non 
dominant 
calf 
7 minutes  47° C Hyperbaric oxygen 
procedure 
90 minutes with 







Control conditions   ambient 
pressure, FIO2 = 
0.21 
Wahl et al. 
(2019) 
Burn injury Calf 7 minutes 47° C Hyperbaric oxygen 
procedure 
90 minutes with 







Control conditions  1ATA, FIO2 = 
0.21 
Manipulation: placebo analgesia (n=1) 
Matre et al. 
(2006) 
Burn injury  Medial 
volar arms 
5 minutes  46° C Placebo analgesia   Participants 
were informed 
that a magnet 
had analgesic 
properties.  




They were told 
that the aim of 
the study was to 
investigate the 
hypersensitivity 
of the skin to 
painful stimuli.  
Manipulation: cognitive behavioural therapy (n=1) 
Salomons et al. 
(2014) 
Burn injury   Left volar 
forearm 
28 minutes Individualised 
intensity: 
temperature 









rated ≤ 6/10 







5 minutes prior 




















their situation to 
Sham  “Trained in 
interpersonal 
effectiveness 



















benefits of the 
training (e.g. 
ability to cope 






training to cope 
with the painful 
experimental 
stimuli." 
Manipulation: transcranial direct current stimulation (n=1) 















20 minutes 1 mA Sham transcranial 
direct current 
stimulation  
20 minutes ‘” Ramped 
current up for 
30 s and then 
down for 30 sec 
and repeated 
for 20 min 
duration” 
Manipulation: spinal manipulation (n=1) 
Mohammadian 
et al. (2004) 
Topical capsaicin  Forearm  20 minutes  1% capsaicin, 
















and was applied 















and the subjects 






in the treatment 







Manipulation: acupuncture (n=1) 












25 lg dissolved 





20 minutes + 80 
minutes during 
procedure  
Sterile 0.30 x 30 
mm needles. 8 
positions in legs, 
arms and neck.  
























Manipulation: sleep disruption (n=1) 




































Risk of bias in included studies  
Table 5 summarises the risk of bias results. Most of the studies (11 of 21) were judged to have a high 
risk of bias overall; only one study (You et al., 2014) was judged to have a low risk of bias overall. The 
remaining nine studies were judged to have unclear risk of bias overall.  





























































































Baron et al. (1999)          
Ditre et al. (2018)          
Helfert et al. (2018)          
Kóbor et al. (2009)       N/A   
Matre et al. (2006)      N/A    
Meeker et al. (2019)      N/A    
Mohammadian et al. (2004)      N/A    
Pud et al. (2006)      N/A    
Rasmussen et al. (2015)      N/A    
Rebhorn et al. (2012)      N/A    
Salomons et al. (2014)      N/A    
Smith et al. (2018)      N/A    
Torta et al. (2019) Experiment 1       N/A   
Torta et al. (2019) Experiment 2       N/A   
van den Broeke et al. (2014)       N/A   
Wahl et al. (2019)      N/A    
Werner et al. (2002)          
You et al. (2014)          
Yucel et al. (2001) Experiment 1      N/A    
Yucel et al. (2001) Experiment 2      N/A    
Yucel et al. (2001) Experiment 3      N/A    
Green = low risk of bias, red = high risk of bias, and orange = unclear risk of bias. SH = secondary 
hyperalgesia. SA = area of secondary hyperalgesia 
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Selection bias  
Six studies (van den Broeke et al., 2014, Torta et al., 2019, Smith et al., 2018, Helfert et al., 2018, 
Rebhorn et al., 2012) were judged to be at low risk of selection bias. Most studies failed to screen 
participants for chronic and current pain and/or did not clearly explain their randomisation 
procedure. Importantly, Matre et al. (2006) and Meeker et al. (2019) reported excluding participants 
who did not develop SH after induction. Meeker et al. (2019) also excluded participants with large 
variances - “more than 25% increase or decrease in pinprick hyperalgesic area” - in hyperalgesia 
expression between testing sessions. For these reasons, both studies were judged to have a high risk 
of selection bias.  
Performance bias 
No studies were judged to be at low risk of performance bias. Most of the studies (17 of 21) failed to 
assess the effectiveness of their blinding procedure. Therefore, it was unclear whether there was 
performance bias or not. The rest of the studies (n=4) were judged to be at high risk of performance 
bias for reporting that participants were not blinded to group allocation and the research question. 
It was reported that blinding of participants to group allocation was not possible with studies using 
hyperbaric oxygen therapy for their manipulation (Rasmussen et al., 2015, Wahl et al., 2019), 
therefore high risk of performance bias was inevitable in these studies.  
Detection bias  
No studies were judged to be at low risk of detection bias. Most studies (17 of 21) did not clearly 
assess whether outcome assessors were blinded to the research question and whether the analysing 
researchers were blinded to group/site allocation of participants. Four studies (Werner et al., 2002, 
Rasmussen et al., 2015, Meeker et al., 2019, Matre et al., 2006) were judged to be at high risk of 
detection bias.  
Risk of manipulation veracity problem  
Thirteen of the 21 included studies were judged to be at low risk of having problems with the 
veracity of the manipulation. Five studies were judged to have unclear risk of having problems with 
the veracity of the manipulation due to ambiguous information given about the manipulation 
procedure. The remaining studies (n=3) were judged to have high risk of having problems with the 
veracity of the manipulation due to missing information about the manipulation procedure. van den 
Broeke et al. (2014) called their manipulation “negative expectation”. However, they did not 
specifically assess participants’ expectations and report whether their manipulations indeed did 




Attrition bias  
All 21 studies were judged to be at low risk of attrition bias for either having no withdrawals, or 
clearly accounting for withdrawals in their statistical analysis.  
Measurement bias  
Risk of measurement bias was assessed separately for intensity and area of SH. Twenty of the 21 
studies used valid and reliable outcome measurements to assess intensity and area of SH. Smith et 
al. (2018) used a 5.18 (15.0g) von Frey filament to assess intensity of hyperalgesia but reported that 
the filament was perceived as a “non-painful…light touch”.  This does not correspond to the 
definition for hyperalgesia used in this review: “increased pain from a stimulus that normally 
provokes pain” (Merskey and Bogduk, 1994). Therefore, the study by Smith et al. (2018) was judged 
to have an unclear risk of measurement bias. 
Most studies (18 of 21) did not clarify whether the same assessor conducted all the assessments 
between group/site/time points. Only three studies (Matre et al., 2006, Meeker et al., 2019, 
Rasmussen et al., 2015) reported that the same assessor conducted all assessments, and were 
therefore judged to be at low risk of measurement bias. All studies used valid and reliable outcome 
measures. 
Reporting bias  
Ten studies (of 21) were judged to be at high risk of reporting bias, for either failing to report on all 
outcome measurements (n=8) or failing to disclose any funding sources or conflicts of interest (n=2) 
(Torta et al., 2019).  
Primary outcome  
The effect of manipulation on the intensity of secondary hyperalgesia (n=9) 
Nine (of 21) studies assessed the intensity of SH after manipulation. Studies have been grouped by 
the hypothesised direction of the effect of the manipulation on the intensity of SH (i.e. either 
increase or decrease in the intensity of SH). Thereafter, studies were subgrouped by the class of 
manipulation procedure, where possible. Those that could not be subgrouped have been reported 
on individually. Table 6 summarises the hypothesised and actual directions of the effect of each 




Table 6 A summary of the hypothesised and actual directions of the effect of each study’s manipulation on intensity of 
secondary hyperalgesia. 
Study  Manipulation  Hypothesised direction of the 
effect of manipulation on the 
intensity of secondary 
hyperalgesia  
Actual direction of the effect 
of manipulation on the 
intensity of secondary 
hyperalgesia  





Decrease*  No effect for both whole-
body heat and whole-body 
cooling 
 




Decrease* No effect 





Decrease*  No effect 





(Eriksen Flanker task)  
 
Decrease  No effect 








Decrease  Decrease  
You et al. (2014) Emotional disclosure  Decrease*  Decrease 
Ditre et al. 
(2018) 
Nicotine deprivation   Increase  Increase 
Helfert et al. 
(2018) 
Verbal suggestion Increase*  No effect 
van den Broeke 
et al. (2014) 
Negative suggestion Increase  Increase 
*Not all studies reported a clear hypothesised direction of effect. In these cases, this author hypothesised the direction of 
effect based on published literature. Studies that failed to report a clear hypothesised direction of the effect and where 
this author hypothesised the direction of the effect have been denoted with an asterisk. 
Baseline data  
None of the studies that assessed the intensity of SH reported baseline data from the time prior to 
manipulation. 
Manipulations hypothesised to decrease the intensity of secondary hyperalgesia (n=6) 
Six studies (of 9) used manipulations hypothesised to decrease the intensity of SH. Interestingly, only 
one of the six studies successfully decreased the intensity of SH, with high cognitive loading using a 
modified version of the N-back Task (Torta et al., 2019) (Experiment 2). Whole-body cooling and 
heating (Baron et al., 1999), localised cold application (Werner et al., 2002), high attentional loading 
(Kóbor et al., 2009), high cognitive loading using the Eriksen Flanker task (Torta et al., 2019) 
(Experiment 1), and emotional disclosure (You et al., 2014) failed to decrease the intensity of SH.  
Effect of heat or cold stimulation on the intensity of secondary hyperalgesia (n=2) 
Two studies used a version of heat or cold stimulation to manipulate the intensity of SH (Baron et al., 
1999, Werner et al., 2002). Baron et al. (1999) used an intradermal capsaicin injection induction 
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while exposing participants to a thermal suit to induce whole-body cooling and whole-body heating 
and reported the intensity of SH 11 minutes after the induction. The temperature of the skin at the 
induction and measurement site was kept at a constant 35°C. Whole-body cooling was intended to 
stimulate sympathetic vasoconstrictor activity (high sympathetic activity) and whole-body heating 
was intended to stimulate sympathetic vasodilator activity (low sympathetic activity). The extent of 
vasoconstriction and vasodilation was determined by measuring skin blood flow using laser Doppler 
and temperature using infrared thermometry at the index finger. It is unclear whether there was a 
statistically significant difference in perfusion and temperature measurements between whole-body 
cooling and whole-body heating. Mean (SEM) intensity ratings (on 0 – 10 ratings scale) stimulated by 
250 mN stiff von Frey filament were 3.2 (0.5) during whole-body cooling (high sympathetic activity) 
and 3.4 (0.7) during whole-body heating (low sympathetic activity). These data suggest that high and 
low sympathetic activity did not influence the intensity of SH induced by an intradermal capsaicin 
injection. 
Werner et al. (2002) used a burn injury induction using a hot contact thermode, and then applied 
contact cold stimulation of 8 °C (experimental) or non-active sham (control) for 30 minutes from 
eight minutes after induction. The median (IQR) (data extracted from plot) intensity ratings 
(reported on 0 – 100 ratings scale, rescaled to 0 – 10) were provided at 10, 40, 80, 120 and 160 
minutes after the manipulation for each group (view Appendix 6, Section 6.1 for intensity ratings at 
each time point for each group). For the current review, mean intensity ratings were calculated to 
facilitate comparison with intensity ratings from Baron et al. (1999). Overall, the mean intensity 
rating were lower than intensity ratings from Baron et al. (1999): 1.2 at the experimental site and 
1.16 at the control site. This may indicate a difference in the potency of these two induction 
procedures (intradermal capsaicin vs a burn injury). Localised application of cold did not have a 
statistically significant effect on reducing SH (p > 0.4. The specific p-value was no reported.) in 
comparison to the control site. These data suggest that application of cold may not influence the 




Effect of modulation of attention or cognitive load on the intensity of secondary hyperalgesia (n=3) 
Kóbor et al. (2009) used a heat and topical capsaicin induction and then exposed participants to 
either high attentional load tasks (experimental manipulation) or low attentional load tasks (control 
manipulation). Forty-five minutes after the induction, static mechanical stimulation was provided 
using 180 g and 300 g von Frey filaments and intensity ratings (on 0 – 10 ratings scale) were 
recorded during experimental and control manipulations. Intensity ratings were reported as mean 
(SEM) (data extracted from a bar graph), but after being normalised to a range of 0 – 1. Original pain 
ratings from the 0 – 10 scale were not reported. These data were requested from the corresponding 
author, but the author did not respond. Therefore, these data were considered unavailable. Intensity 
ratings were reported on a bar plot only with the y-axis of the plot ranging from 0 – 0.5, which 
contradicts the explanation of intensity ratings being normalised to a range of 0 – 1. This contributed 
to high risk of reporting bias, discussed above. The author of this current review requested 
clarification on the discrepancy in the plot’s range and the normalised intensity ratings range, but 
the corresponding author did not respond. Kóbor et al. (2009) reported that attentional loading did 
not influence intensity of secondary hyperalgesia, but this could not be verified without the raw 
data.  
Torta et al. (2019) (Experiment 1 and 2) assessed the effect of cognitive loading on the intensity of 
SH. In Experiment 1 participants engaged in the well-validated Eriksen Flanker task (Eriksen and 
Eriksen, 1974), which is known to require a lot of focus. In Experiment 2 a different cohort engaged 
in a modified version of the N-back task, which is known to require a lot of attention and working 
memory (Kane et al., 2007). Both tasks were performed while low-frequency electrical stimulation 
was simultaneously used to induce SH on one of the participants’ arms (experimental site). SH was 
not induced on the other arm (control site), providing a within-subject comparison. Participants 
reported the extent of engagement required for each task on a 0 – 10 scale, where 0 = “not 
difficult/engaging at all” and 10 = “as difficult/engaging as possible”. The mean (SD) extent of 
engagement was 4.28 ± 2.24 for the Eriksen Flanker Task and 6.76 ± 1.37 for the N-back task. This 
indicates that the Modified version of an N-back was a harder task than the Eriksen Flanker task, i.e. 




In Experiment 1, the mean intensity (reported on 0 – 100 ratings scale, rescaled to 0 - 10) was 
reported to be 2.5 at the experimental site and 2.0 at the control site 20 minutes after induction. At 
45 minutes after the induction, the intensity ratings were 2.2 at the experimental site and 1.8 at the 
control site (data extracted from a plot). There was a statically significant increase (p < 0.001. The 
exact p-value was not reported) in intensity ratings over time at the experimental site. Conversely, 
there was not a statically significant (p = 0.326) increase in ratings over time at the control site. 
These data indicate that the manipulation (Eriksen Flanker task) was ineffective in preventing the 
development of SH.  
In Experiment 2, the mean intensity (reported on 0 – 100 ratings scale, rescaled to 0 – 10) was 
reported to be 3.0 at the experimental site and 2.0 at the control site 20 minutes after induction. At 
45 minutes after the induction, the intensity ratings were 2.5 at the experimental site and 1.9 at the 
control site (data extracted from a plot). There was not a statically significant (p = 0.108) increase in 
ratings over time at the experimental site. Therefore, this higher cognitive loading task (modified 
version of an N-back) was effective (at a group level) in preventing the development of hyperalgesia 
induced by low-frequency electrical stimulation.  
The effect of emotional disclosure on the intensity of secondary hyperalgesia (n=1) 
You et al. (2014) used a topical capsaicin induction four days and one month after exposing 
participants to once-off emotional disclosure (experimental manipulation group) or sham 
intervention (control manipulation group). Experimental and control groups both consisted of a 
cohort of women with and without a history of trauma. Four days after the manipulations, the mean 
(SEM) intensity ratings (reported on 0 – 10 ratings scale. Data extracted from a bar graph) were 2.7 
(2.3 – 2.9) for participants in the experimental group with a history of trauma and 1.3 (0.8 – 2.8) for 
participants in the experimental group without a history of trauma. The mean (SEM) intensity ratings 
were 2.1 (1.5 – 2.5) for participants in the control group with a history of trauma and 2.2 (1.9 – 2.4) 
for participants in the control group without a history of trauma. The difference in intensity ratings 
between the experimental and control group was statistically significant (p <0.050. The exact p-value 
was not reported), suggesting that the emotional disclosure was effective in reducing the intensity of 
SH at four days. In the experimental group, there was also a statistically significant difference (p < 
0.025. The exact p-value was not reported) in the intensity of SH between those with a history of 
trauma and those without a history of trauma, indicating that emotional disclosure was more 




Intensity ratings were repeated at one month after the manipulation. Intensity ratings were 1 (0.7 – 
1.3) for participants in the experimental group with a history of trauma and 2 (1.6 – 2.3) for 
participants in the experimental group without a history of trauma. Intensity ratings were 1.7 (1.2 – 
2.1) for participants in the control group with a history of trauma and 1.2 (0.8 – 1.4) for participants 
in the control group without a history of trauma. There difference between the experimental and 
control group was statistically significant (p < 0.025. The exact p-value was not reported), suggesting 
that the emotional disclosure was effective in reducing the intensity of SH at one month. In the 
experimental group, there was also a statistically significant difference (p < 0.050. The exact p-value 
was not reported) in the intensity of SH between those with a history of trauma and those without a 
history of trauma, indicating that emotional disclosure was more effective in reducing the intensity 
of SH in participants with a history of trauma at one month. 
Manipulations hypothesised to increase the intensity of secondary hyperalgesia (n=3) 
Three studies used manipulations hypothesised to increase the intensity of SH. Two studies 
successfully increased the intensity of SH with nicotine deprivation (Ditre et al., 2018) and negative 
suggestion about the induction procedure (van den Broeke et al., 2014). Verbal suggestion (Helfert 
et al., 2018) failed to increase the intensity of SH.  
The effect of nicotine deprivation on the intensity of secondary hyperalgesia (n=1) 
Ditre et al. (2018) used a topical capsaicin induction in a cohort of smokers after exposing them to 12 
– 24 hours of nicotine deprivation (experimental group) and compared it participants allowed to 
continue smoking (control group). They used an unusual approach to assess the intensity of 
secondary hyperalgesia: Pinprick stimuli, using a 6.65 con Frey filament, were “applied at points one 
centimetre apart alone eight linear paths radiating from the centre of the application site, forming 
eight concentric rings”. At each ring, the pinprick stimulus was applied eight times. The sum of the 
eight pinprick stimuli (rated on a 0 – 10 ratings scale) was calculated for the intensity of SH for each 
participant. Therefore, the intensity ratings ranged from 0 – 80 at each ring. The mean (SD) were 
reported for the summed intensity ratings at eight concentric rings one centimetre apart, starting at 
the centre of the induction site (view Appendix, Section 6.2 for summed intensity ratings at each ring 
for each group). The induction site was 1.5 centimetres by 1.5 centimetres. Therefore, the ratings at 
the innermost ring represents primary hyperalgesia and ring 2 – 8, at a diameter of two to eight 
centimetres around the centre of the application site represents secondary hyperalgesia. This 
distinction between primary and SH was not reported by the researchers; it is this author’s 
interpretation of the data. The overall mean (SD) intensity was 17, 05 (11.0) for the nicotine-
deprived group and 4.04 (4.12) for the continued smoking group. Ditre et al. (2018) reported a 
statistically significant (p < 0.05. The exact p value was not reported.) difference in SH intensity 
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ratings at each concentric ring between nicotine-deprived group and continued smoking group. 
These data suggest that nicotine deprivation is effective in manipulating the intensity of SH induced 
by topical capsaicin application.    
The effect of verbal suggestion and negative suggestion on the intensity of secondary hyperalgesia 
(n=2) 
Helfert et al. (2018) used a high-concentration topical menthol induction while exposing participants 
to verbal suggestion about the induction procedure. Participants underwent four testing sessions 
where they received high-topical menthol application twice and topical ethanol application twice, in 
a randomised order. Participants were blinded to group allocation and therefore were unaware of 
specifically which substance was being applied. The verbal suggestion manipulation consisted of 
participants being told correct information for two of the four sessions and incorrect information for 
the other two sessions about which substance was being applied. Specifically, there were four 
testing conditions: 1) participants were told that menthol was being applied and menthol was 
actually applied (told correct information), 2) participants were told that menthol was being applied 
when in fact ethanol was being applied (told incorrect information), 3) participants were told that 
ethanol was being applied and ethanol was actually applied (told correct information), and 4) 
participants were told that ethanol was being applied when in fact menthol was being applied (told 
incorrect information). No individual nor group results were reported, despite the aim of the study 
being to investigate the effect of verbal suggestion on experimentally induced SH. These data were 
requested from the corresponding author; however, the author did not respond. These missing data 
added to the high risk of reporting bias outlined in the risk of bias assessment section above. 
Although it was reported that there was no significant change in the intensity of SH after 
manipulation, this can not be verified without access to the missing data.  
van den Broeke et al. (2014) used a high-frequency electrical stimulation induction after exposing 
participants to a negative suggestion about the induction procedure (experimental) or control 
conditions. Participants were randomly assigned to either the negative suggestion or control group. 
The negative suggestion was achieved by informing participants that: “After the HFS stimulation, 
your skin will become more sensitive to the pinprick stimulation”. Mean intensity ratings (pain 
ratings were measured on a 0 cm – 10 cm scale but were then reported on a 0 mm – 100 mm scale. 
Therefore, in this current review, ratings were rescaled to 0 – 10 ratings scale, to allow for 
comparability) were recorded at 10 minutes and 20 minutes after induction for both the negative 
suggestion and control groups at both the conditioned site (receiving the induction). At 10 minutes 
after the induction, the mean intensity ratings were 3.81 for the experimental group and 2.62 for the 
control group. At 20 minutes after the induction, the mean intensity ratings were 3.82 for the 
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experimental group and 2.31 for the control group. These data indicate that negative suggestion 
about the HFS induction procedure was effective in increasing the intensity of SH.  
Pooling of data 
Two subgroups of classes of manipulation were identified and explored for pooling: 1) attentional 
and cognitive loading, and 2) verbal suggestion and negative suggestion. Three studies were 
included in Subgroup 1 (Kóbor et al., 2009, Torta et al., 2019) (Experiment 1 and 2) and two studies 
were included in Subgroups 2 (Helfert et al., 2018, van den Broeke et al., 2014). No other studies 
could be pooled by class of manipulation. However, pooling of data was not possible for both 
subgroups due to the unavailable intensity ratings data in Kóbor et al. (2009) (Subgroup 1) and 
Helfert et al. (2018) (Subgroup 2).  
Relative ranking of manipulations   
It was not possible to pool many studies that investigated the effect of manipulations on intensity of 
secondary hyperalgesia, owing to the high clinical heterogeneity among the studies and unavailable 
data. Therefore, the quantity and quality of data did not allow for determining the pooled effect 
sizes relative ranking of the different manipulations in the order of potency and risk.  
Publication bias  
It was outlined in the protocol that funnel plots will be examined for publication bias. However, 
there was vast clinical heterogeneity among the studies. Therefore, it was not possible to pool more 
than 10 studies and assess for publication bias (Higgins and Green, 2011). Alternative methods for 
assessing publication bias were explored. One such method is the Fail-safe N method, which 
“identifies the number of additional negative studies that would be needed to increase the P-value 
in a meta-analysis to above 0.5” (Dalton et al., 2016). However, this method is not recommended by 
The Cochrane Group because it focuses on an “arbitrary threshold” (the p-value) rather than the 
estimated size of the interventions’ effect (Higgins and Green, 2011). Therefore, the Fail-safe N 
method was deemed inappropriate to assess for publication bias among included studies in this 
review. No other appropriate methods of measuring publication bias were identified.  
Measures of manipulation effect 
Studies were subgrouped by the hypothesised direction (i.e. decrease or increase) of manipulation 
effect on intensity of SH. There was high clinical heterogeneity among the studies in each group; 
therefore, it was not possible to measure the manipulation effect and estimate the potencies of the 
manipulation methods. Appendix 6, Section 6.3 describes the differences in the reporting of the 
intensity ratings across the studies in such subgroup.    
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Assessment of the quality of body of evidence  
Only one class of manipulation was used by more than one study: attentional and cognitive loading (Torta et al., 2019, Kóbor et al., 2009). Tables 7 
summarises the assessment of the quality of body of evidence for the effect of attentional and cognitive loading on intensity of SH. There were serious 
limitations in the study designs and reporting results in both studies having an overall unclear risk of bias. Therefore, the quality of evidence was 
downgraded by 1 level for risk of bias. This small body (n = 3 studies) of evidence was assessed as having moderate quality.  
Table 7 Assessment of the quality of body of evidence for the effect of attentional and cognitive loading on intensity of secondary hyperalgesia  
Population: healthy human adults (>18 years old)  
Setting: experimental laboratory  
Intervention (manipulation): attentional and cognitive loading 
Comparison (control): N/A (within-subject comparison) 
 
Outcome measurement: intensity of secondary hyperalgesia  Test accuracy 
of certainty of 
evidence  
Number of studies 
(number of 
participants) 
Study design  Factors that may decrease certainty of evidence 
Risk of bias  Indirectness Inconsistency Imprecision  
2 (56 participants) 
(Torta et al., 2019, 










The effect of manipulation on area of secondary hyperalgesia (n=17) 
Seventeen (of 21) studies assessed area of SH after manipulation. Studies have been grouped by the 
hypothesised direction of the effect of the manipulation on the area of SH (i.e. either increase or 
decrease area of SH). Thereafter, Studies were pooled by manipulation procedures, where possible. 
The remaining manipulation procedures have been reported individually. Table 8 the hypothesised 
and actual directions of the effect of each study’s manipulation on the area of SH. 
Table 8 A summary of the hypothesised and actual directions of the effect of each study’s manipulation on the area of 
secondary hyperalgesia 
Study reference  Manipulation  Hypothesised direction 
of the effect of 
manipulation on 
surface area of 
secondary hyperalgesia  
Actual direction of the 
effect of manipulation 
on surface area of 
secondary hyperalgesia 
Baron et al. (1999) Whole-body cooling and 
whole-body heating  
Decrease*  No effect for both 
whole-body heat and 
whole-body cooling 
Werner et al. (2002) Localised cold application  Decrease*  No effect 
Pud et al. (2006) Localised cold application  Decrease* Increase 
Yucel et al. (2001) 
Experiment 1 
Localised cold application  Decrease* Data unavailable  
Yucel et al. (2001) 
Experiment 2 
Localised cold application  Decrease* Data unavailable 
Yucel et al. (2001) 
Experiment 3 
Localised cold application  Decrease* Data unavailable 
Rasmussen et al. 
(2015) 
Hyperbaric oxygen therapy Decrease  Decrease 
Wahl et al. (2019) Hyperbaric oxygen therapy Decrease  Decrease 
You et al. (2014) Emotional disclosure  Decrease* Decrease 
Salomons et al. (2014) Cognitive behavioural 
therapy 
Decrease  Decrease 
Matre et al. (2006) Placebo analgesia  Decrease  Decrease 
Meeker et al. (2019) Transcranial direct current 
stimulation 
Decrease Anodal: decrease† 
Cathodal: no effect  





Rebhorn et al. (2012) Acupuncture  Decrease*  No effect 
Ditre et al. (2018) Nicotine deprivation   Increase  Increase 
Helfert et al. (2018) Verbal suggestion Increase*  No effect 
Smith et al. (2018) Sleep disruption  Increase*  Increase (in male 
participants only) 
*Not all studies reported a clear hypothesised direction of effect. In these cases, this author hypothesised the direction of 
effect based on published literature. Studies that failed to report a clear hypothesised direction of the effect and where 
this author hypothesised the direction of the effect have been denoted with an asterisk. 




Baseline data (n=3) 
Only three studies (Mohammadian et al., 2004, Matre et al., 2006, Salomons et al., 2014) reported 
baseline data after induction and before manipulation. Therefore, baseline data was available for 
topical capsaicin inductions (Mohammadian et al., 2004) and burn injury inductions (Salomons et al., 
2014, Meeker et al., 2019) only. Mohammadian et al. (2004) conducted a crossover study in which 
participants received both spinal therapy manipulation and a non-spinal manipulation sham at 
separate sessions, in a randomised order. Sessions were separated by a washout period of at least 
seven days. The baseline surface area of SH was assessed after a topical capsaicin application 
induction and prior to manipulation, and the data were pooled by manipulation (spinal manipulation 
therapy or sham) across the two sessions. There was a discrepancy in the pooled baseline surface 
area ratings: 46cm2 prior to receiving the spinal manipulation therapy and 34cm2 prior to receiving 
the non-spinal manipulation therapy (extracted from a bar graph).  
Matre et al. (2006) conducted a between-group comparison study in which participants were 
randomised to either placebo analgesic manipulation (experimental) group or sham manipulation 
group. The baseline surface area of SH was assessed after inducing a burn injury at two independent 
induction sessions. These surface area ratings were assessed prior to participants receiving either 
placebo analgesic manipulation (experimental) or sham manipulation because the manipulation 
occurred only at a third independent session (sessions separated by four to seven days). The 
participants in the experimentally group were informed at the beginning of the study that the 
researchers were investigating “the analgesic effectiveness of a magnet against heat pain”. The 
magnet (placebo analgesia) was introduced to the participants in the first session but it was 
removed and used ‘as an analgesic’ in the third session only. Participants in the sham manipulation 
(control) group were provided with completely different study information – they were informed 
that the researchers were investigating “the hypersensitivity of the skin after a heat stimulus”. 
Researchers aimed to make the physical environment identical for participants in both groups. 
Therefore, a magnet was also used for participants in the sham manipulation group, but they were 
informed that it was a thermometer. The magnet (sham thermometer) was introduced to the 
participants at the first session and used in the third session only. The median (IQR) surface area for 
the experimental group was 75 cm2 (45- 95) (session one) and 49 cm2 (40 - 80) (session two) (data 
extracted from box and whisker plot). The median (IQR) surface area for the control group was 50 





Salomons et al. (2014) conducted a between-group comparison study in which participants were 
randomised to receiving either cognitive behavioural therapy (experimental) or sham manipulation 
(control). The baseline surface area of SH was assessed after inducing a burn injury, prior 
commencement of the cognitive behavioural therapy and sham manipulation sessions. The cognitive 
behavioural therapy was approximately five minutes long and focused on reducing participants’ 
negative thoughts and emotions towards painful stimuli. The sham manipulation was also 
approximately five minutes long and focused on teaching participants how to balance goals, 
expectations and communicate assertively to manage external pressures (interpersonal 
effectiveness skills). The baseline means (SEM) area of SH was 48.0 cm2 (7.01) for the experimental 
group and 45.0 cm2 (6.29) for the control group. Overall, participants receiving a burn injury 
induction displayed the largest surface area of SH. However, Matre et al. (2006) reported a larger 
area than Salomons et al. (2014). Topical capsaicin application induced a similar area of SH to that of 
the burn injury reported by Salomons et al. (2014). This may indicate a similar potency between burn 
injury inductions and topical capsaicin induction.  
Manipulations hypothesised to decrease the area of secondary hyperalgesia (n=14) 
Fourteen studies used manipulations hypothesised to decrease area of secondary hyperalgesia. 
Seven studies successfully decreased the area of SH with hyperbaric oxygen therapy (Wahl et al., 
2019, Rasmussen et al., 2015), emotional disclosure (You et al., 2014), cognitive behavioural therapy 
(Salomons et al., 2014), placebo analgesia (Matre et al., 2006), transcranial direct current stimulation 
(Meeker et al., 2019) and spinal manipulation therapy (Mohammadian et al., 2004). Four of the five 
studies that used localised application of cold reported no effect (Werner et al., 2002, Yucel et al., 
2001) and the remaining one reported an increase in the area of SH (Pud et al., 2006). However, the 
latter study had a high risk of reporting bias, as discussed in the Risk of bias section above. Whole-
body cooling and heating (Baron et al., 1999) and acupuncture (Rebhorn et al., 2012) failed to 




The effect of heat or cold stimulation on the surface area of secondary hyperalgesia (n=6) 
Six studies used a version of heat and or cold stimulation to manipulation area of SH (Yucel et al., 
2001, Pud et al., 2006, Werner et al., 2002, Baron et al., 1999). As discussed above, Baron et al. 
(1999) used an intradermal capsaicin injection induction and then exposed participants to a whole-
body cooling and whole-body heating manipulation. There were negligent differences in the mean 
(SEM) area of SH between the two manipulations: 88.1 cm2 (13.1) with whole-body cooling (high 
sympathetic activity) and 86.4 cm2 (13.1) with whole-body heating (low sympathetic activity). These 
data suggest that high and low sympathetic activity did not influence the area of SH induced by an 
intradermal capsaicin injection. 
Pud et al. (2006) and Werner et al. (2002) both used localised application of cold to manipulate 
secondary hyperalgesia, however, their methods differed slightly. Pud et al. (2006) used capsaicin 
injection induction and then exposed participants to cold stimulations of 20°, 10° and 0°, in 
randomised orders for 30 seconds each, eight minutes after induction. Werner et al. (2002) used a 
burn injury induction with a hot contact thermode, and then applied a cold stimulation of 8 °C 
(experimental) or non-active sham (control) for 30 minutes from eight minutes after induction. Pud 
et al. (2006) reported a mean (SEM) area of 21.7 cm2 (2.7) at 8 minutes (directly after manipulation) 
and 15.0 cm2 (3.3) at 30 minutes after induction. The area of SH increased from 5.1 cm2 at baseline 
to 21.7 cm2 8 minutes after a localised cold application. Pud et al. (2006) reported that localised 
application of cold increased the area of SH. The mean (SEM) area of SH at the control site was not 
reported at 8 minutes or 30 minutes after induction. Therefore, it is plausible that the area of SH at 
the control site followed the same trajectory as that at the experimental site, despite the localised 
cold application at the experimental site.  
Werner et al. (2002) reported localised application of cold did not influence the area of secSH. The 
median (IQR) area for experimental and control site were measured at 10, 40, 80, 120 and 160 
minutes after the 30 minutes cooling period (Appendix 6, Section 6.4). In this current study, the 
median area over the entire 160-minute time period was calculated to facilitate comparison with 
surface area data from other studies. The median area was calculated to be 50 cm2 for the 
experimental site and 54 cm2 for the control site. There was not a statistically significant difference 
(p > 0.4. The exact p-value was not reported.) difference in the area of SH between the two groups. 





Yucel et al. (2001) conducted three experiments using differing induction methods (intradermal 
capsaicin injection, topical capsaicin, and burn injury) after exposing participants to a five-minute 
heating manipulation at a temperature of 45 °C. After induction, participants were exposed to 
another heating manipulation for two minutes at a temperature 2°C above their individual heat pain 
threshold. Yucel et al. (2001) reported assessing area of SH. However, these data were not reported. 
The author of this current study attempted to contact the corresponding author, requesting missing 
data, but their email address was no longer active. Therefore, these data were considered 
unavailable for this current review.   
The effect of hyperbaric oxygen therapy on the surface area of secondary hyperalgesia (n=2) 
Rasmussen et al. (2015) and Wahl et al. (2019) conducted crossover studies to assess the influence 
of hyperbaric oxygen therapy on SH. They both used a contact thermode burn injury induction and 
directly after, exposed participants to hyperbaric oxygen therapy (manipulation condition) and to 
ambient pressure and room air (control condition) at two separate sessions. In fact, the latter study 
is a replication of the former study. Rasmussen et al. (2015) reported an average of 37 days and 
Wahl et al. (2019) 28 days or more washout period between each session.  
Rasmussen et al. (2015) pooled the surface area data by manipulation (hyperbaric oxygen therapy vs 
ambient conditions) across both sessions and reported median (95% CI) area of SH at 45, 85, 125, 
175, 235 minutes after induction as well as the overall median (95% CI) over the entire testing period 
(Appendix 6, Section 6.5). Although, Wahl et al. (2019) was a replication study, they did not report 
surface area data at each time point. Instead, they reported the mean (95% CI) area of SH over the 
entire 120-minute period.  
Rasmussen et al. (2015) the median (95% CI) area of SH were 42.0 cm2 (31.1 – 71.4) when 
participants received the hyperbaric oxygen therapy manipulation and 34.6 cm2 (22.9 – 39.8) when 
participants received the induction under ambient conditions (data extracted from plot). There was 
a significant (p = 0.011) difference in the area of SH produced after each of these conditions. These 
data suggest that hyperbaric oxygen therapy is effective in manipulating the area of SH induced by 
burn injury.    
Wahl et al. (2019) reported the mean (95% CI) area of SH to be 18.8 cm2 (10.5– 27.0) when 
participants received the hyperbaric oxygen therapy manipulation and 32.0 cm2 (20.1–43.9) when 
participants received the induction under ambient conditions. There was a significant (p = 0.021) 
difference in the area of SH produced after each of these conditions. These data suggest that 
hyperbaric oxygen therapy is effective in manipulating the area of SH induced by burn injury.    
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The effect of emotional disclosure on the surface area of secondary hyperalgesia (n=1) 
As discussed above, You et al. (2014) used a topical capsaicin induction four days and one month 
after exposing participants to once-off emotional disclosure (experimental) or sham intervention 
(control group). At four days after the manipulation procedure the mean (SEM) area of SH for 
participants in the experimental group 132 cm2 (105 – 159) for those with a history of trauma and 70 
cm2 (38 – 98) for those without a history of trauma. Area of SH for participants in the control group 
was 75 cm2 (61 – 90) for those with a history of trauma and 65 cm2 (50 – 81) for those without a 
history of trauma. The difference in area between the experimental and control group was 
statistically significant (p <0.050. The exact p-value was not reported), suggesting that the emotional 
disclosure was effective in reducing the area of SH at four days. In the experimental group, there was 
also a statistically significant difference (p < 0.025. The exact p-value was not reported) in the area of 
SH between those with a history of trauma and those without a history of trauma, indicating that 
emotional disclosure was more effective in reducing the area of SH in participants with a history of 
trauma at four days.  
At one month after the manipulation procedure the mean (SEM) area of SH for participants in the 
experimental group was 38 cm2 (22 – 56) for those with a history of trauma and 98 cm2 (70 – 120) 
for those without a history of trauma. Area for participants in the control group was 90 cm2 (59 – 
120) for those with a history of trauma were and 50 cm2 (21 – 70) for those without a history of 
trauma (all data extracted from graph). The difference in intensity ratings between the experimental 
and control group was statistically significant (p <0.050. The exact p-value was not reported), 
suggesting that the emotional disclosure was effective in reducing the area of SH at one month. In 
the experimental group, there was also a statistically significant difference (p < 0.025. The exact p-
value was not reported) in the area of SH between those with a history of trauma and those without 
a history of trauma, indicating that emotional disclosure was more effective in reducing the area of 




The effect of cognitive behavioural therapy on the surface area of secondary hyperalgesia (n=1) 
Salomons et al. (2014) used a contact thermode burn injury induction and exposed participants to 
approximately five minutes of cognitive behavioural therapy. Induction and manipulation were 
performed over eight sessions. There were initial and final induction sessions (without the 
manipulation) where baseline and final sensory ratings, respectively, were recorded. The cognitive 
behavioural therapy was focused on reducing participants’ negative thoughts and emotions towards 
painful stimuli. Salomons et al. (2014) reported the mean (SEM) area of SH to be 29.8 cm2 (7.31) for 
the experimental and 48.5 cm2 (8.80) for the control groups. There was a statistically significant 
difference (p < 0.05. The exact p-value was not reported.) between the two groups, suggesting that 
altering pain-related thoughts with cognitive behavioural therapy, is effective influence reducing the 
area of SH induced by burn injury. 
The effect of placebo analgesia on the surface area of secondary hyperalgesia (n=1) 
Matre et al. (2006) used a contact thermode burn injury induction over three experimental sessions, 
separated by four to seven days apart. Placebo analgesia manipulation (experimental group) was 
only used in the third session and was compared with control conditioned. The placebo analgesia 
manipulation consisted of participants in the experimental group being informed that “the aim of 
the study was to test the analgesic effectiveness of a magnet against heat pain”. Participants in the 
control group were inform that “aim of the study was to investigate hypersensitivity of the skin after 
a heat stimulus”. The median (IQR) (on a box and whisker plot) area of SH was 40 cm2 (30 – 65) in 
the experimental group and 50 cm2 (35 – 75) in the control group. A statistically significant 
difference (p = 0.002) was found between baseline area measurements and area measurements 




The effect of transcranial direct current stimulation on the surface area of secondary hyperalgesia 
(n=1) 
Meeker et al. (2019) conducted a crossover study, using a topical capsaicin and heat induction and 
then exposed participants to transcranial direct current stimulation (experimental condition) and 
sham transcranial direct current stimulation (control condition) in separate sessions. Sessions were 
separated by a minimum of two weeks to allow for a washout period. Meeker et al. (2019) reported 
a mean (SEM) area of 20 cm2 (16 – 26) after participants received anodal transcranial direct current 
stimulation, 12 cm2 (6 – 18) after participants received cathodal transcranial direct current 
stimulation, and 11 cm2 (4 – 19) after participants received sham transcranial direct current 
stimulation (data extracted from a plot). There was a significantly greater reduction (p = 0.075) in the 
area of SH after anodal transcranial direct current stimulation as compared to cathodal transcranial 
direct current stimulation. However, the difference in the reduction in area between the anodal 
transcranial direct current stimulation and the sham transcranial direct current stimulation was not 
significant (p = 0.91). These data indicate that anodal transcranial direct current is effective in 
reducing the area of SH; however, it is no better than sham transcranial direct current. 
The effect of spinal manipulation therapy on the surface area of secondary hyperalgesia (n=1) 
Mohammadian et al. (2004) conducted a crossover study and used a topical capsaicin induction and 
then exposed participants to spinal manipulation (experimental manipulation) and non-spinal 
manipulation (sham manipulation) at two separate sessions. Sessions where separated by at least 
seven days to allow for a washout period. Mohammadian et al. (2004) reported the mean (SEM) 
area after spinal manipulation treatment (experimental) and non-spinal manipulation treatment 
(control) and displayed results on a 3-D bar graph; however, the SEM data were not visible due to 
dark shadings on the graph. These data were requested from the corresponding author, but they did 
not respond. The mean area of SH was 27 cm2 after the experimental manipulation and 45 cm2 after 
the sham manipulation. There was a statistically significant difference (p < 0.007. The exact p-value 
was not reported.) between the two groups, suggesting that spinal manipulation therapy, was 




The effect of acupuncture on the surface area of secondary hyperalgesia (n=1) 
Rebhorn et al. (2012) used an intradermal capsaicin injection induction twenty minutes after 
exposing participants to traditional Chinese Medicine acupuncture (experimental group) or sham 
acupuncture (control group). Area was measured at 15 minutes and 30 minutes after induction. The 
mean area (data extracted from graph) was 55 cm2 at 15 minutes and 89 cm2 at 30 minutes after 
induction for the experimental group and the mean area was 60 cm2 at 15 minutes and 91 cm2 at 30 
minutes after the induction for the control group. Rebhorn et al. (2012) reported that the mean area 
for the experimental group was comparable to the mean area for the control group. However, no 
statistics were reported. These data suggest that acupuncture did not influence the area of SH 
induced by intradermal capsaicin injection.  
Manipulations hypothesised to increase the area of secondary hyperalgesia (n=3) 
Three studies used manipulations hypothesised to increase the area of secondary hyperalgesia. 
Nicotine deprivation (Ditre et al., 2018) and sleep deprivation (Smith et al., 2018) successfully 
increased area of secondary hyperalgesia. Importantly, sleep deprivation was successful in increasing 
area of SH in male participants only. There was no effect on area of SH in female participants. Verbal 
suggestion (Helfert et al., 2018) failed to increased area of SH. 
The effect of nicotine deprivation on the surface area of secondary hyperalgesia (n=1) 
As discussed above, Ditre et al. (2018) used a topical capsaicin induction in a cohort of smokers after 
exposing them to 12 – 24 hours of nicotine deprivation (experimental group) and compared it to 
participants who were allowed to continuing smoking (control group). The mean (SD) area of SH was 
71.98 cm2 ± 55.17 for the experimental group and 45.07 cm2 ± 37.14 for the control group. There 
was a statistically significant difference (p < 0.05. The exact p-value was not reported.) in the area 
between the experimental and control groups. These data suggest that acute nicotine withdrawal 




The effect of sleep disruption on the surface area of secondary hyperalgesia (n=1) 
Smith et al. (2018) conducted a crossover study and used a topical capsaicin application induction 
after exposing participants to two consecutive nights of sleep disruption (experimental condition) or 
two nights of undisturbed sleep (control condition). The sleep disruption consisted of participants 
having an eight-hour sleep opportunity; however, participants were woken for one of the eight 
hours and a further three 20-minute periods (randomly assigned). The control condition consisted of 
eight full hours of undisturbed sleep. There was a minimum of two-weeks between each condition, 
to allow for participants to return to their habitual sleep behaviours. The mean (SEM) area was 
reported for male and female participants separately (data extracted from a plot) (area was 
measured in mm2. In this current study, area measurements were converted to cm2 to allow for 
comparison across all included studies). For male participants, the mean area of SH was 18 cm2 after 
the sleep disruption and 11 cm2 after the undisturbed sleep. For female participants, the mean 
(SEM) area of SH was 12.5 cm2 after the experimental condition and 15.1 cm2 after the control 
condition. Post-hoc tests confirmed a significant (p = 0.008) increase in the area of SH after the sleep 
disruption in male participants only. Sleep disruption had no statistically significant effect on the 
area of SH in female participants. These data suggest sleep disruption effectively influenced the area 
of SH induced by topical capsaicin in male participants only.  
The effect of verbal suggestion on the surface area of secondary hyperalgesia (n=1) 
As discussed above, Helfert et al. (2018) used a high-concentration topical menthol induction after 
exposing them to verbal suggestion. No individual nor group data on the effects of the manipulation 
on area of SH were reported. These missing data were requested from the corresponding author; 
however, there was no response. Although it was reported that there was no significant change in 
the area of SH after manipulation, these data could not be verified and were considered unavailable. 
Pooling of data 
Studies were pooled by class of manipulation. Two subgroups of classes of manipulation were 
identified for pooling: 1) localised application of cold, and 2) hyperbaric oxygen therapy. Two studies 
were included in Subgroup 1 (Pud et al., 2006, Werner et al., 2002) and two studies were included in 
Subgroup 2 (Wahl et al., 2019, Werner et al., 2002). No other studies could be pooled by class of 
manipulation. However, pooling of data was not possible for both subgroups because in Subgroup 1, 
Pud et al. (2006), did not report area measurements for the control group, and in Subgroup 2, two 
different statistical measures were used: median (95% CI) (Rasmussen et al., 2015) and mean (95% 
CI) (Werner et al., 2002).   
54 
 
Relative ranking of manipulations   
It was not possible to pool studies that investigated the effect of manipulations on area of secondary 
hyperalgesia, owing to the high clinical heterogeneity among the studies and unavailable data. 
Therefore, the quantity and quality of data did not allow for determining the pooled effect sizes 
relative ranking of the different manipulations in the order of potency and risk.  
Publication bias  
It was outlined in the protocol that funnel plots will be examined for publication bias. However, 
there was vast clinical heterogeneity among the studies. Therefore, it was not possible to pool more 
than 10 studies and assess for publication bias (Higgins and Green, 2011). As discussed above, no 
other appropriate methods of measuring publication bias were identified.  
Measures of manipulation effect 
Studies were subgrouped by the hypothesised direction (i.e. decrease or increase) of manipulation 
effect on intensity of secondary hyperalgesia. There was high clinical heterogeneity among the 
studies in each group; therefore, it was not possible to measure the manipulation effect and 
estimate the potencies of the manipulation methods. Appendix 6, Section 6.6 describes the 
differences in the reporting of the area ratings across the studies in such subgroup.    
Assessment of the quality of body of evidence  
Only two types of manipulation were used by more than one study: hyperbaric oxygen therapy was 
used by two studies (Rasmussen et al., 2015, Wahl et al., 2019), and cold application was used by 
three studies (Werner et al., 2002, Pud et al., 2006, Yucel et al., 2001). Tables 9 summarises the 
assessment of the quality of body of evidence for the effect of hyperbaric oxygen therapy compared 
to ambient conditions on experimentally induced SH in healthy humans. There were serious 
limitations in the designs of these studies resulting in the overall risk of bias being determined as 
unclear (Wahl et al., 2019) and high (Rasmussen et al., 2015). Therefore, the quality of evidence was 
downgraded by 1 level. The accuracy of the certainty of the evidence was graded as moderate, 
meaning that “further research is likely to have an important impact on our confidence in the 
estimate of effect and may change the estimate” (Guyatt et al., 2008) because of the serious 
limitations of the risk of bias and the small sample size in the current body of evidence.  
Table 10 summarises the assessment of the quality of body of evidence for the effect of cold 
application compared to sham on experimentally induced SH in healthy humans. There were very 
serious limitations in the designs of these studies, resulting in a judgment of high risk of bias for both 
studies. Additionally, Pud et al. (2006) scored high for risk of reporting bias. Therefore, the quality of 
evidence was downgraded by 2 levels. There were differences in the induction methods and 
outcome measurements methods (see Table 3). Therefore, the quality of evidence was downgraded 
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by 1 level. There were missing data in that measurements of the area of SH were not reported for all 
time points for both the experimental and control groups (Pud et al., 2006).  Specifically, the mean 
(SEM) area of SH was not reported at 8 minutes or 30 minutes after induction at the control site. 
Therefore, it is plausible that the size of the surface area at the control site followed the same 
trajectory as the size of the surface area at the experimental site. The localised cold application may 
not have increased in area at the experimental site, but rather the increase in the area at 8 minutes 
may have been the normal trajectory of the effect of the induction procedure. The accuracy of the 
certainty of the evidence was graded as very low, meaning “Any estimate of effect is very uncertain” 
(Guyatt et al., 2008) because of the very serious limitations in the risk of bias and imprecision and 





Table 9 Assessment of the quality of body of evidence for the effect of hyperbaric oxygen therapy compared to ambient conditions on area of secondary hyperalgesia  
Population: healthy human adults (>18 years old)  
Setting: experimental laboratory  
Intervention (manipulation): hyperbaric oxygen therapy  
Comparison (control): ambient conditions  
 
Outcome measurement: area of secondary hyperalgesia  Test accuracy 
of certainty of 
evidence  
Number of studies 
(number of 
participants) 
Study design  Factors that may decrease certainty of evidence 
Risk of bias  Indirectness Inconsistency Imprecision  
2 (36 participants) 
(Rasmussen et al., 











Table 10 Assessment of the quality of body of evidence for the effect of cold application compared to sham on area of secondary hyperalgesia  
Population: healthy human adults (>18 years old)  
Setting: experimental laboratory  
Intervention (manipulation): cold application  
Comparison (control): sham  
 
Outcome measurement: area of secondary hyperalgesia  Test accuracy 
of certainty of 
evidence  
Number of studies 
(number of 
participants) 
Study design  Factors that may decrease certainty of evidence 
Risk of bias  Indirectness Inconsistency Imprecision  
2 (38 participants) 
(Pud et al., 2006, 








Pain ratings during the induction of secondary hyperalgesia (n=7) 
Seven studies (Mohammadian et al., 2004, Yucel et al., 2001, Wahl et al., 2019, Werner et al., 2002, 
Pud et al., 2006) assessed pain elicited by the induction, prior to the manipulation. Yucel et al. (2001) 
(Experiment 2) and Pud et al. (2006) reported similar pain ratings during induction with intradermal 
capsaicin injection. Mean (SD) pain ratings during intradermal capsaicin injection were 7.8 (2.0) (0 – 
10 VAS) (Yucel et al., 2001) and 7.5 (0.38) (originally reported on 0 – 100 VAS, rescaled to 0 – 10) 
(Pud et al., 2006). Yucel et al. (2001) (experiment 1) and Mohammadian et al. (2004) reported similar 
pain ratings during application of topical capsaicin. The mean pain ratings during topical capsaicin 
application were 4.05 (Yucel et al., 2001) (Experiment 1) and 4.0 (Mohammadian et al., 2004). Yucel 
et al. (2001) (Experiment 1 and 2) also pre-heated the experimental site for five minutes at 45°C 
prior to intradermal capsaicin injection and topical application, whereas Pud et al. (2006) and 
Mohammadian et al. (2004) did not. These data suggest that pre-heating may not influence pain 
ratings during induction of SH by intradermal or topical capsaicin. 
Wahl et al. (2019) and Werner et al. (2002) reported pain during a contact thermode burn injury 
induction prior to their manipulation procedures. Wahl et al. (2019) reported the mean pain 
intensity (0 – 10 VAS) during the burn injury before for each manipulation (hyperbaric oxygen 
therapy or ambient conditions) separately. This was a crossover study (i.e. participants received both 
the hyperbaric oxygen therapy manipulation and the ambient conditions on separate occasions. 
Data were reported for all participants before both hyperbaric oxygen therapy manipulation and the 
ambient conditions), therefore, there should be no difference in pain ratings during induction prior 
to each manipulation. Therefore, in this current study, the combined mean pain ratings during the 
burn injury induction, before the manipulation, was determined to be 3.15 (view Appendix 6, 
Section 6.7 for the pain ratings during induction for each group). Werner et al. (2002) reported 
median (IQR) pain ratings for each group for every minute during the burn injury induction, before 
the manipulation. In this current study, the overall median pain ratings were determined for each 
group: 3.39 for the experimental group and 3.33 for the control group (view Appendix 6, Section 6.8 
for pain during induction at each time point for each group). 
One study assessed pain ratings during topical capsaicin induction, after the manipulation with 
nicotine deprivation (Ditre et al., 2018). After the manipulation, pain ratings (0 – 10 VAS) were 
reported at 0, 5, 10, 15, 20, 25 and 30 minutes during the 30-minute application of topical capsaicin 
for the nicotine-deprived (experimental) and continued smoking (control) groups separately (view 
Appendix 6, Section 6.9 for pain during induction at each time point for each group). This current 
study determined the mean (SD) pain intensity during the 30-minute application of topical capsaicin 
to be 3.63 (3.12) for the nicotine deprivation group and 2.52 (2.31) for the control group. 
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One study performed a low-frequency electrical stimulation induction simultaneously during 
manipulation with cognitive loading in two independent experiments (Torta et al., 2019) 
(Experimental 1 and 2). The mean (SD) pain ratings (originally reported on 0 – 100 NRS, rescaled to 0 
– 10) during low-frequency electrical stimulation were 6.8 (1.9) in Experiment 1 and 6.6 (1.6) in 
Experiment 2.  
These data suggest that intradermal capsaicin injection may be the most painful induction used to 
induced secondary hyperalgesia, followed by low-frequency electrical stimulation. Similar pain 
ratings were reported during topical capsaicin application and burn injury.  
Pain during manipulation of secondary hyperalgesia (n = 2) 
One would suspect that certain manipulations, such as acupuncture, spinal manipulation, and cold 
application, might be painful. However, no studies reported on pain during those manipulations. 
Only Pud et al. (2006) and Werner et al. (2002) reported on pain during manipulation procedures, 
which were both localised application of cold. Both studies used a contact thermode for localised 
application of cold. Pud et al. (2006) reported pain ratings during the cold stimuli at 20 °C, 10 °C and 
0 °C. The combined mean (SD) pain ratings for both experimental and control arms were 0.76 (0.16) 
for the 20 °C cold stimulus, 1.33 (0.35) for the 10 °C stimulus and 2.2 (0.47) for the 0 °C cold stimulus 
(reported on 0 – 100, rescaled to 0 – 10). Interestingly, Werner et al. (2002) reported pain to 
localised application of cold (8°C) to be negligible - reporting a mean of 0 and range 0 – 1 (0 – 100 
VAS), rescaled to a range of 0 – 0.1 (0 – 10).  
Discussion  
The aim of this study was to systematically identify, collate, and describe all the published studies 
that have applied non-pharmacological manipulations intended to influence experimentally induced 
SH in healthy human participants. Investigating the effects of these non-pharmacological 
manipulations is important to improve insight into the mechanisms of SH. Manipulations thought to 
influence central processes contributing to pain were more likely to be successful in manipulating 
experimentally induced SH than manipulations thought to influence peripheral processes 
contributing to pain.  
Hypothesised main site of action: peripheral and central action 
As discussed in Chapter 1, pain is extremely complex: even the latest theoretic models of pain have 
limitations (Griffin and Tsao, 2012). Pain is influenced by many physiological processes at the 
periphery, spinal cord and brain. Nevertheless, certain manipulations will primarily influence 
afferent sensory signaling (site of principal action: peripheral), whereas others will primarily 
influence central nervous system activity (site of principal action: central). These sites of action do 
60 
 
not work in isolation; instead, peripheral and central (spinal cord and cortex) mechanisms are 
interlinked and influence each other (D'Mello and Dickenson, 2008, Stucky et al., 2001). However, 
for clarity’s sake, the results of this review are discussed with manipulations grouped by these 
presumed sites of principal action: peripheral and central. Some manipulations were not considered 
to have a principal site of action and target both peripheral and central actions. These manipulations 
were considered to have a ‘controversial’ main site of action and have been discussed separately 
below.  
Principal site of action: peripheral  
Six manipulations targeted primarily peripheral processes. These were: localised application of cold 
(Werner et al., 2002, Pud et al., 2006, Yucel et al., 2001)9 and whole-body cooling and heating (Baron 
et al., 1999). Localised application of cold and whole body cooling and heating had no effect on the 
intensity of SH (Werner et al., 2002, Baron et al., 1999). One study reported localised application of 
cold increased area of SH (Pud et al., 2006), and another reported no effect (Werner et al., 2002). 
Localised application of cold has previously been tested for reducing pain (Dehghan and Farahbod, 
2014, Ni et al., 2015, Thienpont, 2014, Algafly and George, 2007, Nadler et al., 2004, Ivey et al., 
1994, Hirvonen et al., 2006) because it is thought to inhibit peripheral inflammation (Werner et al., 
2002), thus decreasing the afferent nociception that can induce secondary hyperalgesia. Individual 
studies have found it to reduce post-operative pain after various orthopaedic procedures, of which 
SH is a common feature (Quinlan et al., 2017, Cohn et al., 1989, Barber, 2000, Bert et al., 1991, Levy 
and Marmar, 1993, Scarcella and Cohn, 1995). However, a systematic review of localised application 
of cold for reducing pain, blood loss and improving function after knee arthroplasty (Adie et al., 
2012) judged most of the evidence to be of ‘low’ or ‘very low’ quality and concluded that any benefit 
may not be clinically significant. The current results are in line with the findings of Adie et al. (2012): 
localised cold application and whole-body cooling and heating had no effect on secondary 
hyperalgesia.  
Principal site of action: central 
Thirteen manipulations targeted primarily central processes. These manipulations were: cognitive 
behavioural therapy (Salomons et al., 2014), emotional disclosure (You et al., 2014), hyperbaric 
oxygen therapy (Rasmussen et al., 2015, Wahl et al., 2019), verbal suggestion (Helfert et al., 2018), 
negative suggestion (van den Broeke et al., 2014), high attentional and cognitive loading (Kóbor et 
al., 2009, Torta et al., 2019) placebo analgesia (Matre et al., 2006), sleep deprivation (Smith et al., 
 
9 Yucel et al., 2001 reported on three studies but data were unavailable for all three studies. 
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2018), nicotine deprivation (Ditre et al., 2018) and transcranial direct current stimulation (Meeker et 
al., 2019). Each manipulation has been discussed separately below.  
Cognitive behavioural therapy  
Cognitive behavioural therapy manipulation, focused on reducing participants’ negative thoughts 
and emotions towards painful stimuli, successfully reduced the area of SH (Salomons et al., 2014). 
Cognitive behavioural therapy (CBT) has been previously been tested for reducing pain (Bergeron 
and Lord, 2003, Evans et al., 2003, Mayou et al., 1997, Monticone et al., 2015, Newton-John et al., 
1995, Thomas, 2000, Tichelaar et al., 2007) because it is thought to improve the affective and 
motivational dimensions of pain by changing unhelpful or harmful patterns of thinking or emotional 
responses (Sheldon, 2011). Two systematic reviews of CTB for chronic pain reported CBT to be 
superior to waiting list control conditions in decreasing pain; however, CBT was no better than other 
active treatments. (exercise and relaxation) (Morley et al., 1999, Monticone et al., 2015). 
Additionally, CBT in addition to other activity treatments was no better than CBT alone (Monticone 
et al., 2015). Importantly, the studies included in those reviews were deemed to have ‘low’ quality 
evidence. Another study reported statically significant improvement in self-reported disability and 
function but not in pain severity in adolescence with chronic pain (Eccleston et al., 2003). An 
important difference to note is that the clinical studies reported here used pain severity as the 
outcome, whereas the experimental study in this current review used area of SH as the outcome. 
Therefore, there are limitations in comparing the experimental study included in this current review 
with the clinical studies discussed here. Further high-quality research is required to determine and 
compare the effectiveness of CBT on general pain severity and SH (as assessed by intensity and area 
of secondary hyperalgesia).  
Emotional disclosure  
Once-off emotional disclosure successfully decreased the intensity and area of SH in both 
participants with and without a history of trauma at four days and one month after the manipulation 
(You et al., 2014). Interestingly, participants with a history of trauma had significantly reduced 
intensity and area of SH than participants without a history of trauma at both four days and one 
month after the manipulations. This suggests that the emotional disclosure manipulation was more 
effective at influencing SH in participants with a history of trauma than those without a history of 
trauma. A history of traumatic events has been reported to be associated with chronic pain 
(Goldberg et al., 1999, Nicol et al., 2016). There are conflicting reports on the use of written 
emotional disclosure of traumatic events for treating chronic pain (Lumley et al., 2012). The 
mechanisms by which emotional disclosure may decrease pain are unclear but it has been proposed 
that it may decrease pain through improving mood and decreasing psychological distress (Lumley et 
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al., 2012). However, emotional disclosure has been reported to improve negative emotions and 
psychological distress (Ullrich and Lutgendorf, 2002), enhance immune functioning (Pennebaker et 
al., 1988), and decrease clinic visits six months after the intervention (Pennebaker and Beall, 1986). 
Emotional disclosure has been reported to have delayed beneficial effects and may decrease mood 
and increase psychological distress directly after the intervention (Pennebaker and Beall, 1986, Sloan 
and Marx, 2004, Sloan et al., 2005, Lumley et al., 2012). The results in this current study support 
these reported long-term benefits, since a reduction in SH was still present one month after the 
emotional disclosure. You et al. (2014) did not induced and assess the intensity and the area of SH 
directly after the emotional disclosure. Therefore, it is unclear whether emotional disclosure only 
has delayed benefits or also reduces the magnitude of SH directly after the manipulation.  
Placebo analgesia, negative suggestion and verbal suggestion 
Placebo analgesia successfully decreased the area of SH (Matre et al., 2006). Negative suggestion 
associated with the HFS induction procedure successfully increased the intensity of SH (van den 
Broeke et al., 2014). Verbal suggestion was reported to have failed to increase the intensity and area 
of SH but data were unavailable, as discussed in the Results section (Helfert et al., 2018).  
The effect of placebo analgesia is explained by the placebo response, in which positive expectations 
lead to symptoms improving (Benedetti and Piedimonte, 2019). In contrast, the effect of negative 
suggestion10 is explained by the nocebo response, in which negative expectations leads to symptoms 
worsening (Benedetti et al., 2007). The placebo response has been studied extensively in 
experimental pain research (Benedetti et al., 2007, Benedetti and Piedimonte, 2019, Colloca and 
Benedetti, 2007). However, the same can not be said for the nocebo response due to ethical 
constraints associated with inflicting harm on participants (Colloca and Benedetti, 2007). A decrease 
or increase in anxiety has been reported to be one of the main mechanisms contributing to the 
placebo and nocebo responses, respectively, in experimental pain research (Benedetti et al., 2007, 
Benedetti and Piedimonte, 2019). Increased anxiety has been associated with increased pain 
severity ratings through upregulation of central processes contributing to pain (Colloca and 
Benedetti, 2007). Positive expectations reduce anxiety, thus may have an analgesic effect. Negative 
expectations increase anxiety, thus may have a hyperalgesic effect (Benedetti and Piedimonte, 
2019).  Interestingly, neither Matre et al. (2006) nor van den Broeke et al. (2014) assessed and 
compared anxiety levels before and after their manipulations. A recommendation for future 
 
10 van den Broeke et al. (2013) referred to the manipulation as “negative expectation”. However, as explained 
in the Risk of bias section, van den Broeke et al. (2013) did not specifically assess participants’ expectations 
and report whether their manipulations indeed did induce negative expectations. Therefore, in this current 
review, this manipulation was renamed “negative suggestion”. 
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research on placebo and nocebo responses in experimental pain research would be to assess for a 
change in anxiety.  
This author argues that Matre et al. (2006) did not provide the control participants with neutral 
information, and instead may have introduced a nocebo response. Participants in the control group 
were informed “the aim of the study was to investigate hypersensitivity of the skin after heat 
stimulus”. This information may have introduced negative expectations and therefore greater 
reported pain. Researchers conducting pain studies with the placebo response must ensure to 
provide control participants with neutral information only, to avoid inducing negative expectations. 
An additional recommendation for future research would be for researchers to assess both the 
intensity and area of SH. van den Broeke et al. (2014) assessed intensity of SH only. This is a possible 
limitation because participants in the experimental group may have felt socially obligated to report 
increased sensitivity after being informed by an authoritative figure (the researcher) that their skin 
would “become more sensitive to the pinprick stimulator”. van den Broeke et al. (2014) should have 
also assessed the area of SH, out of participants’ view.  
The results in this current review suggest the placebo and nocebo responses can manipulate SH 
through targeting central actions. However, further research is required into the specific 
mechanisms of the placebo and nocebo responses leading to a change in SH.  
Hyperbaric oxygen therapy  
Hyperbaric oxygen therapy (HB02) successfully decreased the area of SH in two experimental studies 
included in this current review (Rasmussen et al., 2015, Wahl et al., 2019) but, interestingly, failed to 
influence primary hyperalgesia (Wahl et al., 2019). This may be because primary hyperalgesia is 
thought to be peripherally mediated and HB02 primarily influences centrally mediated processes 
(Casale et al., 2019). A recent narrative review reported HB02 to be an effective treatment for 
fibromyalgia, a centrally mediated chronic pain condition (Atzeni et al., 2020). Therefore, HB02 may 
be a promising therapeutic modality for neuropathic pain.  
Interestingly, both Wahl et al. (2019) and Rasmussen et al. (2015) reported an ordered effect:  As 
described in the Results section above, Wahl et al. (2019) and Rasmussen et al. (2015) conducted 
crossover studies where sessions were separated with a washout period of at least 28 days. Despite 
this washout period, participants who received the HB02  manipulation in session one had a smaller 
area of SH in session two (when receiving the induction under ambient conditions) than those who 
received the induction under ambient conditions in session one and under HB02 in session two.   
proposed that this may be due to “a protective, preconditioning effect of the HB02”, leading to long 
lasting neuroplastic changes induced by the HB02 at session one and still present at session two 
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(under ambient conditions). This author proposes another possible explanation: the placebo 
response, but only if participants were not effectively blinded to the research hypothesis.  
In both studies it was unclear whether participants were blinded to the research hypothesis. 
Participants received “sparse information” about the experimental procedure (Wahl et al., 2019) but 
the exact details of the information given were not reported. Both studies reported that blinding to 
group allocation was not possible because of the difficulties of having a reliable sham procedure 
conducted in an unpressurised hyperbaric chamber. These challenges were not reported in both 
papers; therefore, this author consulted a research colleague with vast experience in conducting 
experimentally research with hyperbaric oxygen therapy to discuss potential challenges with 
blinding.  Some of the challenges may be that: 1) blinding would not be compelling as participants 
would soon realise that the chamber is not pressurised due to the lack of needing to equalise 
pressure build up between the middle ear and the atmosphere, and 2) even when unpressurised, 
participants would be exposed to a higher partial pressure of oxygen inside the chamber, therefore 
not accurately exposing participants to ambient conditions. A blinding assessment to ensure 
participants were blinded to the research hypothesis was not conducted in either study. Therefore, 
it is not possible to confidently conclude whether participants were effectively blinded to the 
research hypothesis. It is plausible that participants that participants knew researchers were 
investigating the analgesic effect of HB02. Therefore, participants receiving the HB02 at session one 
may have had positive expectations about the analgesic effects of HB02 that were still present at 
session two.  
There are few randomised controlled trials on the use of HB02 for treating chronic pain. More clinical 
research is required on this potentially promising treatment modality to determine its effectiveness 
for treating neuropathic pain. 
High attentional and cognitive loading  
High attentional loading successfully decreased the intensity of SH in one of three studies (Torta et 
al., 2019) (Experiment 2), but had no effect in the remaining two studies (Kóbor et al., 2009, Torta et 
al., 2019) (experiment 1). There is a large body of evidence reporting that attention is closely 
associated with reported pain severity: when participants’ attention is focused on the painful stimuli 
they report increased pain severity and when participants’ attention is focused away (distracted or 
cognitively loaded by another task) from the painful stimuli they report decreased pain severity 
(Bantick et al., 2002, Arntz et al., 1991, de Wied and Verbaten, 2001, Legrain et al., 2009, Wiech et 
al., 2005, Vlaeyen and Linton, 2000, Rode et al., 2001). However, there is limited research 
investigating whether high attentional and cognitive loading influences SH. The results of this 
current review suggest that a difficult, high engaging task can influence the intensity of SH.  
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Sleep disruption   
Sleep disruption successfully increased the area of SH in male participants; there was no effect in 
female participants (Smith et al., 2018). Sleep disruption is commonly associated with chronic pain; 
however, the direction of causation is unclear (Lautenbacher et al., 2006). A clinical study including 
patients with burn injuries reported poor self-reported sleep significantly predicted greater pain the 
subsequent day, however, greater pain during the data did not significantly predict poor self-
reported sleep the subsequent night (Raymond et al., 2001). There are conflicting reports on the 
effect of sleep deprivation on pain pressure thresholds: some studies reported sleep deprivation 
reduced pain pressure thresholds (Moldofsky et al., 1975, Moldofsky and Scarisbrick, 1976, Lentz et 
al., 1999) and some reported no effect (Drewes et al., 1997, Older et al., 1998, Arima et al., 2001); 
however, there is little research on the effect of sleep deprivation on the area and intensity of 
secondary hyperalgesia. It has been proposed that frequent sleep disruption, rather than prolonged 
sleep deprivation, influences endogenous opioid activation, leading to decreased inhibition and thus 
increased pain (Smith et al., 2007). The results of this current review are in line with reports from 
Smith et al. (2007): sleep deprivation increased the area of SH in male participants only. It is unclear 
why there was no effect in female participants. Aside from obvious hormonal differences between 
the male and female participants, another possible reason for why sleep deprivation effectively 
manipulated SH in male participants only, is that male participants had approximately 25 minutes 
less sleep than female participants. Further research is required to investigate physiological and 
hormonal changes in response to sleep deprivation and how this may influence SH in both males and 
females.  
Nicotine deprivation  
Nicotine deprivation successfully increased the intensity and area of SH (Ditre et al., 2018). Nicotine 
activates alpha-4-beta-2 nicotinic receptors and endogenous opioids, leading to an analgesic effect, 
thus nicotine deprivation among smoker is thought to increased pain through inactivation of these 
descending inhibitory mechanisms (LaRowe et al., 2018). An experimental study on a cohort of 
smokers investigating nicotine deprivation on pain severity reported an increase in pain 12 – 24 
hours after the manipulation (LaRowe et al., 2018). Interestingly, participants with no pain at 
baseline were approximately 3.5 times more likely to report pain after the manipulation. This 
supports other reports that nicotine has an analgesic effect (Ditre et al., 2016, Cosgrove et al., 2010, 
Cosgrove et al., 2009). The current results are in line with the findings of LaRowe et al. (2018): 
nicotine deprivation increases intensity and area of SH within 12 – 24 hours after the manipulation. 
The duration of increased pain after initiation of nicotine deprivation is unclear. This author 
recommends that researchers explore the duration increased hyperalgesia to nicotine deprivation. 
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Transcranial direct current stimulation  
Anodal transcranial direct current stimulation targeting the motor cortex successfully decreased the 
area of SH; however, the effect was no better than sham transcranial direct current stimulation. 
Cathodal transcranial direct current stimulation had no effect (Meeker et al., 2019). Transcranial 
direct current stimulation is thought to decrease pain through activation of the anterior cingulate 
and anterior midcingulate cortex leading to descending inhibition of nociception from the cortex to 
the spinal cord (Meeker et al., 2019, Fregni et al., 2006). A critical review reported motor cortex 
stimulation effective in reducing neuropathic pain (Fontaine et al., 2009). However, all studies 
included in that review did not have effective blinding strategies and control comparisons. The 
findings in this current study are in line with those of previous reports that anodal transcranial direct 
current stimulation is more effective in reducing pain than cathodal transcranial direct current 
stimulation  (Mylius et al., 2012, Vaseghi et al., 2015, Vaseghi et al., 2014). Although transcranial 
direct current stimulation has been reported to be effective in reducing pain, anodal transcranial 
direct current stimulation was no better than the sham in reducing the area of SH this current 
review. Therefore, this manipulation may be not be effective in influencing SH. 
Principal site of action: controversial  
Two manipulations were considered to have a controversial main site of action. These manipulations 
were acupuncture (Rebhorn et al., 2012) and spinal manipulation therapy (Mohammadian et al., 
2004).  
Acupuncture 
Acupuncture is a form of traditional Chinese medicine which has been used for treating pain for 
thousands of years (Staud and Price, 2006). The mechanisms by which acupuncture achieves an 
analgesic effect are unclear (Rebhorn et al., 2012). One proposed mechanism is that acupuncture 
targets central actions by stimulating the release of endorphins, which in turn inhibits ascending 
nociception from the spinal cord to the brain (Lin and Chen, 2008). Another proposed theory is that 
acupuncture targets peripheral actions by stimulating A-beta nerve fibres at the periphery, which 
results in competing stimuli at the dorsal horn of the spinal cord (Melzack, 1976). These competing 
stimuli inhibit nociception from the spinal cord to the cortex. This modulation of stimuli at the dorsal 





Acupuncture failed to decrease the area of SH in this current review (Rebhorn et al., 2012). There are 
conflicting data on the effectiveness of acupuncture for treating pain. Four systematic reviews 
reported acupuncture to be effective in treating pain associated with peripheral joint arthritis 
(Manheimer et al., 2010), tension-type headache (Linde et al., 2016), neck disorders (Trinh et al., 
2016), and as a migraine prophylaxis (Linde et al., 2009). Three systematic review reported data 
were inconclusive for the effectiveness of acupuncture for treating shoulder pain (Green et al., 
2005), lower back pain (Furlan et al., 2005) and lateral elbow pain (Green et al., 2002). One 
systematic review reported acupuncture to be ineffective for treating pain associated with 
rheumatoid arthritis (Casimiro et al., 2005). Acupuncture has been researched extensively: eight 
systematic review on the effects of acupuncture for different pain conditions were conducted by the 
Cochrane Group between 2002 – 2016. Despite the vast data, acupuncture is still a controversial 
treatment for pain. This may indicate that it is not an appropriate treatment managing chronic pain 
conditions.  
Spinal manipulation therapy 
Spinal manipulation therapy successfully decreased the area of SH in this current review 
(Mohammadian et al., 2004). Similarly, to acupuncture, spinal manipulation therapy targets central 
actions by stimulating the release of endorphins, which in turn inhibit ascending nociception from 
the spinal cord to the brain (Vernon et al., 1986), and targets peripheral actions through modulation 
of afferent stimuli at the dorsal horn of the spinal cord is termed The Gate Control Theory (Melzack, 
1996). Spinal manipulation therapy has been reported to be inferior to exercise for reducing chronic 
neck pain (Bronfort et al., 2001). Interestingly, a systematic review reported spinal manipulation 
therapy to be effective in reducing acute lower back pain but no better than the sham for chronic 
lower back pain (Bronfort et al., 2004). These findings were interesting since SH is a common feature 
of chronic pain. Mohammadian et al. (2004) had a high risk of reporting bias and it was unclear 
whether participants were effectively blinded to the research hypothesis and group allocation. 
Further research, with effective blinding strategies – including blinding assessments, need to be 




Secondary outcome: baseline data 
No studies reported baseline data on the intensity of SH after induction and before manipulation of 
secondary hyperalgesia. Only three of 21 studies reported baseline surface area of SH data. The 
failure to assess baseline data contributes to measurement bias and the failure to report baseline 
data contributes to reporting bias. Baseline measurements of intensity and area of SH are essential 
for establishing the efficacy of the induction method and estimating the potency of the manipulation 
by comparing the pre-manipulation (baseline) to the post-manipulation assessments (i.e. intensity 
and/or area of SH).  
Two difference induction methods were used by the three studies that reported baseline area of SH 
before manipulation: burn injury (Salomons et al., 2014, Matre et al., 2006) and topical capsaicin 
(Mohammadian et al., 2004). Matre et al. (2006) reported an area of 62.5 cm2 at session one and 52 
cm2 at session two after a burn injury induction. Possibilities for this decrease in area across the two 
sessions are discussed below. Interestingly, Salomons et al. (2014) reported a slightly a smaller mean 
area after a burn injury induction: 45.0 cm2, despite their burn injury being significantly longer (28 
minutes vs. five minutes) and being of similar temperatures (mean of 48.3 °C for the experimental 
group and 47.9 °C for the control group vs. 46 °C for all participants) to that of the burn injury 
reported by Matre et al. (2006). The mean baseline area of SH induced by topical capsaicin was 
smaller than that of the area induced by a burn injury: 40 cm2 (Mohammadian et al., 2004).  
Discrepancies in the magnitude of induced surface area of SH were recorded in two studies (Matre 
et al., 2006, Mohammadian et al., 2004). As explained in the Results section, Mohammadian et al. 
(2004) conducted a crossover study (i.e. participants received both the manipulation and the sham 
on separate occasions and data were reported for all participants before the manipulation and the 
sham), therefore, there should be no difference in baseline surface area ratings prior to each 
manipulation. However, there was a discrepancy in the pooled baseline surface area before the 
spinal therapy manipulation (46 cm2) and non-spinal therapy sham manipulation (36 cm2). 
Possibilities for this discrepancy in area are: 1) ineffective blinding of participants, 2) ineffective 
blinding of researchers conducting the outcome measurements, and 3) lack of standardisation of the 
assessor conducting the outcome measurements. Addressing points 1) and 2), Mohammadian et al. 
(2004) reported that participants and researchers conducting the outcome measurements were 
blinded to group allocation; however, blinding was not formally assessed. It is plausible that blinding 
of participants and outcome assessors could have been broken. Addressing point 3), it was not 
reported whether the same assessor conducted the outcomes measurements for both groups. It is 
plausible that two researchers conducted the outcome measures, one for each manipulation, and 
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did not use a standardised approach, leading to the discrepancy in baseline area data prior to each 
manipulation.   
Matre et al. (2006) assessed surface area of SH after a burn injury induction at two independent 
testing sessions prior to participants receiving a placebo analgesia manipulation or sham 
manipulation. The manipulation only occurred at a third independent session (sessions were 
separated by four to seven days). The median (IQR) for the area of SH was different between 
participants receiving the placebo analgesia manipulation and those receiving the sham 
manipulation at both session one and session two. Although participants were randomly assigned to 
each group those who were to receive the placebo analgesia manipulation at session three had a 
much larger area of SH at session one than those who were to receive the sham manipulation at 
session three (75 cm2 vs 50 cm2). The area of SH at session two was smaller than at session one for 
participants who were to receive the placebo analgesia manipulation: 75 cm2 in session one and 49 
cm2 in session two. Interestingly, the opposite occurred for participants who were to receive the 
sham manipulation, where the area of SH at session two was larger than at session one: 50 cm2 at 
session one and 55 cm2 session two.  
A possible reason for this discrepancy in the trend of surface area measurements across session one 
and two, could be the recruitment strategy and the different information told to participants in each 
group (placebo analgesia manipulation vs sham manipulation). Participants in the placebo analgesia 
group were recruited with a separate advertisement to those in the sham manipulation group. 
Participants in the placebo analgesia group were informed “the aim of the study was to test the 
analgesic effectiveness of a magnet against heat pain”. This information was on the advertisement 
and was repeated at the first session. This information may have been priming participants to expect 
an analgesic effect at each session, even though the magnet was only present at the third session. 
Participants in the sham manipulation group were informed “the aim of the study was to investigate 
hypersensitivity of the skin after a heat stimulus”. This information may have been priming 
participants to expect pain to increase at each session. This is a hypothesis based on findings 
reported by van den Broeke et al. (2014) (study included in this review) that negative expectations 
increase intensity of SH. Therefore, researchers need to be careful of wording on recruitment 
advertisements, study information sheets and any other verbal instructions or explanations given to 
participants in experimental pain research. The positive or negative association with the wording 
may increase or decrease pain ratings.  
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Secondary outcome: pain during induction  
Intensity of pain during induction varied based on induction method. Pain during induction and 
before manipulation of SH were reported for the following three induction procedures: intradermal 
capsaicin injection (n = 2 studies), topical capsaicin application (n = 2 studies) and thermal injury (n = 
2 studies). The reported pain ratings during induction were similar across the two studies for each 
induction method. The most painful induction method was intradermal capsaicin with mean pain 
ratings of 7.8 (Yucel et al., 2001) (experiment 2) and 7.5 (Pud et al., 2006) (reported on 0 – 100 
ratings scale and rescaled to 0 – 10). The second most painful induction method was topical 
capsaicin application with mean pain ratings of 4.05 (Yucel et al., 2001) (experiment 1) and 4.0 
(Mohammadian et al., 2004). Surprisingly, the least painful induction method was burn injury with 
pain ratings of 3.15 (Wahl et al., 2019) and 3.35 (Werner et al., 2002). 
Low-frequency electrical stimulation induction was performed during the manipulation procedure in 
two experiments reported in a single paper (Torta et al., 2019). The mean pain ratings during 
induction were 6.8 (experiment 1) and 6.6 (Experiment 2). Therefore, low-frequency electrical 
stimulation may be the second most painful induction method behind intradermal capsaicin 
injection if delivered under conditions of high cognitive loading.  
There is limited research directly comparing different methods of experimentally inducing sSH. It 
was out of the scope of this review to directly compare the effectiveness of each induction method, 
but in fact such a comparison would have been impossible because only two studies reported 
baseline data from SH assessments. Based on the limited published data available, it is not possible 
to conclude which induction method induces the most potent model of SH.  
Researchers planning experimental pain research should be mindful of these pain ratings during 
induction when deciding which induction procedure to use. Intradermal capsaicin was reported to 
be a lot more painful than a burn injury. Researchers must uphold bioethical principles when 
undertaking experimental research. When deciding which induction procedures to use, researchers 
must ensure non-maleficence and not put participants through potentially unnecessarily painful 
experiments when less painful options are available. The current data suggest that a burn injury 
induction would be less painful to an intradermal capsaicin injection induction. However, further 
research comparing the effectiveness of induction methods is indicated to allow researchers to 




Limitations of this review 
Rescaling of pain rating scales from 0 – 100 to 0 – 10 opens the data to possible inaccuracies. The 
discrepancies with anchor labelling across the studies and to a greater extent the use of labeling 
sections of the scales as representing “non-painful” sensations (Torta et al., 2019, Matre et al., 2006) 
added to the imprecision and limited the reliability of comparing ratings data. Standardisation of 
anchors for sensation and pain ratings scales ensure is required to allow for accurate comparisons of 
different induction and manipulation modalities.   
Much of the data were extracted from plots, with no raw data being reported. Some plots were not 
clearly visible. Even though data were extracted in duplicate, independently and discrepancies were 
compared, there could still be inaccuracies in the data points read from the plots. Additionally, some 
studies included 3-D bar graphs. Although the evidence is not conclusive, it has been argued that 3-D 
bar graphs may be more difficult for the reader to examine and produce more inaccuracies in 
judgement than when examining a 2-D bar graph (Siegrist, 1996). To combat these limitations, 
researchers need to make their raw data accessible to the public through online platforms such as 
Open Science Framework, for example (Piedra et al., 2016).  
Open access to raw data will also assist with combating high clinical heterogeneity. In this current 
review, here was high clinical heterogeneity among the study designs, which limited the ability of 
conducting the meta-analysis. Open access to raw data allows researchers to be able to get unbiased 
estimates of the effect size when conducting meta-analyses.  
Lastly, the blinding strategies were poor in the included studies in this review. None of the studies 
assessed if blinding was upheld among participants and researchers. This opened studies up to 
unclear and high risks of performance and measurement bias. Researchers conducting experimental 
research needed to be mindful of this and ensure to thoroughly report on blinding strategies and 
always assess if blinding was upheld among both participants and researchers.  
Strengths of this review  
To this author’s best knowledge, this is the first review to systematically identify, appraise and 
compare non-pharmacological modalities used to manipulate experimentally induced secondary 
hyperalgesia. This review provides some insight into the mechanisms underlying SH and guides 





In conclusion, 21 non-pharmacological manipulations used to manipulate SH were identified by this 
review. Nine (of 12) successfully increased or decreased the magnitude of SH, as assessed by the 
intensity and/or area of SH. Manipulations hypothesised to mainly target central actions were more 
effective in manipulating SH than manipulations hypothesised to mainly target peripheral actions. 




Chapter 3: Experimental study  
Introduction  
Chronic pain can be partially attributed to structural and functional changes in the central and 
peripheral nervous systems, referred to as central and peripheral sensitisation, respectively 
(Sandkühler and Gruber-Schoffnegger, 2012, van Wilgen and Keizer, 2012). Some of these changes 
cause the nervous system to respond more strongly to input, specifically within the neuronal 
synapses of the dorsal horn of the spinal cord (Sandkühler and Gruber-Schoffnegger, 2012). This 
enhanced synaptic activity is termed ‘spinal long-term potentiation’ (LTP) because it resembles the 
hippocampal long-term potentiation that is thought to support memory (Ji et al., 2003). Spinal LTP 
underlies the amplification and prolongation of nociceptive afferent stimuli (Nickel et al., 2012). As 
such, it is an important physiological mechanism that contributes to central sensitisation and 
increased pain sensitivity. 
Spinal LTP likely contributes to three important clinical phenomena that are commonly found in 
patients with neuropathic pain: allodynia, primary hyperalgesia and SH (Jensen and Finnerup, 2014). 
Allodynia is increased sensitivity to a stimulus that is normally non-painful (Merskey and Bogduk, 
1994). Hyperalgesia is formally defined as “increased pain from a stimulus that normally provokes 
pain” (Merskey and Bogduk, 1994) and can occur within the area of tissue damage (primary 
hyperalgesia) and/or adjacent to the area of tissue damage (secondary hyperalgesia). Although 
spinal LTP can be assessed using multiple outcomes, this study will focus on these three specific 
indicators of spinal LTP.  
There are many experimental methods to induce SH (refer to the systematic review in Chapter 2 
where many methods for inducing SH are discussed), including repeated thermal stimulation 
(Salomons et al., 2014), high-frequency electrical stimulation (HFS) (Henrich et al., 2015), low-
frequency electrical stimulation (Klein et al., 2004), and intradermal or topical application of 
capsaicin (Serra et al., 2004). High-frequency electrical stimulation (HFS) is a reliable method to 
induce an experimental (i.e. short-lived) form of SH (Klein et al., 2008, Klein et al., 2004, Vo and 
Drummond, 2013, van den Broeke and Mouraux, 2014). The half-life of SH after HFS induction was 
4.9 hours, in a sample of 55 healthy human subjects (Pfau et al., 2011). This indicates that HFS is a 




Reports (refer to systematic review in Chapter 2) have shown that experimentally induced SH can be 
manipulated with pharmacological and non-pharmacological modalities (Andersen et al., 1996, van 
den Broeke et al., 2014, Ditre et al., 2018). For example, cognitive behavioural therapy intended to 
reduce negative emotions and thoughts related to pain has been shown to reduce thermally induced 
SH (Salomons et al., 2014). However, the mechanisms underlying this effect are unclear. The effect 
could be attributed to a reduction in the threat value of the stimulation, or to other consequences of 
the cognitive behavioural therapy intervention, such as inducing neuroplastic changes in the regions 
of the brain associated with descending inhibitory control of nociception, leading to a decrease in 
central sensitisation at the dorsal horn of the spinal cord. Additionally, inducing negative 
expectations of pain sensitivity increases the intensity of SH after HFS induction (van den Broeke et 
al., 2014). These reports indicate that SH can be manipulated with non-pharmacological modalities, 
via descending cortical mechanisms.  
Pain is known to be influenced by the threat value of a stimulus (Arntz and Claassens, 2004, Wiech et 
al., 2010b). Instructions signifying that a stimulus will be of high intensity appear to increase 
reported pain intensities of the stimulus, despite the intensity of the stimulus being unchanged 
(Moseley and Arntz, 2007). The meaning behind a stimulus - for example, the degree to which a 
person feels threatened that the stimulus can cause tissue damage - is subjective (Arntz and 
Claassens, 2004). Personal and cultural beliefs, previous experiences, and expectations all play a role 
in determining the threat value of a stimulus. However, the physiological mechanisms by which 
threat influences pain are unclear. Specifically, it is not known if threat influences the extent to 
which synaptic activity is enhanced after sustained or intense neural signalling (spinal LTP). 
Therefore, the aim of this study was to investigate the effect of a manipulation of the threat value of 
a stimulus on experimentally induced SH in healthy human volunteers. 
The objectives of the study were:  
a) to differentially manipulate the threat associated with high-frequency electrical stimulation 
at two different sites within each participant;  
b)  to assess and compare (1) intensity ratings (primary outcome) and (2) surface area 
(secondary outcome) of experimentally induced SH (as assessed using mechanical punctate 
stimulation) between the sites, and  
c)  to assess and compare intensity ratings given (exploratory outcomes) for static light touch, 
dynamic light touch, and a single electrical stimulation, before and after the experimental 
induction of SH, between the sites.  
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It was hypothesised that greater threat will be associated with (hypothesis 1) greater intensity and 
(hypothesis 2) greater surface area of induced SH. Data obtained from assessing static light touch, 
dynamic light touch and single electrical stimulation will be used for exploratory purposes only. 
Methods  
Study design  
The study was designed as a within-subject, double-blinded, experiment. It was conducted at the 
University of Cape Town, South Africa. The protocol was approved by the Faculty of Health Sciences 
Human Research Ethics Committee (REF 498/2019) (Appendix 7), University of Cape Town.    
Piloting procedure  
An extensive piloting procedure was conducted to ensure the effectiveness of the threat 
manipulation procedure. This author predicted that it may be difficult to make participants feel 
threatened due to the controlled environment associated with experimental research paradigms. 
Throughout the piloting procedures, this author conducted open interviews with participants after 
each piloting procedure to obtain feedback on the effectiveness of the threat manipulation. Below is 
a summary of the piloting process including the objectives of each stage, themes arising from the 
post-procedure interviews, outcomes of each stage and amendments made to the threat 
manipulation (Tables 11, 12 and 13). 
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Piloting: stage one 
Table 11 Outlining the objectives, outcome, reflections, and strategies used to overcome the challenges of piloting stage one 
Number of participants:  
n = 10 
 
Objective: To assess the effectiveness of a visual threat manipulation consisting of images of injured (assumed to be threatening - 
experimental) and uninjured (control) upper limbs.  
 
Themes arising from post-procedure interviews:  
- Difficulty in obtaining images of arms belonging to a variety of skin colours – potentially influencing the relatability of the 
threat manipulation to participants with difference skin colours to those in the images.  
- Participants were not concerned about potential tissue damage to their own arm while viewing images of other people’s 
injured arms.  
- The threat manipulation was not personal enough and therefore did not evoke a sense of threat in the participants.  
 
Outcome: The visual threat manipulation was not effective in producing a plausible threat of tissue damage in the participants.  
 
Amendments to the threat manipulation:  
Goal: to make the threat more personal 
- the threat manipulation was changed to be an audio voice recording explaining the potential risks of the HFS procedure.  





Piloting: stage two  
Table 12 Outlining the objectives, outcome, reflections, and strategies used to overcome the challenges of piloting stage two 
Number of 
participants:  
n = 9 
 
Objective: To assess the effectiveness of an audio threat manipulation consisting of threatening (experimental) and non-threatening (control) information about the 
HFS procedure. This is a similar threat manipulation to that used by Van Damme et al. (2008) in which participants were given either threatening or neutral 
information about a cold pressor test prior to immersing their hand into the bucket of cold water. Using self-reported anxiety and catastrophic thoughts about the 
cold pressor test as the manipulation check, Van Damme et al. (2008) concluded that this threat manipulation was effective. 
 
Themes arising from post-procedure interviews:  
- Participants trusted that the HFS procedure would not be harmful and assumed the researchers were being excessively cautious. 
- Participants who were socially acquainted with the researchers were particularly trusting and did not find the threat manipulation compelling.  
- Again, the threat manipulation was not personal enough to evoke a personal threat of tissue damage.  
 
Outcome: The audio threat manipulation was not effective in producing a plausible threat of tissue damage in the participants. 
 
Amendments to the threat manipulation:  
Goal: To make the threat manipulation even more personal.  
- The threat manipulation was further adapted to a sham skin examination procedure. In this procedure the integrity of participants’ skin around the HFS site 
was ‘assessed’ (sham). 





Piloting: stage three  
Table 13 Outlining the objectives, outcome, reflections, and strategies used to overcome the challenges of piloting stage three 
Number of participants:  
n = 6 
 
Objective: To assess the effectiveness of a sham skin examination procedure for the threat manipulation. This is a similar threat 
manipulation to that used by Wiech et al. (2010). In that study, a sham skin integrity test was conducted in which areas of the skin at 
the site intended to receive laser stimulation were initially categorised as either “fully approved” for the delivery of laser stimulation or 
“approved with reservations”. Participants were informed that the sites that were “fully approved” were strong enough to withstand 
the laser stimulus. But the site “approved with reservations” needed close monitoring to prevent tissue damage during the laser 
stimulation. Using pain ratings from the laser stimulus as a manipulation check, 
Wiech et al. (2010) concluded this threat manipulation to be effective in their cohort. 
 
Themes arising from post-procedure interviews:  
- The researcher conducting the experiment was able to figure out which arm was receiving the HFS under a condition of threat 
and which was not, thus rendering them unblinded. During this piloting stage, participants were randomised into two groups: 
Group 1 received the HFS under a condition of threat on the right arm and Group 2 received HFS under a condition of threat on 
the left arm. The researcher conducting the experiment knew whether participants were in Group 1 or Group 2 but was naïve 
to site allocation for each group, i.e. they were not informed which arm received the HFS under a condition of threat in each 
group. However, after conducting informal interviews with the researcher, it became apparent that the researcher was able to 
fairly accurately estimate site allocation, based on participants’ facial expressions during the HFS procedure and verbal 
feedback from participants after the procedure. Therefore, rendering them unblinded for the subsequent participant.   
- This threat manipulation was conducted on a very small cohort. Therefore, it was underpowered to perform statistical 
comparisons to determine whether there was a significant difference in anxiety ratings and/or threat ratings between site 
allocation (i.e. which arm received the HFS under a condition of threat). However, based on informal feedback discussions with 
participants, this threat manipulation was deemed to be the most compelling.  
 
Outcome:  




Amendments to the threat manipulation:  
Goal: ensure blinding of the researcher conducting the experiment.  
To achieve this goal, three researchers were involved in running the procedure to ensure blinding of the researcher conducting the 
outcome measurements. The first, independent researcher randomly allocated participants to site allocation, i.e. which arm would 
receive the HFS under a condition of threat. A second, independent assistant designated the site allocation in the Affect5 programme. 
The third researcher conducted the full HFS procedure and outcome measurements without being informed of the site allocation. 
Additionally, the third researcher (conducting the full HFS procedure and outcome measurements) completed a blinding assessment 
where they were asked two questions: 1) “Which arm do you think received the HFS under a condition of threat?” and 2) “How 
confident are you in your answer to the previous questions?” (answered on a on a five-point Likert scale consisting of “not at all 
confident”, “not confident”, “neutral”, “confident”, “extremely confident”).  
 






Volunteers were recruited from the general public using advertisements, social media channels such 
as Facebook and Twitter, and word of mouth (Appendix 8). Volunteers were sent the study 
information sheet outlining the details of the procedure via email. Volunteers were screened for 
exclusion criteria by completing an online eligibility quiz using the Responster platform 
(https://responster.com) (Appendix 9). After completing the screening quiz, eligible volunteers were 
contacted via email to organise a booking. Volunteers not eligible for this study were thanked for 
their interest and given the opportunity to have their details added to the research team’s database 
for notifications about future studies. Participants were able to withdraw from the study at any 
stage during the procedure or up to 48 hours after the procedure. They were compensated 
ZAR10011, in cash, for their time and inconvenience, even if they withdrew from the study. However, 
no participants withdrew.  
Inclusion and exclusion criteria  
Volunteers needed to be healthy, pain-free adults between the ages of 18 – 65 (to control for the 
possible presence of age-related peripheral loss of sensation), be able to consent autonomously, and 
be fluent in speaking, understanding and reading English (all as per volunteers’ self-reports).  
Volunteers were excluded from the study if they reported one or more of the following: chronic pain 
– pain for most days for the past three months (Blyth et al., 2001), pain on the day of testing, self-
reported pregnancy, electronic implant (e.g. pacemaker), any kind of heart/cardiovascular problem, 
diabetes mellitus, neurological problems (e.g. epilepsy), peripheral vascular disease, problems with 
skin healing, use of analgesics within 24 hours before testing, use of medication that could alter skin 
sensitivity or healing (analgesic medication, topical medical creams or immune modulators, for 
example), history of psychiatric problems (fear or anxiety disorder, or clinical depression, for 
example), and previous participation in this study or a closely related study. Additionally, volunteers 
with upper limb tattoos distal to the anode were ineligible to participate as some tattoo inks contain 
metals. Tattoo ink containing iron oxide (usually within black pigmented tattoos) theoretically can 
conduct an electrical current (Ross and Matava, 2011). Therefore, applying HFS near these tattoos 
could cause minor skin burns. Due to difficulty identifying the composition of tattoo ink, all 
volunteers with tattoos at or distal to the intended site of the anode were excluded from 
participating in this study. Table 14 summarises the inclusion and exclusion criteria.  
  
 
11 On 13 March 2020 ZAR100 was equivalent to USD6,21  
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Table 14 Inclusion and Exclusion Criteria to be eligible to participate in the experimental study 
Inclusion criteria Exclusion criteria 
Between the ages of 18 - 65 Chronic pain (pain most days for the past three months) 
Provide written informed consent Pain on the day of testing  
 Usage of analgesics within 24 hours of testing 
 Sensory impairments  
 Mental illnesses (depression and anxiety were 
considered mental illnesses for this study) 
 Self-reported pregnancy  
 Electrical or metal implants  
 Upper limb tattoos distal to anode.   
 Cardiovascular conditions 
 Diabetes mellitus  
 Neurological problems e.g. epilepsy  
 Peripheral vascular disease 
 Usage of medication that could alter skin sensitivity or 
healing (e.g. analgesic medication, topical medical 
creams or immune modulators) 
 
Roles of researchers involved in this study  
Three researchers and one research assistant were involved in this experimental study. Each person 
had specific roles to ensure blinding, where necessary, and to ensure that the procedure was well-
organised and ran smoothly. 
Researcher 1: 
- Conducted randomisation of participants for site allocation, i.e. which arm (left or right) 
would receive the HFS under a condition of threat.  
- Re-coded the participants’ site allocation prior to statistical analysis to ensure blinding of 
Researcher 3 during analysis.  
Researcher 2:  
- Conducted the experimental procedure and sensory testing. 
Researcher 3:  
- Conducted the statistical analysis.  
Research assistant:  
- Designated the site allocation in the Affect5 programme to ensure blinding of Researcher 2 
during the experimental procedure and sensory testing. 
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Randomisation and blinding  
Participants received the HFS on both forearms separately. High-frequency electrical stimulation was 
delivered to one arm under a condition of threat (experimental) and to the other arm under a 
neutral condition (control), thus providing a within-subject comparison. An Excel sheet was used to 
randomise site allocation. First, 13 instances of both Group 1 (receiving the HFS under a condition of 
threat on the right arm) and Group 2 (receiving the HFS under a condition of threat on the left arm) 
were entered into Excel to account for a sample size of 26 (see Sample size calculations below). The 
list was then randomised (Appendix 10). Second, papers stating either ‘Group 1’ or ‘Group 2’ (13 for 
each group) were placed into 26 opaque envelopes. The envelopes were numbered on the outside 
to match the order specified by the Excel sheet. Third, the envelopes were used in the order 
specified by the numbers written on them. Researcher 2 (who conducted the assessments) gave the 
sealed envelope to the research assistant who opened the envelope and designated the site 
allocation in the Affect5 programme while Researcher 2 was outside the room. Researcher 2 was 
thus unaware of participants’ site allocation.  
Blinding of participants  
Participants were blinded to the study goals: they were informed that the researchers were 
investigating how people experience painful and non-painful stimulations.  
Blinding of the researchers conducting the experiment 
Researcher 2, who conducted the measurement and sensory testing, was blinded to site allocation, 
i.e. which arm (right or left) received the HFS under a condition of threat, thus mitigating verification 
bias. Researcher 2 completed a blinding assessment after participants received the HFS and before 
the sensory testing battery. The blinding assessment consisted of two questions: first, Researcher 2 
was asked which arm she thought received the HFS under a condition of threat. If she was uncertain, 
she was instructed to guess. Second, Researcher 2 rated her confidence in her answer to the first 
question on a five-point Likert scale consisting of “not at all confident”, “not confident”, “neutral”, 




Blinding of the researchers undertaking statistical analyses  
Researcher 3, who was performing the statistical analyses, was blinded to site allocation while 
conducting the analyses. Prior to the statistical analysis being performed, Researcher 1 re-coded 
participants’ site allocation. As explained above, participants in Group 1 received the HFS under a 
condition of threat on their right arm (left arm was the control site) and participants in Group 2 
received the HFS under a condition of threat on their left arm (right arm was the control site). 
Participants’ site allocation was re-coded to “Condition A” or “Condition B”, as follows:  
Condition A:  
- Participants in Group 1 and ratings data from their right arm 
- Participants in Group 2 and ratings data from their left arm  
Condition B:  
- Participants in Group 1 and ratings data from their left arm  
- Participants in Group 2 and ratings data from their right arm  
Therefore, condition A consisted of outcome measurements on the arm receiving the HFS under a 
condition of threat and condition B consisted of outcome measurements from the arm not receiving 
the HFS under a condition of threat. Condition A and B were interpreted by Researcher 3 after all 
analyses were completed.   
Sample size calculation   
Pilot data and the GLIMMPSE online calculator (Kreidler et al., 2013) were used to estimate the 
sample size required to achieve 80% power to detect a minimum 5-point difference on the Sensation 
and Pain Ratings Scale (SPARS) (see explanation of scale below), which is a scales that has a 100-
point range, in SH with alpha set at 0.05. A mixed linear regression was planned, in which the 
dependent variable was the mean SPARS rating to both pinprick stimulators (128 and 256 mN) at 
each time point after HFS, minus the equivalent mean rating at the baseline time point (before HFS). 
The model structure allowed each participant to have their own intercept (i.e. individual participant 
(ID) was a random factor). The independent variable ‘condition’ (i.e. experimental or control site) 
was a fixed factor, and the repeated measures variable ‘time’ was nested within and fully crossed 
with ID, because each participant was assessed at each time point. In the lme4 package (Loy and 
Hofmann, 2014, Bates et al., 2015) of R (version 3.5.3 (2019-03-11)), the model structure would be: 
lmer(rating ~ condition + (1|ID/time). 
This study focused on detecting a main effect of condition. GLIMMPSE estimated that a sample size 
of 25 participants was required. Therefore, a sample size of 26 was used to allow for 




High-frequency electrical stimulation was provided using a constant current stimulator (DS7A, 
Digitimer Limited, Hertfordshire, UK). The electrical impulses were controlled by the software 
programme Affect5 (Spruyt, 2010). Current was directed from the DS7A to a pair of electrodes. The 
electrodes consisted of two cathodes and two anodes. The cathodes had 10 blunt steel pins 
arranged in a circle (Fig 2) and were secured to both anterior forearms. The anodes were large 
surface electrodes (Fig 3), which were secured to both upper arms (Fig 4). 
 
Figure 2 Image of cathode with 10 blunt steel pins arrange in a circle 
 





Figure 4 Image of arrangement of cathode secured with double-sided tape to the participant's anterior forearm and anode 
secured with Velcro to participant's mid-upper arm 
Manipulated variables 
High-frequency electrical stimulation  
The cathodes were secured on the anterior aspects of both the participant’s forearms, with a 
double-sided sticker, approximately eight centimetres distal to the cubital fossa, and avoiding any 
visibly prominent vasculature. Large surface electrodes were placed around both upper arms and 
served as the anodes. 
The appropriate intensity of the HFS depended on the electrode used and individual’s electrical 
detection threshold. The electrodes in this study most closely resembled those used by Klein et al. 
(2004), Klein et al. (2008) and Henrich et al. (2015). Their work and pilot work done by this current 
study’s authors have shown robust SH with HFS delivered at 100Hz, at a current of ten times the 
individual detection threshold.  
Participants were orientated to the electrical stimulus (refer to the Procedure section) and the 
stimulus was calibrated to the participant’s individual electrical detection threshold. This calibration 
consisted of single electrical stimuli, with a pulse width of two milliseconds. An adaptive staircase 
approach was used to determine the individual electrical detection threshold. The electrical 
detection threshold was used to determine the intensity of the HFS: ten times the electrical 
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detection threshold. Klein et al. (2004) reported participants’ electrical detection threshold to be 
0.11 ± 0.06 mA (mean ± SD). Therefore, it was anticipated that the range of currents would be 
similar in this current study. 
The high-frequency electrical stimulation consisted of five one-second trains, two milliseconds pulse 
width, of 100 Hz frequency, with a nine second break between sequential trains. The intensity of the 
stimulation was ten times the participant’s individual electrical detection threshold. 
Threat manipulation  
The threat manipulation procedure was similar to that used by Wiech et al. (2010) and consisted of a 
sham skin examination. In that study a sham skin integrity test was conducted whereby areas of the 
skin at the site of laser stimulation were initially equally categorised into two categories: “fully 
approved” and “approved with reservations”. Half of the skin sites were graded as strong enough to 
withstand the laser stimulus (the “approved” category) and the other half were graded as needing 
close monitoring by the participant during the laser stimulation to prevent tissue damage (the 
“approved with reservations” category). This sham skin test is presumed to have resulted in a 
perception that the laser stimulus would be more threatening at certain skin sites compared to 
others. Participants reported increased pain severity and anxiety when the laser stimulus was 
applied over the skin sites categorised as “approved with reservations” than when it was applied to 
the “approved” skin sites. Furthermore, the functional magnetic resonance imaging found that the 
threat manipulation resulted in increased activity within the mid-cingulate cortex and anterior insula 
– areas of the brain associated with the perception of threat – during the application of the laser 
stimuli. Similarly, in this current study, the sham skin examination was conducted after the baseline 
sensory assessment and before participants received the HFS. Researcher 2 informed the 
participants that they were examining the robustness of the skin around the electrodes, while using 
an otoscope to shine light onto the skin and magnify the view of the area. The purpose of the sham 
skin examination was framed as to determine the risk of skin damage associated with that site 
undergoing HFS. The (sham) results were shown on a computer screen not visible to the researcher 
(Fig 5, 6, 7 and 8). For each participant, the experimental site was deemed “approved with 
reservations” on the screen, with participants instructed to monitor their “fragile” skin closely during 
the HFS as there was “moderate risk of injury”. For the control site, “fully approved” was reported 
on the screen, with participants informed that the skin is “robust” and there was “low risk of injury”. 
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Threat manipulation check  
The effect of the manipulation was assessed by comparing 1) pain ratings, 2) self-reported anxiety, 
and 3) self-reported fear of tissue damage between each arm during the HFS induction. A mixed 
model analysis was used to compare ratings of the HFS trains between each arm. A main effect of 
condition (receiving the HFS under a condition of threat or neutral conditions) on ratings was tested, 
whilst allowing for a random intercept for each participant.  
Measured variables  
Participants verbally reported sensation or pain ratings using the SPARS (Fig 9) (Madden et al., 2016, 
Madden et al., 2019b, Madden et al., 2019a). This scale is useful as it provides for a range of non-
painful and painful sensory experiences. The non-painful range, on the left-hand side of the scale, 
ranges from -50 – “no sensation” – to 0 – “the exact point at which what you feel transitions to 
pain”. The SPARS is sensitive to change in both painful and non-painful sensory experiences 
(Madden et al., 2019a).  
Figure 8 Sham skin examination results shown on computer 
screen to each participant. This image was used to induce a 
context of threat of HFS stimulation at the right forearm 
Figure 7 Sham skin examination results shown on computer 
screen to each participant. This image was used as a control 
for the right forearm. 
Figure 6 Sham skin examination results shown on computer 
screen to each participant. This image was used to induce a 
context of threat of HFS stimulation at the left forearm. 
Figure 5 Sham skin examination results shown on computer 
screen to each participant. This image was used as a control 




Outcome measurements  
Primary outcome 
Mechanical punctate stimulation  
Mechanical punctate stimulation was provided with two pinprick stimulators (MRS Systems, 
Heidelberg, Germany), exerting forces of 128mN and 256mN. Increased SPARS ratings to these 
modalities in the region surrounding the distal electrode, after the HFS, indicated the presence of 
SH. The mean SPARS ratings of the two different pinprick weights were used to determine the 
overall mechanical punctate stimulation rating.   
Secondary outcome  
Mapping surface area of secondary hyperalgesia  
The area of SH was mapped using the eight-radial-lines approach (Fig 10 and 11) and a pinprick 
stimulator exerting a force of 128mN (You et al., 2014). 




Figure 11 Image showing the mapping of the 8 radial lines  
at 45° angles on a participant’s forearm. Each dot was  
separated by 1 centimeter. 
 
Exploratory outcomes  
Static light touch  
Static light touch sensation was assessed with application of a von Frey filament (MARSTOCK, 












Figure 10 Graphical representation of the 8 radial lines, intersecting 
at 45° angles, labelled A – H. 
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Dynamic light touch  
Dynamic light touch was measured using a cotton wisp and soft brush stroke. Henrich et al. (2015) 
reported increased non-painful dynamic light touch sensation using cotton wool and a soft brush 
stroke one to two centimetres over the skin surrounding the area where the stimulus was provided. 
In that study participants were asked to report pain (with the instruction that any sensation felt as 
pricking or burning should be reported as painful) on a numerical rating scale, where “0 = no pain 
and 100 = most intense pain imaginable”. This approach was adapted slightly in this current study by 
asking participants to report their sensation or pain ratings using the SPARS. Dynamic light touch 
stimulations are typically perceived as non-painful in unsensitised areas as they only activate low-
threshold mechanoreceptors (Leem et al., 1993). Therefore, allodynia was deemed present if 
participants indicated pain to dynamic light touch after HFS.  
Single electrical stimulation  
A single electrical stimulation was used to assess primary hyperalgesia. The electrical stimulus was 
two milliseconds long with an intensity of ten times the individual’s electrical detection threshold 
(Henrich et al., 2015).  
Questionnaires 
A history of previous trauma has been associated with increased area of SH (You et al., 2016). 
Women reporting childhood trauma and/or recent trauma displayed a larger surface area of SH after 
application of topical capsaicin than women without a history of trauma (You et al., 2016). 
Therefore, data from the Childhood Trauma Questionnaire short form (CTQ-SF) and a modified 
version of the World Health Organisation Composite International Diagnostic Interview for post-
traumatic stress disorder (WMH-CIDI) were used in a secondary analysis, to investigate the 
relationship between a history of trauma and experimentally induced secondary hyperalgesia, in an 
attempt to replicate the work by You et al. (2016a). Participants also completed several other 
questionnaires: 10-item Connor-Davidson Resilience Scale, Cohen’s Perceived Stress Scale, Pain 
Catastrophising Scale, Multidimensional Scale of Perceived Social Support, and 16-item Pain 
Vigilance and Awareness Questionnaire, which were used for exploratory analyses to inform the 
development of future research questions only. Therefore, data from all those questionnaires have 
not been reported in this current study. The full list of questionnaires includes: 
1. Basic demographic and participant information questionnaire, which included the 
following items: participant ID code, group allocation, age, sex, ethnicity, medication 
use, caffeine intake, hand dominance, detection threshold on each arm, and time and 
day of procedure (Appendix 11).  
91 
 
2. Childhood trauma and adult trauma were screened for using the Childhood Trauma 
Questionnaire (CTQ-SF) (Bernstein et al., 2003) and a modified version of the World 
Mental Health Survey Initiative version of the World Health Organisation Composite 
International Diagnostic Interview for post-traumatic stress disorder (WMH-CIDI) 
(Kessler et al., 2004), respectively. The CTQ-SF focuses on 5 criteria: emotional abuse, 
physical abuse, sexual abuse, emotional neglect, and physical neglect (Appendix 12).  
The modified version of the WMH-CIDI has questions drawn directly from the WMH-CIDI 
(Kessler et al., 2004). The modified version aims to determine whether participants have 
been through specific traumatic events. It was used as an inventory and the researcher 
did not investigate the details of the traumatic event (Appendix 13).  
3. A customised questionnaire was used to check the threat manipulation. After the 
procedure, participants were asked to indicate on a five-point Likert scale the extent to 
which they agreed or disagreed with the following statements: “At the time of receiving 
the intense electrical stimulation, I was concerned that it would cause damage to my 
skin on my right/left arm” and “At the time of receiving the intense electrical stimulation 
on my right/left arm, I felt anxious”. Participants completed these questions with 
reference to each arm separately (Appendix 14).  
4. Resilience was assessed using the 10-item Connor-Davidson Resilience Scale (CD-RISC-
10) (Campbell-Sills and Stein, 2007), which is a validated, shortened version of the 25-
item Connor-Davidson Resilience Scale (CD-RISC) (Appendix 15). 
5. Stress was assessed using Cohen’s Perceived Stress Scale (PSS) (Lee, 2012, Cohen, 1988) 
(Appendix 16). 
6. Pain catastrophising is associated with increased pain sensitivity (Sullivan et al., 2005). 
Therefore, the Pain Catastrophising Scale (PCS) – a valid and reliable outcome measure – 
was used to assess participants’ catastrophic thoughts about pain (Sullivan et al., 1995). 
The instructions and text of this scale were modified to prompt participants to respond 
with reference to their thoughts during the HFS (Appendix 17). 
7. Pain can be influenced by perceived social support. Social support has been shown to 
decrease pain intensity (López-Martínez et al., 2008). Therefore, participants’ perceived 
social support was assessed using the Multidimensional Scale of Perceived Social 
Support (MSPSS) (Zimet et al., 1990). The MSPSS is a 12-item scale on which participants 
respond to certain statements about the support they receive from family, friends and a 
significant other using a 7-point Likert-type scale ranging from “very strongly disagree” 
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to “very strongly agree”. It has been shown to be valid with a South African cohort 
(Bruwer et al., 2008) (Appendix 18).  
8. Attention to pain and changes in pain were assessed using the 16-item Pain Vigilance 
and Awareness Questionnaire (PVAQ) (McCracken, 1997). The PVAQ is a valid 
questionnaire for assessing awareness, intrusion and monitoring of pain in non-clinical 
samples (McWilliams and Asmundson, 2001) (Appendix 29).   
These questionnaires do not require expert training to administer. They were all administered via a 
computer. To ensure confidentiality, the researcher did not have viewing access to the relevant 
computer screen while the participant completed the questionnaires.  
Semi-structured interview  
After the threat manipulation check, Researcher 2 asked participants why they did/did not feel 
anxious of fearful about the HFS induction. Researcher 2 wrote down direct quotes of participants’ 
responses. These responses were used to gain further insight into the effectiveness of the threat 
manipulation.  
Post-hoc analyses  
Post-hoc analyses were performed on the mean (range) of the Pain Catastrophising Scale (Sullivan et 
al., 1995) and the 10-item Connor-Davidson Resilience Scale (Campbell-Sills and Stein, 2007). These 
analyses were not initially planned nor described in this study’s protocol. These analyses were 





Overview of procedure  
The procedure was conducted in a small and quiet room in the Research Laboratory in the 
Department of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital, Cape Town. The 












Researcher 2  
A postgraduate student was hired and trained to conduct the experimental procedures (Researcher 
2). Researcher 2 underwent extensive training to learn how to perform the HFS procedure safely and 
conduct the sensory measurements accurately. She used a formal script (Appendix 20) during the 
procedure to standardise all the information presented to participants. She conducted all the formal 
data collection.  
Preparation 
Before the experimental procedure, Researcher 2 used a formal checklist to ensure accurate 
preparation of the procedure (Appendix 21). Participants were asked to re-read the study 
information sheet (Appendix 22), confirm that none of the exclusion criteria (Appendix 24) applied, 
and sign the document of informed consent (Appendix 24). Thereafter, participants were asked to 
remove any jewellery (rings, watch or bracelets) from their arms and to turn off mobile phones or 
smart watches so that they would not be distracted by any alerts during the procedure. Participants 
were clearly briefed about the HFS procedure by Researcher 2. 
  
0 
Figure 12 An overview of the experimental procedure. Quantitative sensory testing (QST) occurred at 20, 26, 32, 38, 40, 50, 56 and 60 
minutes after the HFS and has been represented at each timepoint by an asterisk.  


























20       26       32        38       40       44       50        56       60  
QST    QST     QST     QST    QST    QST     QST     QST    QST  
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Researcher 2 used a stencil to mark locations for the electrodes and to mark eight surrounding radial 
lines, arranged at 45-degree angles to one another, on the participant’s skin. The anodes and 
cathodes were secured to both of the participants’ forearms, as described above in the Manipulated 
variables section. 
Participants were orientated to the SPARS and the sensory testing battery. This orientation consisted 
of an explanation of how to use the SPARS and a brief demonstration of each of the sensory tests on 
Researcher 2’s arm (Refer to the script in Appendix 20). Participants had an opportunity to practice 
using the SPARS while Researcher 2 ran through a practice round of the sensory testing battery.  
Individual electrical detection threshold  
Participants were orientated to the electrical stimulus and the stimulus was calibrated to the 
participant’s individual electrical detection threshold. This calibration consisted of single electrical 
stimuli, with a pulse width of two milliseconds. The intensity started at zero and slowly increased 
until the participants reported that they could feel it. Participants were asked to ‘say yes’ if they felt 
it, even a little bit. They were informed that the electrical stimulus would feel like a very tiny 
pinprick. This adaptive staircase approach was used to determine the individual electrical detection 
threshold. The electrical detection threshold was used to determine the intensity of the HFS: ten 
times the electrical detection threshold. 
Baseline testing  
Once the participants were comfortable with using the SPARS, the sensory testing battery consisting 
of punctate mechanical stimulation, static light touch, and dynamic light touch (refer to Outcome 
measurements above) was conducted six times (three times on each arm) to obtain baseline sensory 
ratings. Initially, the protocol outlined that primary hyperalgesia will not be assessed at this time 
point, as the electrical stimulation would not yet be calibrated to the participant. This was an error in 
the protocol and therefore, there was a deviation from the protocol and baseline primary 
hyperalgesia was assessed. The area of SH was not mapped at this point as SH had not yet been 
induced by the HFS.  
Sham skin examination  
The sham skin examination was performed by Researcher 2 after the baseline testing and before the 
HFS procedure (see Threat Manipulation above). As detailed above, Researcher 2 was blinded to site 
allocation. A comparison of the HFS SPARS ratings, self-reported anxiety and self-reported fear of 




High-frequency electrical stimulation  
Participants were thoroughly briefed on what to expect from the HFS. Participants were informed 
that most people find the HFS “moderately painful” and they may withdraw with immediate effect 
at any point during the procedure. They were instructed to say “STOP” if they wished to withdraw, in 
which case Researcher 2 would have flicked the safety switch on the stimulator to deactivate the 
stimulator immediately.  
Waiting period  
There was a waiting period of approximately 20 minutes after the HFS to allow time for the SH to 
develop. To optimise time, this period was used to administer the questionnaires. 
Follow-up testing 
The battery of sensory testing was conducted at the following time points after HFS: 20 minutes, 26 
minutes, 32 minutes, 38 minutes, 40 minutes, 44 minutes, 50 minutes and 56 minutes. Importantly, 
the order of the sensory testing modalities was randomised within each time point, for each 
participant, to decrease predictability and ensure accurate ratings (with the same order used for 
both arms, within each time point). The surface area of SH was mapped at 20-minute intervals after 
receiving the HFS, namely: at 20 minutes, 40 minutes and 60 minutes after the HFS.  
Post-experiment questionnaire and debriefing 
After the follow-up testing, the electrodes were removed, and participants were asked to complete 
the post-experiment questionnaire. Finally, participants were debriefed on the threat manipulation 
and reassured about the safety of the procedure by Researcher 2.  
Participants completed all the questionnaires in privacy, and on a computer. Details of any traumatic 
events was not requested. For these reasons, together with the strict eligibility criteria, it was 
unlikely the questionnaires would have evoked strong emotional responses at the time of testing.  
Nevertheless, after the procedure, participants were provided with an information pamphlet 
(Appendix 25) outlining the local non-profit organisations where they could access psychological 
assistance, if they wished to do so. Additionally, all participants received a list of the community 
health care centres in Cape Town that provide psychological counselling (Appendix 26) as well as a 
list of a couple of private practice psychologists within the University of Cape Town’s neighbouring 




Statistical analysis  
Primary analysis 
Data were analysed using a linear mixed modelling approach, so as to account for individual 
variability in responses whilst still testing for a between-site effect at the group level.  The study was 
designed to have within-subject controls of both pre- and post-induction measurements and control 
site measurements.  Therefore, the change in sensitivity (pre-induction measurements subtracted 
from post-induction measurements) was compared between arms (within subjects). The exact 
parameters for the analysis were chosen on the basis of visual inspection of the data (including an 
assessment of distribution), and the appropriate tests to confirm or refute any assumptions of the 
analytical strategy.  As specified above, the primary outcome was the magnitude of secondary 
hyperalgesia.  
The planned data analysis using the full pilot study data (Appendix 28) was finalised. The protocol 
(Appendix 29) and the pilot analysis were preregistered with Open Science Framework at 
https://osf.io/. Preregistration ensures detailed documentation of the research process, therefore 
supporting accountability and study replication (Lindsay et al., 2016). Initial processing of the formal 
data had commenced at the time of this protocol being locked online. However, the analysis of the 
formal data had not been completed. The pilot analysis was not substantively changed after initial 
processing of the formal data commenced, except that the assessment of the model fit was added, 
having been omitted from the pilot data analysis.  
A mixed linear modelling approach, using the robust ‘lmer’ option within the lme4 package (Loy and 
Hofmann, 2014, Bates et al., 2015) was used for the formal data analysis. It allows for both random 
effects (participant) and fixed effects (threat condition), as used in our sample size calculation. Two 
models were tried for this analysis: the first was a fully crossed model with ID (rating_controlled 
~condition + (1|id/time)). The second model was one in which that assumption was not made 
(rating_controlled ~ condition + (1|id)). ‘Fully crossed with’ means that every time point was 
assessed for every ID. This was indeed the case in this present study’s design. Therefore, the fully 
crossed model most closely represents the design of this experiment. The fully crossed model was 
compared to the null version of the model (rating_controlled ~ (1|id)) (which does not include 
condition as a predictor variable). If the ANOVA that compares two models (fully crossed and null 
version) yields a significant p-value then it was concluded that the fully crossed model fits the data 




It was plausible that the individual calibration approach could have confounded the results, because 
HFS delivered at a higher current could result in greater SH. This was tested for in the analysis, 
although a previous, well powered (n = 170, unpublished) investigation of this relationship had 
found no association. 
Researcher 2, who conducted the experiment, was blinded to site allocation. A blinding assessment 
was performed (as explained above). Cohen’s kappa coefficient was determined to ensure blinding 
was successful. Cohen’s kappa ranges from -1 to +1, where ‘0’ represents “random change” and ‘1’ 
represents “perfect agreement” (McHugh, 2012). Blinding was determined to be successful if Cohen 
kappa’s coefficient was ≤ 0, indicating no agreement between Researcher 2’s estimation of site 
allocation and actual site allocation.    
Assessment of model fit for the primary analysis  
An assessment of model fit was conducted for both the intensity and surface area analyses. The 
model assessed for intensity of SH was called model_pre_condition_crossed and had the structure: 
rating_controlled ~ condition + (1|id/time). The model assessed for area of SH was called 
model_pre_condition_crossed_sa and had the structure: SA ~ condition + (1|id/time). Four 
assumptions were assessed. If any of the assumptions was violated, the model was deemed unfit. 
The four assumptions were: 1) linearity, 2) absence of collinearity, 3) homoscedasticity, and 4) 
normally distributed residuals (Winter, 2013).  
Secondary analysis 
A secondary analysis investigated the relationship between a history of trauma and the surface area 
showing experimentally induced secondary hyperalgesia, replicating the work by You et al. (2016a). 
In their study, they summed the results of participants’ individual scores from the Childhood Trauma 
Events Scale and the Recent Traumatic Events Scale to obtain an individual stressful life events score. 
Similarly, in this current study the results of the CTQ-SF and WMH-CIDI were summed. You et al. 
(2016a) reported a larger surface area of capsaicin-induced SH in participants with a history of 
trauma than participants without a history of trauma. However, there were no differences in the 
intensity of SH between those with and those without a history of trauma. In this current study, a 
univariate regression analysis was conducted to examine whether stressful life events correlate with 





Appendix 30 includes the full data analysis and results.  
Participants  
Forty people volunteered to participate in this study and completed the eligibility quiz. Fourteen 
volunteers were excluded for having tattoos distal to the anode (n = 5), chronic pain (n = 5), history 
of mental illness (n = 3), and unavailable for testing (n = 1). A sample of 26 participants was used for 
this study. The median age was 21 (range 18 – 55) years old. Of the 26 participants, 16 were female. 
None of the participants had taken any medication prior to the procedure.  
Manipulation checks  
HFS intensity ratings  
All HFS trains were rated as ‘painful’, using the SPARS. The mean (± SD) was 38.77 (± 11.34) at the 
threatened site and 39.07 (± 11.31) at the control site (Fig 13). These SPARS ratings were not 
predicted by condition (p = 0.64). 
 
Figure 13 Grouped SPARS ratings during each train 
Self-reported anxiety during HFS 
The mean (± SD) anxiety ratings were 3.31 (± 1.12) for the threatened site and 3.42 (± 1.14) for the 
control site out of a maximum of five. The grouped effect of condition was not significantly (p = 0.31) 




Self-reported fear of tissue damage during HFS  
The mean (± SD) fear of tissue damage ratings were 2.81 (± 1.30) for the threatened site and 2.50 (± 
1.14) for the control site. The grouped effect of condition was not significantly (p = 0.11) predictive 
of threat ratings (Fig 15).  
Figure 14 The grouped effect of condition on anxiety ratings 
There is no upper line on the box and whisker plot on the far right because the upper quartile value was equal 
to the maximum value. Additionally, the median anxiety ratings for the control site on the left arm (first box on 
the left) was the same at the upper quartile. The median anxiety ratings for the threatened site on the left arm 
was the same as the lower quartile. The median anxiety ratings for the control site on the right arm was the 
same as the lower quartile. The median anxiety ratings for the threatened site on the right arm was the same as 




Figure 15 The grouped effect of condition on fear of tissue damage ratings 
 
Blinding assessment of the researchers conducting the experiment  
A blinding assessment (see section on Randomisation and blinding above) was used to determine 
whether Researcher 2 reliably predicted site allocation (i.e. which arm was receiving the HFS under a 
condition of threat). Researcher 2 guessed site allocation correctly 42.31% of the time. Cohen’s 
kappa coefficient was calculated to be 0.23, indicating weak agreement between Researcher 2’s 
guess of site allocation and actual site allocation (Calculations in Appendix 30). Therefore, it was 
confidently concluded that Researcher 2 was effectively blinded to site allocation. Additionally, 
Figure 16 shows that Researcher 2 made confident assertions that were incorrect. This further 
indicates that she was effectively blinded.   
There are no whiskers on the box and whisker plot on the far right because the upper quartile value was equal 
to the maximum value and the lower quartile was equal to the minimum value. Additionally, the median threat 
ratings for the control site on the left arm (first box on the left) was the same at the upper quartile. The median 
threat ratings for the threatened site on the left arm was the same as the lower quartile. The median threat 




Figure 16 Boxplots displaying the researcher’s confidence level over their frequency of correctness 
Semi-structured interview  
In general, participants reported being more anxious about anticipating the pain associated with the 
HFS induction rather than the results of the (sham) skin examination. Participants also reported 
trusting that enough precautions had been taken to ensure the safety of the procedure. Appendix 31 
includes quoted responses from participants explaining why they were/were not anxious and/or 
fearful of tissue damage during the HFS.  
Primary analysis 
Primary outcome: Mechanical punctate stimulation  
The primary aim was to determine the intensity of SH at each site and compare between conditions 
(site under a condition of threat: threaten site and site not under a condition of threat: control site). 
Figure 17 displays the intensity of SH over time, grouped by condition. Figure 18 displays the 
grouped mean intensity of SH over time. There was no clear difference in the intensity of SH 




Figure 17 Boxplot displaying the intensity of secondary hyperalgesia over time, grouped by condition. 
 
 
Figure 18 plot describing the grouped mean intensity of secondary hyperalgesia over time. The red vertical line indicates 





Figure 19 Boxplot describing the difference between condition over time 
Assessment of model fit 
The model is called model_pre_condition_crossed and has the structure: rating_controlled ~ 
(1|id/time). All plots can be viewed in Appendix 30, section title: SH: Assessment of model fit. First, 
linearity was assumed by plotting fitted values against residual values, for the fixed factor 
‘condition’. There was increased density in a blob on the left, but no obvious linear or curvilinear 
pattern. The assumption deemed to have been upheld. Second, the assumption of absence of 
collinearity was assessed by checking correlation between time and condition. There was no 
collinearity observed in the plot and it was deemed that the assumption of absence of collinearity 
was upheld. Third, assumption of homoscedasticity was assessed, i.e. assessment for equal variance 
across the range of predicted values. There was increased density in a blob to the left, but the range 
of the maximum and minimum values seemed consistent across the x-axis. Therefore, the 
assumption of homoscedasticity was deemed to have been upheld. Fourth, the assumption that 
residuals were normally distributed was assessed. The Q-Q plot showed extremely minor deviations 
from the diagonal reference line and the histogram showed acceptable distribution. Therefore, the 
assumption that residuals were normally distributed was deemed to have been upheld. In 
conclusion, all four assumptions were upheld by the data, rendering the model suitable.  
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Assessing for confounding of the intensity of secondary hyperalgesia from individual 
calibration approach  
The mean (± SD) detection threshold and intensity used for the HFS procedure was 1.60 mA (± 0.64 
mA). It is plausible that the individual calibration approach could confound the intensity of SH 
results. This is because HFS delivered at a higher current could result in greater secondary 
hyperalgesia. Therefore, each participants’ maximum recorded intensity of SH was assessed for 
correlation with their individual current used for the HFS induction procedure. The Shapiro-Wilk Test 
showed that the data were not normally distributed (p = 0.011). Therefore, a Spearman rank-order 
correlation test was used to check for a relationship between the calibration current and the peak 
intensity of secondary hyperalgesia. The peak intensity of SH was determined for each participant 
individually, i.e. the maximum SPARS rating for each ID code was used. There was no significant 
correlation between the calibration current and the peak intensity of SH (rho = 0.040; p = 0.78).  
Secondary outcome 
Mapping surface area of secondary hyperalgesia  
The secondary aim was to determine the surface area of SH on each arm and compare between 
arms. Figure 20 displays the grouped area of SH over time. Secondary hyperalgesia surface area was 
not predicted by condition (p = 0.16).  
 
Figure 20 Boxplot describing the grouped area of secondary hyperalgesia over time 
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Assessment of model fit  
The model is called model_pre-condition_crossed_sa and has the structure: SA ~ condition + 
(1|id/time All plots can be viewed in Appendix 30, section title: SA: Assessment of model fit. First, 
linearity was assumed by plotting fitted values against residual values, for the fixed factor 
‘condition’. There was no obvious linear or curvilinear pattern; therefore, the assumption was 
deemed to have been upheld. Second, the assumption of absence of collinearity was assessed by 
checking correlation between time and condition. There was no collinearity observed in the plot; 
therefore, the assumption of absence of collinearity was deemed to have been upheld. Third, 
assumption of homoscedasticity was assessed, i.e. assessment for equal variance across the range of 
predicted values. There was a slightly increased density in a blob in the middle and the range of the 
maximum and minimum values seemed slightly lower on the left than on the right. Alternative 
methods of assessing homoscedasticity were explored. However, the Imer package has been 
reported to be a robust in fitting linear mixed-effect model to data (Loy and Hofmann, 2014). 
Therefore, the assumption of homoscedasticity was deemed to have been upheld. Fourth, the 
assumption that residuals were normally distributed was assessed. The Q-Q plot and the histogram 
shows normal distribution.  
Exploratory outcomes  
Static light touch 
There was a wide variability in the intensity of static light touch after induction. The mean (± SD) 
SPARS ratings over the entire sensory testing period were -29.27 (± 20.41) at the threatened site and 
-29.58 (± 20.79) at the control site. Static light touch intensities were not predicted by condition (p = 
0.34) (All plots can be viewed in Appendix 30, section title: Exploratory outcomes). 
Dynamic light touch  
There was a wide variability in the intensity of dynamic light touch after induction. The mean (± SD) 
SPARS ratings over the entire sensory testing period were -41.71 (± 8.40) at the threatened site and -
41.42 (± 8.31) at the control site. Dynamic light touch intensities were not predicted by condition (p 
= 0.20) (All plots can be viewed in Appendix 30, section title: Exploratory outcomes). 
Single electrical stimulation  
The was a wide variability in the intensity of single electrical stimulation after induction. The mean (± 
SD) SPARS ratings over the entire sensory testing period were -29.27 (± 20.41) at the threatened site 
and -29.58 (± 20.79) at the control site. Single electrical stimulation intensities were not predicted by 
condition (p = 0.34) (All plots can be viewed in Appendix 30, section title: Exploratory outcomes). 
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Secondary analysis  
Summed trauma scores and surface area of secondary hyperalgesia  
A Shapiro-Wilk test showed that the data were normally distributed (p = 0.48), therefore a Pearson’s 
correlation test was used. There was no statistically significant correlation between summed trauma 
score and surface area of SH (p = 0.16) (Appendix 30, section title: Childhood and recent trauma 
scores).  
Post-hoc analyses 
There were technical issues with the computer resulting in data from Question 8 of the Pain 
Catastrophising Scale (PCS) being missing for the first two participants. Therefore, PCS data from 
these two participants were excluded in this post-hoc analysis. The mean (range) PCS scores 31 (14 – 
50). The mean (range) of resilience, as measured on the 10-item Connor-Davidson Resilience Scale 
(CD-RISC-10) was 40.81 (32 – 48) (Appendix 30, section title: Post-hoc analysis). 
Discussion  
The aim of this study was to investigate the effect of a manipulation of the threat value of a stimulus 
on experimentally induced SH in healthy human volunteers. It was hypothesised that greater threat 
– as indicated by greater self-reported anxiety, fear of tissue damage and HFS intensity ratings at the 
arm receiving the HFS under a condition of threat - would be associated with (hypothesis 1) greater 
intensity and (hypothesis 2) greater surface area of secondary hyperalgesia. Despite a careful and 
thorough piloting procedure to develop and pre-test the threat manipulation, the manipulation 
checks showed that the threat manipulation (a sham skin examination) was not effective in eliciting 
a threat of tissue damage. Therefore, one would anticipate that intensity and area of SH would not 
be predicted by site allocation. The results in this current study confirmed that neither intensity nor 
area of SH was predicted by site allocation (i.e. which arm received the HFS under a condition of 
threat).  
Threat manipulation  
Although a similar sham skin examination has been used effectively as a threat manipulation before 
(Wiech et al., 2010), sham skin examination did not affect self-reported anxiety or fear of tissue 
damage in this current study. Additionally, there was no difference in HFS ratings between arms. 
There are many possibilities as to why this threat manipulation was not effective. These possibilities 
have been broadly summarised under the following subheadings and explained below: 1) Safety 





First possibility: Safety requirements  
The Human Research Ethics Committee at the University of Cape Town, Department of Health 
Sciences required that the safety of the HFS procedure was to be explicitly stated in the informed 
consent form and study information sheet. Therefore, the informed consent document stated, “This 
procedure involves some pain; however, it is a well-established procedure and is known not to cause 
any skin damage”. Explicitly and repeatedly reassuring participants of the safely of the HFS 
procedure could have reduced the threat value of the HFS, thus reducing participants’ self-reported 
anxiety, fear of tissue damage and pain ratings during the HFS induction. 
Second possibility: Trust 
Trust between friends and family and even more importantly between strangers is essential for 
cooperation and societal development (Balliet and Van Lange, 2013, Dunning et al., 2014). Trust 
allows for cohesion within social/cultural groups and across different social/cultural groups. 
Furthermore, trust is essential when conducting human research. The importance of trust between 
participants and researchers is explicit in the guidelines of many national human research 
committees, including those of Australia, New Zealand, Canada and America (Guillemin et al., 2018). 
Results from the semi-structured interview indicated evidence of trust from the participants of the 
researchers in this current study: One participant reported that they trusted that enough 
precautions had been taken to ensure the safety of the procedure. Another participant reported that 
they trusted the Human Research Ethics Committee would not approve an experiment that could 
cause damage to participants’ skin. The threat manipulation was not compelling enough to 
overcome participants’ trust in the researchers and the safe of the research procedure. This could 
explain why participants did not report greater anxiety and fear of tissue damage at the site 
receiving the HFS under a condition of threat than at the control site.  
Third possibility: safety cues 
Certain social situations have been reported to provide people with safety cues, thus decreasing the 
threat value of the situation (Tang et al., 2007, Lohr et al., 2007). A study investigated the influence 
of the presence of an observer and perceived threat on reported pain during a cold pressor task 
(Vlaeyen et al., 2009). Under neutral conditions, i.e. when no threatening information was given to 
participants about the cold pressor task, there was no influence of the presence of an observer on 
reported pain. However, under a condition of threat, i.e. when participants were told threatening 
information about the cold pressor task, participants reported greater pain severity when no 
observer was present than when an observer was present during the procedure. This suggests that 
the observer acted as a safety cue in the presence of a threat manipulation. Perhaps the researcher 
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conducting the experiment, acted as a safety cue for the participants in this current study, thus 
decreasing the threat value and reported pain during the HFS procedure.  
Fourth possibility: competing threats 
The threat of the pain associated with the HFS may have competed with the threat of tissue damage. 
Researcher 2 was instructed to ask participants for feedback on why they agreed or disagreed to 
feeling anxious or fearful of tissue damage during the HFS procedure. Almost all the participants 
reported feeling more anxious about anticipating the pain associated with the HFS than about 
possible tissue damage. The anticipation of the pain associated with the HFS may have been a more 
powerful threat than the threat of tissue damage; therefore, distracting participants away from the 
imposed threat of tissue damage.  
Fifth possibility: Sampling bias  
As discussed in Chapter 1, people that volunteer for pain studies are not representative of the 
general population. A recent study compared the characteristics of people that volunteered for a 
pain-related study to those of people that volunteered for a non-pain related study (Karos et al., 
2018). Low fear of pain and older age predicted the likelihood of someone volunteering for a pain-
related study. Karos et al. (2018) proposed that individuals who display protective behaviours may 
be less likely to participate in pain-related studies. However, they did not formally assess this. Fear 
of pain was not assessed in this current study but pain catastrophising was assessed using the Pain 
Catastrophising Scale (PCS) (Sullivan et al., 1995). A post-hoc analysis of the participants’ PCS scores 
was conducted in this current study as a proxy for fear of pain. In this current study the wording in 
the PCS was slightly modified to be relevant to the pain induced by the HFS procedure. The mean 
(range) PCS score was 31 (14 – 50). Catastrophising is considered clinically significant with a score of 
30 (Sullivan et al., 1995).  Therefore, the mean score of 31 in this current study suggests that some 
participants had clinically relevant levels of pain catastrophising about the HFS procedure.  
This proxy for fear of pain conflicts with the finding of Karos et al. (2018), where it was reported that 
participants who volunteer for pain-related studies display low fear of pain. This conflict may be due 
to a discrepancy in the focus of the PCS used in this current study and the Fear of Pain Questionnaire 
used in Karos et al. (2018). Specifically, the PCS was focused on pain relating to participants’ 
experience of the HFS procedure. The Fear of Pain Questionnaire asked participants to imagine 
different situations, (e.g. a vehicle accident) and report how fearful they are about the potential pain 




An additional limitation for using PCS as a proxy for fear of pain, is that Karos et al. (2018) did not 
find a significant correlation between pain catastrophising and willingness to participate in a pain-
related study. Additionally, in this current study the PCS was administered after the threat 
manipulation. It is plausible that the threat manipulation induced catastrophic thinking about the 
HFS procedure, rather than participants displaying clinically relevant levels of catastrophising prior to 
the procedure, i.e. at baseline. Participants in Karos et al. (2018) were undergraduate students from 
universities in Belgium and the Netherlands. To this author’s knowledge, there are no published data 
on the characteristics of individuals willing to participate and those who do participate in 
experimental pain research in South Africa. Therefore, further investigations into the characteristics 
of South African volunteers willing and not willing to participate in pain-related studies are required. 
This may provide more information on potential sampling bias in experimental pain studies.  
Sixth possibility: South African context 
It is important for researchers to reflect on the specific context in which their experiments are 
conducted and what contextual backgrounds their participants come from. Social, environmental, 
political and cultural contexts all play a role in influencing pain (Keefe and France, 1999, Turk and 
Okifuji, 2002). Participants bring their individual biases from previous life experiences, which may 
influence results experimental pain studies.  
This current study was conducted in a South African context, with participants ranging between 18 
and 55 years of age. Many South Africans live under permanent threat (Hinsberger et al., 2016). 
There are daily media reports of murders, sexual assaults, robberies and gang violence. In certain 
areas in South Africa many people experience emotional and/or physical and/or psychological abuse 
daily, either endured themselves or by others. There is very little research investigating the influence 
of this repetitive exposure to threat on pain in the South African context. Perhaps regular exposure 
to threat habituates people to threat and may raise their ‘threat tolerance/threshold’. Perhaps this 
could be why participants in this present study were not easily threatened by a relatively minor 
threat, particularly when they were in a relatively safe environment. Importantly, this is speculation 
and substantially more investigation into these ideas is needed before these conclusions can be 
confidently drawn.  
This researcher proposes further experimental studies in the South African context formally 
comparing 1) the intensity and magnitude of experimentally induced SH in participants with and 
without a history of trauma, 2) the effectiveness of different threat manipulations in participants 
with and without a history of trauma, and 3) the influence of a threat manipulation on the intensity 
and magnitude of experimentally induced in participants with and without a history of trauma.  
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Proposed improvements to the threat manipulation  
Inducing a threat manipulation in a laboratory setting is known to be difficult. Threat manipulations 
are known to induce “weak…concerns about the pain stimulus” by participants in experimental pain 
studies (Vlaeyen et al., 2009). This may be due to participants knowing the pain will be short-lived 
and assuming the safety of the procedure due to knowledge of strict requirements from human 
research ethics committees. Although threat manipulations are difficult to conduct in the laboratory 
setting, there are reports of effective threat manipulations in previous studies (Vlaeyen et al., 2009, 
Jackson et al., 2005, Van Damme et al., 2008). However, these were not sham skin examinations; 
these treat manipulations consisted of providing participants with threatening information about the 
experimental procedure. As discussed in the Piloting procedure section, threatening information 
about the HFS procedure was ineffective in eliciting threat of tissue damage in this current study’s 
piloting sample.  
Reflecting on the above described theories for why the threat manipulation was not effective, this 
author proposes the following modifications to improve the effectiveness of the threat 
manipulation: 1) removing the statement that HFS is “known not to cause any skin damage” from 
the informed consent form. This modification would need to be negotiated with the ethical 
committee to ensure participants are adequately informed prior to participating, 2) Adjusting the 
social context so that the researcher does not act as a safety cue, thus decreasing the threat value of 
the situation. 3) Only conducting HFS on one arm rather than two. This modification will remove the 
competing threat of anxiety about anticipating the HFS on the second arm, after receiving the HFS 
on the first arm. Further, participants may not have found it compelling that the skin on their one 
forearm is robust but the skin on the other forearm is fragile. However, this was not assessed in this 
present study. If this was the case, informing participants that their skin is fragile might be more 
compelling if the assessment and procedure is only conducted on one arm.  
Summed trauma scores and area of secondary hyperalgesia 
Summed trauma scores were not correlated with increased area of SH in this current study. This 
conflicts with published pilot data where summed trauma scores were correlated with increased 
area but not increased intensity of SH (You et al., 2016). 
It is important to note some of the differences between this current study and that conducted by 
You et al. (2016b) as these differences may account for the conflicting results. The eligibility criteria 
for inclusion differed between studies. In this present study, volunteers were not eligible to 
participate if they presented with a history of mental illness; depression and anxiety disorders were 
considered a mental illness for this study. Additionally, the recruitment poster advertisement 
outlined that participants needed to complete questionnaires about previous trauma. Therefore, it 
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was unlikely that the sample in this current study would consist of participants with an extensive 
history of trauma. You et al. (2016b) specifically recruited female participants with and without a 
history of trauma. Volunteers were screened using the Childhood Trauma Events Scale and the 
Recent Traumatic Events Scale. Volunteers reporting no history of trauma and those reporting nine 
or more traumatic events were invited to participate in their study. Therefore, this author speculates 
that participants in this current study may have had lower summed trauma scores than participants’ 
summed trauma scores in You et al. (2016b).  
Another difference between this current study and You et al. (2016b) may be a difference in 
participants’ characteristics. The mean (range) resilience score of participations in this current study, 
as reported in the Post-hoc analysis section was 40.81 (32 – 48). Interestingly, this is higher than 
previously reported CD-RISC-10 scores that ranged between 29 – 33.5 in the general population 
(Campbell-Sills and Stein, 2007, Goins et al., 2013, Levasseur et al., 2017, Lopes and Martins, 2011, 
Antúnez et al., 2015) and between 20.8 – 33.5 in students and young adults (Hartley, 2012, 
Campbell-Sills and Stein, 2007, Jones et al., 2017, Reyes et al., 2018, Shlomi, 2010, Rahimi et al., 
2014). Data from the second population group were included for the comparison because most 
participants in this current study were students and young adults. Importantly, none of these studies 
were conducted on a South African cohort. It would be speculative to conclude that this high 
resilience score presented in this current study is representative of the general South African 
population. Therefore, further research is required to investigate whether the high resilience score 
in this current study is representative of the general South African population.  
People with high resilience scores are able to cope with stressful life events better (Connor and 
Davidson, 2003) and have faster physiological recovery after stressful events (Lü et al., 2016) than 
people with low resilience scores on the CD-RISC. Further, people with high resilience handle 
repeated exposure to stressful events better than people with low resilience. Resilience is relevant 
here, because pain is a considered a stressor (You et al., 2016). Chronic pain can increase the 
demand of physiological functioning to maintain homeostasis, i.e. chronic pain increases allostatic 
load (Sturgeon and Zautra, 2010). Physiologically, people with high resilience have better heart rate, 
respiratory sinus arrhythmia, and systolic and diastolic blood pressure recovery after repeated 
stressful events than people with low resilience (Lü et al., 2016). Further, people with high resilience 
are more amenable to adopting strategies to cope with pain than people with low resilience 
(Sturgeon and Zautra, 2010). High resilience improves coping mechanisms and physiological 
functioning following stressful events, and therefore may improve pain management outcomes. 
Unfortunately, You et al. (2016b) did not assess participants’ resilience, therefore preventing a 
comparison between their study and this current study. This author speculates that high resilience 
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may influence the relationship between trauma history and area of secondary hyperalgesia. It would 
be beneficial for future research to investigate resilience among South Africans and whether 
resilience is associated with the repetitive trauma experienced by South Africans. An improved 
understanding of resilience within the South African context may allow for optimisation of improved 
treatments for chronic pain.  
Strengths  
This study provides a comprehensive overview of the challenges associated with conducting a threat 
manipulation for experimental pain research. This overview will be of benefit to researchers when 
designing a threat manipulation. This study also highlights the need and provides recommendations 
for future research investigating the association between threat and chronic pain among South 
Africans. 
Limitations  
An obvious limitation of this study is that the threat manipulation was ineffective. Therefore, it is still 






In summary, despite a careful and thorough piloting procedure, the threat manipulation (sham skin 
examination) used in the current study was not effective in eliciting a threat of tissue damage. The 
results in this current study confirmed that neither intensity nor area of SH was predicted by site 
allocation (i.e. which arm received the HFS under a condition of threat), which would be anticipated, 
given that the threat manipulation was not effective. Further investigations are required to develop 
effective threat manipulations for experimental pain research. Summed trauma scores were not 
correlated with increased area of SH in this current study. This conflicts with published pilot data in 
which summed trauma scores were correlated with increased area but not increased intensity of SH 
(You et al., 2016). Further research is required in the South African context to investigate the can 
you be a bit more general and say the potential relationship? between trauma history and the 




Chapter 4: Conclusion  
Research objectives  
The two main objectives of this research were: 1) to conduct a systematic review identifying and 
describing non-pharmacological modalities used to manipulate (i.e. increase or decrease) 
experimentally induced secondary hyperalgesia (SH), and 2) to conduct an experimental study 
investigating the effect of a threat manipulation on experimentally induced SH. The purpose of the 
systematic review was to identify and describe which non-pharmacological manipulations have an 
influence on experimentally induced SH and whether these manipulations increase or decrease the 
magnitude of SH. A better understanding of the effects of these non-pharmacological manipulations 
will provide insight into the mechanisms associated with SH. The purpose of the experimental study 
was to determine whether greater threat was associated with (hypothesis 1) greater intensity and 
(hypothesis 2) greater surface area of experimentally induced SH. This concluding chapter will 
summarise the main findings, the strengths, and the limitations of both the systematic review and 
experimental study, and provide recommendations for future research.  
Summary of main findings  
Systematic review  
Of the 21 studies included in the systematic review, there were six different methods used to 
experimentally induce SH, with the most common methods being topical capsaicin (seven of 21) and 
burn injury (six of 21). Interestingly, 15 different non-pharmacological manipulations were used. 
Most studies (12 of 21) assessed the effect of a manipulation on the area of SH only (Matre et al., 
2006, Mohammadian et al., 2004, Meeker et al., 2019, Pud et al., 2006, Rasmussen et al., 2015, 
Salomons et al., 2014, Wahl et al., 2019, Yucel et al., 2001, Smith et al., 2018, Rebhorn et al., 2012) 
(Yucel et al. (2001) reported on three studies, all of which were included in this review). Four studies 
assessed the effect of a manipulation on the intensity of SH only (Kóbor et al., 2009, Torta et al., 
2019, van den Broeke et al., 2014) (Torta et al. (2019) reported on three studies, of which two were 
included in this review), and five studies assessed the effect of a manipulation on both the area and 
the intensity of SH (Baron et al., 1999, Ditre et al., 2018, Helfert et al., 2018, Werner et al., 2002, You 
et al., 2014).  
Manipulations were categorised and reported based on the hypothesised direction of effect (i.e. 
increase or decrease) on the magnitude of SH. Most manipulations were hypothesised to decrease 
the intensity (six of nine) (Baron et al., 1999, Werner et al., 2002, Kóbor et al., 2009, Torta et al., 
2019, You et al., 2014) and the area (14 of 17) (Baron et al., 1999, Werner et al., 2002, Pud et al., 
2006, Yucel et al., 2001, Rasmussen et al., 2015, Wahl et al., 2019, You et al., 2014, Salomons et al., 
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2014, Matre et al., 2006, Meeker et al., 2019, Mohammadian et al., 2004, Rebhorn et al., 2012) of 
secondary hyperalgesia. The remaining manipulations were hypothesised to increase the intensity 
(three of nine) (Ditre et al., 2018, Helfert et al., 2018, van den Broeke et al., 2014) and the area 
(three of 17) (Ditre et al., 2018, Helfert et al., 2018, Smith et al., 2018) of SH.  
Only two studies were successful in decreasing the intensity of SH. The studies used an emotional 
disclosure manipulation (You et al., 2014) and high cognitive loading with a modified version of the 
N-Back task (Torta et al., 2019) (Experiment 2). Four studies failed to decrease the intensity of SH. 
These studies used whole-body cooling and heating (Baron et al., 1999), localised cold application 
(Werner et al., 2002), high attentional loading (Kóbor et al., 2009), and high cognitive loading using 
the Eriksen Flanker Task (Torta et al., 2019) (Experiment 1). Two studies successfully increased the 
intensity of SH. These studies used 24 hours of nicotine deprivation (Ditre et al., 2018) and negative 
suggestion (van den Broeke et al., 2014). One study failed to increase the intensity of SH. This study 
used verbal suggestion by reporting correct or incorrect information about the contents of the 
substance used for the induction (Helfert et al., 2018).  
Seven studies were successful in decreasing the area of SH. These studies used hyperbaric oxygen 
therapy (Rasmussen et al., 2015, Wahl et al., 2019), emotional disclosure (You et al., 2014), cognitive 
behavioural therapy (Salomons et al., 2014), placebo analgesia (Matre et al., 2006), transcranial 
direct current stimulation applied to target the motor cortex (Meeker et al., 2019) and spinal 
manipulation therapy applied to the thoracic spine (Mohammadian et al., 2004). Three studies failed 
to decrease the area of SH. These studies used whole-body cooling and heating (Baron et al., 1999), 
localised cold application (Pud et al., 2006, Werner et al., 2002) and intradermal capsaicin (Rebhorn 
et al., 2012). Interestingly, although localised cold application was hypothesised to decrease the area 
of SH, one study reported that it increased the area of SH (Pud et al., 2006). However, this study had 
a high risk of reporting bias. Another study with a low risk of reporting bias reported that localised 
cold application had no effect on the area of SH (Werner et al., 2002). Two studies successfully 
increased the area of SH. These studies used nicotine deprivation (Ditre et al., 2018) and sleep 
deprivation (Smith et al., 2018). Interestingly, sleep deprivation was effective in increasing the area 
of SH in male participants only; there was no effect in the area of SH in female participants. One 
study failed to increase the area of SH. This study used verbal suggestion by reporting correct or 
incorrect information about the contents of the substance used for induction (Helfert et al., 2018).  
Most of the manipulations – except for acupuncture, low cognitive loading and negative suggestion 
– that were thought to influence central processes contributing to pain were successful in either 
increasing or decreasing the intensity and/or area of SH. Conversely, manipulations that influence 
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peripheral processes contributing to pain, such as localised cold application, failed to manipulate the 
intensity and area of SH. These findings support the theory that SH is modulated by central 
processes. It is possible that the manipulations that were successful in increasing or decreasing the 
magnitude of SH achieved this by facilitating or inhibiting spinal LTP at the dorsal horn of the spinal 
cord. Alternatively, these manipulations may have influenced cortical processes contributing to pain 
resulting in an increase or decrease in SH. Further research is needed to gain insight into how each 
of these manipulations was or was not successful in manipulating experimentally induced SH. This 
will provide clarity of the mechanisms of SH. Clarification of these mechanisms will inform 
development of non-pharmacological therapies that directly target the mechanisms of SH.  
Experimental study  
The aim of this within-subject, double-blinded experimental study was to investigate the effect of a 
threat manipulation – brought about by a sham skin examination – on experimentally induced 
secondary hyperalgesia, using HFS. The effect of the threat manipulation was expected to be 
indicated by greater self-reported anxiety, fear of tissue damage and HFS intensity ratings for the 
arm receiving the HFS under a condition of threat. It was anticipated that inducing threat of tissue 
damage in an experimental pain study would be difficult given the strict ethical requirements and 
controlled environment associated with experimental studies. A careful and thorough piloting 
procedure was conducted to develop and pre-test the threat manipulation. Additionally, the chosen 
threat manipulation procedure (sham skin examination) had been used and reported successful in 
eliciting threat of tissue damage in a previously published study (Wiech et al., 2010). Despite this, 
the threat manipulation was ineffective in eliciting a threat of tissue damage in this current study. 
Therefore, in accordance with this lack of difference in threat value between sites, there was no 
difference in the intensity and area of SH at the experimental site (i.e. the site received the HFS 
under a condition of threat) and the control site. Six possible reasons were identified to explain why 
the threat manipulation was ineffective in this current study’s sample population: 1) Safety 
requirements, 2) Trust, 3) Safety cues, 4) Competing threats, 5) Sampling bias, and 6) South African 
context. Researchers should consider these challenges to ensure that the threat manipulation is 




Chronic life stress has been reported to influence central processes contributing to increased pain 
severity (Kehlet et al., 2006). However, the mechanisms by which chronic life stress achieves this are 
unclear. A secondary analysis was conducted to assess for a correlation between each participant’s 
summed trauma score and their mean area of SH across both sites. A previously published pilot 
study reported a history of trauma correlated with an increased area of SH, following the application 
of topical capsaicin (You et al., 2016). Interestingly, the results of this current study did not support 
those findings – there was no correlation between summed trauma scores and the area of SH in this 
current study. To this author’s best knowledge, there are no other published studies reporting on 
the correlation (or lack thereof) between trauma history and area of SH.  
These conflicting results may be due to differing characteristics between participants in You et al. 
(2016b) and those in this current study. A post-hoc analysis of participants in this current study’s 
resilience scores, as measured on the CD-RISC-10, showed that they had higher resilience scores 
than those from the general population (Campbell-Sills and Stein, 2007, Goins et al., 2013, Levasseur 
et al., 2017, Lopes and Martins, 2011, Antúnez et al., 2015), and in a population of students and 
young adults (Hartley, 2012, Campbell-Sills and Stein, 2007, Jones et al., 2017, Reyes et al., 2018, 
Shlomi, 2010, Rahimi et al., 2014). High levels of resilience have been associated with improved 
management of stressful life events and faster physiological recovery after stressful life events. 
Participants in You et al. (2016b) may have had low levels of resilience – this was not formally 
assessed and is therefore a speculation. However, the high resilience score in this current study may 
account for the lack of correlation found between trauma history and area of secondary 
hyperalgesia, because resilience is associated with improvement management of stressful life 
events. None of those published studies on resilience scores included a cohort of South Africans. 
Therefore, it is unclear whether the high resilience scores in this current study are specific to this 
sample or similar to that of the general South African population. Therefore, it would be interesting 
and useful for future research to investigate the relationship between trauma history and the area of 




Strengths of research  
Systematic review  
This is the first systematic review collating and describing non-pharmacological modalities used to 
manipulate experimentally induced SH, to this author’s best knowledge. Secondary hyperalgesia is 
widely considered to be a centrally mediated process and the findings of this review support this. 
Therefore, to effectively treat SH therapeutic modalities may need to influence central, rather than 
peripheral processes thought to contribute to pain. This review is beneficial in providing insight into 
the mechanisms of SH.  
Experimental study  
There is limited published research on the effects of threat of tissue damage on experimentally 
induced secondary hyperalgesia. To this author’s best knowledge, there are no published 
experimental studies investigating threat and SH within the South African context. Data obtained 
from national World Mental Health Surveys support that chronic pain is highly prevalent in South 
Africa, with and approximately half (48.3%) of South Africans experiencing chronic pain within the 12 
months prior to the survey (Tsang et al., 2008). Many South Africans also live under constant threat 
(Scorgie et al., 2017). Therefore, there is a clear need for further research investigating the 
association between threat and chronic pain among South Africans. This thesis describes specific 
challenges to inducing a threat of tissue damage within a controlled experimental environment and 
important factors for researchers to consider when designing a threat manipulation.   
Limitations of research  
Systematic review  
A considerable limitation of this review was that a meta-analysis could not be conducted - there was 
high clinical heterogeneity among the studies and unavailable data, rendering pooling of studies’ 
results impossible. Therefore, it was not possible to generate stable effect sizes of the potencies of 





Experimental study  
An obvious limitation of the experimental study is that the threat manipulation was ineffective in 
eliciting a threat of tissue damage. Therefore, the question of whether threat of tissue damage is 
associated with greater intensity and area of SH remains unanswered.  
This experimental study was conducted on healthy humans, i.e. humans without chronic pain. 
Experimental pain research on healthy humans is useful for bridging the gap between animal studies 
and research on patients with chronic pain. However, there are limitations when extrapolating 
findings from experimental pain studies with healthy human participants and applying them to 
patients with chronic pain. A specific limitation is that experimentally inducing short-lived SH may 
not reflect the exact physiological changes associated with clinical SH. Therefore, to thoroughly 
investigate the mechanisms of SH associated with neuropathic pain, further research is required in 
patients with chronic pain using credible threat manipulations.   
Recommendations for future research  
This author proposes open access to raw data on online platforms and the standardisation of rating 
scales in experimental pain research. This will improve the quality of the published experimental 
pain research and allow for statistically sound comparisons across different studies.  
Additional research is required to investigate the specific physiological effects of non-
pharmacological modalities reported to manipulate experimentally induced SH. This will provide an 
improved understanding of the mechanisms of SH and pave the way for the development of 
improved treatment modalities. 
There is limited research into the influence of threat of tissue damage on SH. Further research is 
required to develop a robust threat manipulation model for experimental pain research. 
Additionally, the effect of threat on SH in patients with chronic pain needs to be investigated.  
There is limited research into the relationship between trauma history and area of secondary 
hyperalgesia. The results of this study conflicted with those of a previously published pilot study. 
Further research is required to investigate whether there is a relationship between a history of 
trauma and area of secondary hyperalgesia. Finally, it was out of the scope of this current study to 
investigate the relationship between resilience and SH. As discussed in the Summary of findings 
above, high resilience was speculated to be a possible reason for the lack of correlation between 
trauma history and area of SH. Further research is required to investigate if resilience could 
influence a relationship between trauma history and secondary hyperalgesia. This may be useful for 
developing further research investigating whether treatments aimed at improving resilience would 
also reduce the magnitude of SH.   
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To conclude, the findings described in this thesis support recent theoretical models of pain that 
propose that pain is not merely a biological process. Rather, pain is a biopsychosocial sensory and 
emotional experience. These findings (specifically, those of the systematic review) support that pain 
can be modulated by non-pharmacological modalities. Further research into specific variables that 
modulate pain is required for the development of improved treatment modalities, specifically 
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Appendix 1: A systematic review of experimental methods to 


















Appendix 2: Risk of bias assessment tool  
Performance bias   
Blinding Decision Justification 
Were participants blinded to the 
research question and paradigm 
and [if relevant] group allocation? 
  Yes           No   Unclear  
Risk of performance bias 
summary 
  High  
   
  Low   
 
  Unclear  
 
 
Article ID:                                                                                  Reviewer: 
Selection bias  
 Decision  Justification  
Was the sampling/recruitment 
strategy appropriate to minimise 
bias? 
  Yes           No   Unclear  
Was it clearly and appropriately 
determined that participants 
were pain-free? 
  Yes           No   Unclear  
[B-G only] Similar baseline 
demographics among participants 
(age/sex/medical/psychological 
state)? 
  Yes           No   Unclear 
 
 
[Psych manip] Neutral psych 
status? 
  Yes           No   Unclear 
 
 
[B-G only] Random allocation 
[B-site] Random allocation 
  Yes           No   Unclear  
Risk of selection bias summary    High   (failure to include any of the above probably influenced results  
  FOR THE QUESTION OF THIS REVIEW)  
  Low   (results unlikely to have been influenced) 
 
  Unclear (not enough information) 
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Detection bias   
Were outcome assessors blinded 
to the research question and 
paradigm? 
  Yes           No   Unclear  
Were analysing researchers 
blinded to the group allocation of 
participants and/or to site 
allocation? 
  Yes           No   Unclear  
Risk of detection bias summary   High   
  Low   
  Unclear  
Manipulation veracity 
[Psych] Did a manipulation check 
confirm the effectiveness of the 
manipulation? 
  Yes           No   Unclear  
Risk of manipulation veracity 
problem 
  High    Low    Unclear   
Attrition bias 
Incomplete outcome data  Decision Justification 
Have attrition/exclusions/ 
withdrawals been reported and 
appropriately dealt with in 
analysis? 
  Yes           No   Unclear  
Risk of attrition bias summary   High    
  Low   
  Unclear  
Measurement bias 
 Decision Justification 
Were valid and reliable outcome 
measurements used to assess 
severity & SA of secondary 
hyperalgesia?  
2H:   Yes           No   Unclear 
 
SA:   Yes           No   Unclear 
 
Were identical equipment items 
used for measurements between 
groups/sites/time points?  
2H:   Yes           No   Unclear 
 
SA:   Yes           No   Unclear 
 
Did the same assessor conduct 
assessments between 
groups/sites/time points?  





SA:   Yes           No   Unclear 
Risk of measurement bias 
summary 
2H:   High           Low   Unclear 
 
SA:   High           Low  Unclear 
Reporting bias 
Selective reporting Decision Justification 
Were all outcomes for 
experimental and control groups 
reported on?  
  Yes           No   
Were conflicts of interest and 
funding sources declared? 
  Yes           No   
Risk of reporting bias summary   High    
  Low   
  Unclear  
 Risk of bias summary  
Risk of bias Description Study bias outcome 
High risk of bias Plausible bias that seriously weakens confidence in the results.  
Low risk of bias Plausible bias unlikely to seriously alter or diminish trust in the results.  






Appendix 3: Risk of bias guide to decision-making for risk of bias 
assessment 
Performance bias   
Blinding Decision Justification 
Were participants blinded to the 
research question and paradigm 
and [if relevant] group allocation? 
  Yes          
  No  
  Unclear 
Yes: evidence provided - blinding strategy AND blinding check AND 
results reported AND analysis done accordingly 
No: Blinding reported broken  
Article ID:                                                                                  Reviewer: 
Selection bias  
 Decision  Justification  
Was the sampling/recruitment 
strategy appropriate to minimise 
bias? 
  Yes          
  No  
  Unclear 
Yes: general population or subgroup. Convenience sampling is 
acceptable as long as eligibility criteria do not restrict to a certain 
group that could plausibly respond differently to the induction. 
No: group selected on basis of particular feature (e.g. high 
catastrophising positive affect / athletes in training) 
Was it clearly and appropriately 
determined that participants were 
pain-free? 
  Yes          
  No  
  Unclear 
Yes: participant self-report of no pain at time of testing AND no history 
of chronic pain (pain on most days for > 3 months) in preceding 2 
years. 
No: reports failure to ask BOTH questions. 
Unclear: does not report asking both questions. 
[B-G only] Similar baseline 
demographics among participants 
(age/sex/medical/psychological 
state)? 
  Yes          
  No  
  Unclear 
 
Yes: Psych (trauma Hx, stress status, general affect, sex, age, 
medication variables accounted for and similar) 
No: Psychiatric diagnoses or medication use (esp. analgesics/anti-
inflammatories/SNRI, etc) amongst participants. 
Unclear: not reported 
*Consider design features, e.g. within-subject control or pre-post 
design 
[Psych manip] Neutral psych 
status? 
  Yes          
  No   Unclear 
 
Yes: Psych variables accounted for and normal 
No: selected for responses on psych assessment 
 
[B-G only] Random allocation 
[B-site] Random allocation 
  Yes          
  No  
  Unclear 
Yes: random sequence generation / roll of die / other truly random 
procedure named 
No: counterbalancing of group size (i.e. pseudo-randomisation) [but 
consider ROB in context] / sequential allocation 
Unclear: not reported in enough detail to allow decision 
Risk of selection bias summary    High   (failure to include any of the above probably influenced results   
  FOR THE QUESTION OF THIS REVIEW) 
  Low   (results unlikely to have been influenced) 
  Unclear (not enough information) 
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Unclear: not enough information / failure to report) 
Risk of performance bias summary   High  
  Low   
  Unclear 
High: Plausible doubt that participant blinding was applied and 
maintained throughout 
Low: Confident that participant blinding was applied and maintained 
throughout 
Unclear: not enough information to make informed judgement (e.g. 
blinding strategy AND blinding check AND results mentioned BUT not 
fully reported) 
Detection bias   
Were outcome assessors blinded to 
the research question and 
paradigm? 
  Yes         
  No  
  Unclear 
Yes: evidence provided - blinding strategy AND blinding check AND 
results reported AND analysis done accordingly 
No: Blinding reported broken  
Unclear: not enough information / failure to report) 
Were analysing researchers blinded 
to the group allocation of 
participants and/or to site 
allocation? 
  Yes          
  No  
  Unclear 
Yes: evidence provided - blinding strategy AND blinding check AND 
results reported AND analysis done accordingly 
No: Blinding reported broken  
Unclear: not enough information / failure to report) 
Risk of detection bias summary   High  
  Low   
  Unclear 
High: Plausible doubt that participant blinding was applied and 
maintained throughout 
Low: Confident that participant blinding was applied and maintained 
throughout 
Unclear: not enough information to make informed judgement (e.g. 
blinding strategy AND blinding check AND results mentioned BUT not 
fully reported) 
Risk of manipulation veracity problem 
[Psych] Did a manipulation check 
confirm the effectiveness of the 
manipulation? 
  Yes           No   Unclear Yes: manip check done and results reported and 
confirmed effectiveness 
No: no manipulation check done OR manip check done 
but results not reported. 
Unclear: manip check done and results confirmed 
ineffectiveness or were inconclusive 
Risk of manipulation veracity 
problem 
  High    Low    Unclear   
Attrition bias 
Incomplete outcome data  Decision Justification 
Have attrition/exclusions/ 
withdrawals been reported and 
appropriately dealt with in 
analysis? 
  Yes           No   Unclear Yes: no attrition/withdrawals OR stats handled 
withdrawals appropriately AND relevant adverse 
events reported  
 
Risk of attrition bias summary   High  
   




  Unclear  
Measurement bias 
 Decision Justification 
Were valid and reliable outcome 
measurements used to assess 
severity & SA of secondary 
hyperalgesia?  
2H:   Yes           No   Unclear 
 
SA:   Yes           No   Unclear 
Yes:  
Self-report: VAS / NRS / validated scale 
Surface area: independently duplicated measurements 
or validated approach 
Consider test-retest reliability if relevant 
No: single measurement of distance/SA; un-validated 
self-report scale 
Were identical equipment items 
used for measurements between 
groups/sites/time points?  
2H:   Yes           No   Unclear 
 
SA:   Yes           No   Unclear 
 
Did the same assessor conduct 
assessments between 
groups/sites/time points?  
2H:   Yes           No   Unclear 
 
SA:   Yes           No   Unclear 
 
Risk of measurement bias 
summary 
2H:   Yes           No   Unclear 
 
SA:   Yes           No   Unclear 
Reporting bias 
Selective reporting Decision Justification 
Were all outcomes for experimental and 
control groups reported on?  
  Yes           No  Check each outcome (compare methods vs results) 
Were conflicts of interest and funding sources 
declared? 
  Yes           No  Consider relevant conflicts 
Risk of reporting bias summary   High   
  Low   
  Unclear  
 Risk of bias summary  
Risk of bias Description Study bias outcome 
High risk of bias Plausible bias that seriously weakens confidence in the results.  
Low risk of bias Plausible bias unlikely to seriously alter or diminish trust in the results.  




Appendix 4: Data extraction form  
 
Study identification 
First author  
Year of publication  
First word of title  





Author’s contact details 






Author’s name  
Study design (RCT / case-control / cross-over / pre-post experimental W-S / pre-post experimental B-G) 
Primary aim  
Sample size  
 
Participants 
Inclusion criteria  
Exclusion criteria  
Sample size calculation  
Baseline characteristics 
 Induction (experimental)  Control Overall 
Age    
Sex (n male; n female)    
Co-morbid diagnoses 
 
   





 Induction (experimental)  Control 
Method/modality:   
Timing   
Duration   
Dosage   
Method of administration   
Equipment required   
Ease of application score   
 
Outcomes 
 Secondary hyperalgesia Secondary allodynia Prim hyperalg Prim allodynia 
 intensity (cont) surf area (cont) allodynia (dyn) allodynia (stat)   
Test stimulus 
modality/ies: 
      
Report scale used       
Time point(s)       
Level reported indiv/ grp indiv/ grp indiv/ grp indiv/ grp indiv/ grp indiv/ grp 
Results 
Note: for point estimate, specify mean/median/mode; for variance, specify SD/SE/SEM/CI. 
Secondary hyperalgesia intensity 
 Baseline Time point 1:  
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         
Control         
 
 Time point: Time point: 
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         




 Time point: Time point: 
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         
Control         
 
Secondary hyperalgesia surface area 
 Baseline Time point 1:  
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         
Control         
 
 Time point: Time point: 
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         
Control         
 
Secondary allodynia (dynamic) 
 Baseline Time point 1:  
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         





 Time point: Time point: 
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         
Control         
 
Secondary allodynia (static) 
 Baseline Time point 1:  
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         
Control         
 
 Time point: Time point: 
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         
Control         
 
Primary hyperalgesia 
 Baseline Time point 1:  
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         





 Time point: Time point: 
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         
Control         
 
Primary allodynia 
 Baseline Time point 1:  
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         
Control         
 
 Time point: Time point: 
 Point est Variance  Sample size p-value Point est Variance  Sample size p-value 
Measure used         
Experimental 1         
Experimental 2         




Number of events  





Appendix 5: Cohen’s Kappa statistic for measuring agreement  
 
Title and abstract screening:  
Step 1: Number in agreement over the total 









































Step 5: Determine Cohen kappa’s coefficient  
𝐾𝐾 =
𝑃𝑃𝑃𝑃 − 𝑃𝑃𝑃𝑃
1− 𝑃𝑃𝑃𝑃  
𝐾𝐾 = 0.47  
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Full test screening: 



























Step 4: Determine the overall probability that the reviewers would randomly agree  














Step 5: Determine Cohen kappa’s coefficient  
𝐾𝐾 =
𝑃𝑃𝑃𝑃 − 𝑃𝑃𝑃𝑃
1− 𝑃𝑃𝑃𝑃  
𝐾𝐾 =  0.59  
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Appendix 6: Supplementary data for systematic review  
6.1 Intensity of secondary hyperalgesia reported in Werner et al. (2002) 
Time point after manipulation 
(minutes) 
Median (IQR) intensity ratings 
for experimental group 
Median (IQR) intensity ratings 
for control group 
10  1.5 (2.3) 1.9 (2.5) 
40  1.2 (2.4) 1.3 (2.4) 
80  1.1 (2.1) 1.0 (2.7) 
120 1.2 (1.7) 1.1 (2.1) 
160 1.0 (1.5) 0.5 (1.5) 
Overall mean determined for 
in this current study 
1.2 1.16 
Intensity ratings were reported on 0 – 100 ratings scale, rescaled to 0 – 10 
 
6.2 Intensity of secondary hyperalgesia reported in Ditre et al. (2018) 
Ring number Mean (SD) intensity ratings 
for experimental group 
Mean (SD) intensity ratings 
for control group 
8th (Outermost)  3.96 (7.08) 1.12 (1.81)  
7th  4.73 (7.63) 1.42 (2.35) 
6th 6.44 (8.98) 2.05 (2.79) 
5th 8.81 (10.43) 3.25 (3.54) 
4th  11.51 (11.73) 4.79 (4.96) 
3rd  15.03 (13.79) 6.55 (5.88) 
2nd (innermost)  18.40 (16.14) 9.10 (7.52) 





6.3 Differences in reporting of intensity of secondary hyperalgesia  
6.3.1 Manipulations hypothesised to decrease the intensity of secondary hyperalgesia 
Study Statistical measure for 
intensity 
Additional notes 
Baron et al. (1999) Mean (SEM) No control data 
Werner et al. (2002) Median (IQR) Range not reported  
Kóbor et al. (2009) Mean (SEM) after being 
normalized to a range of 0-1 
Data unavailable 
Torta et al. (2019) Experiment 1 Mean (SD)  
Torta et al. (2019) Experiment 2 Mean (SD)   
You et al. (2014) Mean (SEM) Intensity of secondary 
hyperalgesia was measured 
four days and one month after 
the manipulation. 
 
6.3.2 Manipulations hypothesised to increase the intensity of secondary hyperalgesia  
Study Statistical measure for 
intensity 
Additional notes 
Ditre et al. (2018) Mean (SD)  
van den Broeke et al. (2014) Mean only  
Helfert et al. (2018)  Data unavailable 
 
6.4 Area of secondary hyperalgesia reported in Werner et al. (2002) 
Time point after manipulation 
(minutes) 
Median (IQR) area for 
experimental group (cm2) 
Median (IQR) area for control 
group (cm2) 
10  50 (30 – 70) 50 (35 – 72) 
40  49 (30 – 73) 63 (28 – 75) 
80  50 (33 – 70) 52 (30 – 73) 
120 44 (27 – 69) 54 (30 – 76) 
160 40 (21 – 71) 42 (25 – 72) 
Overall median determined in 
this current study 





6.5 Area of secondary hyperalgesia reported in Rasmussen et al. (2015) 
Time point after induction 
(minutes) 
Median (95% CI) area for 
experimental group (cm2) 
Median (95% CI) area for 
control group (cm2) 
45  41 (33 – 51) 57 (46 – 67) 
85  37 (27-45) 58 (42 – 74 
125  34 (25 – 40) 54 (39 – 69) 
175  33 (24 – 44) 55 (36 – 70) 
235  29 (17 – 40) 35 (29 – 60) 
Overall median (95% CI) 42.0 (31.1 – 71.4)  34.6 (22.9 – 39.8)  
 
6.6 Differences in reporting of area of secondary hyperalgesia  
6.6.1 Manipulations hypothesised to decrease the area of secondary hyperalgesia 
Study Statistical measure for 
intensity 
Additional notes 
Baron et al. (1999) Mean (SEM) No control data 
Werner et al. (2002) Median (IQR) Range not reported 
Pud et al. (2006) Mean (SEM)  
Yucel et al. (2001) Experiment 1  Data unavailable 
Yucel et al. (2001) Experiment 2  Data unavailable 
Yucel et al. (2001) Experiment 3  Data unavailable 
Rasmussen et al. (2015) Median (95% CI)  
Wahl et al. (2019) Mean (95% CI)  
You et al. (2014) Mean (SEM) Area of secondary 
hyperalgesia was measured 
four days and one month after 
the manipulation. 
Salomons et al. (2014) Mean (SEM)  
Matre et al. (2006) Median (IQR) Range not reported 
Meeker et al. (2019) Mean (SEM)  
Mohammadian et al. (2004) Mean (SEM)  





6.6.2 Manipulations hypothesised to increase the area of secondary hyperalgesia  
Study Statistical measure for 
intensity 
Additional notes 
Ditre et al. (2018) Mean (SD)  
Helfert et al. (2018)  Data unavailable 
Smith et al. (2018) Mean (SEM)  
 
6.7 Pain ratings during induction reported in Wahl et al. (2019) 
 Mean intensity during 
induction in the 
experimental group 
Mean intensity during 
induction in the control 
group 
3.0 3.3 
The overall combined mean pain ratings 
during induction across both groups was 




6.8 Pain during induction reported in Werner et al., 2002 
Time point during induction 
(minutes) 
Median (IQR) area for 
experimental group 
Median (IQR) area for control 
group 
0 33 (22 – 60) 34 (18 – 56)  
1 34 (14 – 48)  34 (14 – 50)   
2 35 (20 – 52) 35 (18 – 54)  
3 35 (22 – 50)  33 (19 – 56)  
4 34 (24 – 54) 32 (14 – 58) 
5 33 (26 – 58) 33 (15 – 53)  
6 33 (24 – 58) 33 (13 – 52)  
7 34 (25 – 64) 32 (14 – 52)  
Overall mean determined in 
this current study  
33.9   33.3 





6.9 Pain ratings during induction reported in Ditre et al. (2018) 
Time point during induction 
(minutes) 
Mean (SD) area for 
experimental group 
Mean (SD) area for control 
group 
0 1.48 (2.40) 1.03 (1.62) 
5 2.48 (2.60) 1.55 (1.75) 
10 3.49 (3.24) 2.25 (2.18) 
15 4.03 (3.28) 2.70 (2.39) 
20 4.49 (3.37) 3.25 (2.67) 
25 4.66 (3.45) 3.47 (2.77) 
30 4.82 (3.53) 3.38 (2.82)  
Overall mean determined for 
in this current study 
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Appendix 9: Eligibility quiz on the Responster platform  
 
Volunteers were asked to answer the following yes/no questions on the Responster platform:  
1. Are you between the ages of 18 – 65 years? 
2. Do you have chronic pain (pain on most days for the past three months)? 
3. Do you have any sensory impairments (decreased sensation in your skin)? 
4. Do you have a mental illness (clinical depression and anxiety counts as a mental illness for 
this study)? 
5. Are you pregnant? 
6. Do you have any electrical or metal implants (e.g. a pacemaker)? 
7. Do you have any tattoos on your forearms? 
8. Do you have a health/cardiovascular condition? 
9. Do you have neurological problems (e.g. epilepsy)? 
10. Do you have peripheral vascular disease? 
11. Do you have problems with skin healing?  
12. Do you use medication that could alter you skin sensitivity or healing (e.g. analgesic 
medication, topical medical creams or immune modulators)?  
The Responster platform was programmed to automatically send the results from the questions to 
the research team’s email address. To be eligible to participate, volunteers had to answer ‘no’ to all 
questions, except question 1.   
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Appendix 10: Randomisation of participants’ ID code  
 
Allocation Group 1: received the HFS under a condition of threat on their right arm (the left arm was 
the control site).  
Allocation Group 2 received the HFS under a condition of threat on their left arm (the right arm was 
the control site).  






























Appendix 11: Basic demographic and participant information   
 
 
12 This was a standardised form used in all HFS studies being conducted by the research team. In some of those 
studies only one arm received the HFS only. For this current study, participants received the HFS on both arms. 





















Caffeine intake:  
 
 
Medication use:  
 
 
















Intensity used for procedure:  
 
 






Appendix 12: Childhood Trauma Questionnaire 
 
Instructions: These questions ask about some of your experiences growing up as a child and a 
teenager. For each question, circle the number that best describes how you feel. Although some of 
these questions are of a personal nature, please try to answer as honestly as you can. Your answers 







































1. I didn’t have enough to eat. 1 2 3 4 5 
2. I knew there was someone to take care of me and protect me 1 2 3 4 5 
3. People in my family called me things like “stupid”, “lazy”, or “ugly”. 1 2 3 4 5 
4. My parents were too drunk or high to take care of me. 1 2 3 4 5 
5. There was someone in my family who helped me feel important or special. 1 2 3 4 5 
6. I had to wear dirty clothes. 1 2 3 4 5 
7. I felt loved. 1 2 3 4 5 
8. I thought that my parents wished I had never been born. 1 2 3 4 5 
9. I got hit so hard by someone in my family that I had to see a doctor or go to the 
hospital. 
1 2 3 4 5 
10. There was nothing I wanted to change about my family. 1 2 3 4 5 
11. People in my family hit me so hard that it left bruises or marks. 1 2 3 4 5 
12. I was punished with a belt, a board, a cord, or some hard object. 1 2 3 4 5 
13. People in my family looked out for each other. 1 2 3 4 5 
14. People in my family said hurtful or insulting things to me. 1 2 3 4 5 
15. I believe that I was physically abused. 1 2 3 4 5 
16. I had the perfect childhood. 1 2 3 4 5 
17. I got hit or beaten so badly that it was noticed by someone like a teacher, neighbour, 
or doctor. 
1 2 3 4 5 
18. I felt that someone in my family hated me. 1 2 3 4 5 
19. People in my family felt close to each other. 1 2 3 4 5 
20. Someone tried to touch me in a sexual way, or tried to make me touch them. 1 2 3 4 5 
21. Someone threatened to hurt me or tell lies about me unless I did something sexual 
with them. 
1 2 3 4 5 
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22. I had the best family in the world. 1 2 3 4 5 
23. Someone tried to make me do sexual things or make me watch sexual things. 1 2 3 4 5 
24. Someone molested me. 1 2 3 4 5 
25. I believe that I was emotionally abused. 1 2 3 4 5 
26. There was someone to take me to the doctor if I needed it. 1 2 3 4 5 
27. I believe that I was sexually abused 1 2 3 4 5 







Appendix 13: Modified version of the World Mental Health Survey 
Initiative version of the World Health Organisation Composite 
International Diagnostic Interview for post-traumatic stress disorder 
 
Instructions: The following questions ask about some of your experiences. For each question, 
indicate "yes" or "no". Although some of these questions are of a personal nature, please try to 
answer as honestly as you can. 
Questions Yes No 
1. Did you ever participate in combat, either as a member of the 
military, or as a member of an organised non-military group? 
  
2. Did you ever serve as a peacekeeper, or relief worker in a war 
zone or in a place where there was ongoing terror of people 
because of political, ethnic, religious or other conflicts? 
  
3. Were you ever an unarmed civilian in a place where there was 
a war, revolution, military coup or invasion? 
  
4. Did you ever live as a civilian in a place where there was 
ongoing terror of civilians for political, ethnic, religious or other 
reasons? 
  
5. Were you ever a refugee – that is, did you ever flee from your 
home to a foreign country or place to escape danger or 
persecution?  
  
6. Were you ever kidnapped of help captive?   
7. Were you ever exposed to a toxic chemical or substance that 
could cause you serious harm?  
  
8. Were you ever involved in a life-threatening automobile 
accident?  
  
9. Did you ever have any other life-threatening accidents, 
including on your job?  
  
10. Were you ever involved in a major natural disaster, like a 
devastating flood, hurricane, or earthquake? 
  
11. Were you ever in a man-made disaster, like a fire started by a 
cigarette, or a bomb explosion? 
  
12. Did you ever have a life-threatening illness?    
13. As a child, were you ever badly beaten up by your parents or 
the people who raised you?  
  
14. Were you ever badly beaten up by a spouse or romantic 
partner?  
  
15. Were you ever badly beaten up by anyone else?   
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The next question is about rape. We define this as an event during 
which one person has sexual intercourse with or penetrates the body of 
another person without their consent, or when they were too young to 
know what was happening.  
16. Did you ever experience an event like the one just described?  
  
The next question is about sexual assault. We define this as an event 
during which one person touches another person inappropriately, or 
without that person’s consent.  
17. Other than rape, did you ever experience an event like the one 
just described?  
  
18. Has someone ever stalked you – that is, followed you or kept 
track of your activities in a way that made you feel you were in 
serious danger?  
  
19. Did someone very close to you ever die unexpectedly; for 
example, they were killed in an accident, murdered, 
committed suicide, or had a fatal heart attack at a young age?  
  
20. Did you ever had a son or daughter who had a life-threatening 
illness or injury?  
  
21. Did anyone very close to you ever have an extremely traumatic 
experience, like being kidnapped, tortured or raped?  
  
22. When you were a child, did you ever witness serious physical 
fights at home, like when your father beat up your mother?  
  
23. Did you ever see someone being badly injured or killed, or 
unexpectedly see a dead body?  
  
24. Did you ever do anything that accidently led to the serious 
injury or death of another person?  
  
25. Did you ever on purpose either seriously injury, torture, or kill 
another person? 
  
26. Did you ever see atrocities or carnage such as mutilated bodies 
or mass killings?  
  
27. Did you ever experience any other extremely traumatic or life-






Appendix 14: Threat manipulation check  
 
 Instructions: please indicate to what extent you agree or disagree with the following statements: 
 Strongly 
disagree 
Disagree Neutral  Agree Strongly 
agree 
1. At the time of receiving the intense 
electrical stimulation, I was 
concerned that it would cause 
damage to my skin on my RIGHT 
arm. 
 
     
2. At the time of receiving the intense 
electrical stimulation, I was 
concerned that it would cause 
damage to my skin on my LEFT 
arm. 
 
     
3. At the time of receiving the intense 
electrical stimulation on my RIGHT 
arm, I felt anxious. 
     
4. At the time of receiving the intense 
electrical stimulation on my LEFT 
arm, I felt anxious. 





Appendix 15: 10-item Connor-Davidson Resilience Scale  
 
Instructions: Please indicate how much you agree with the following statements as they apply to 
you over the last MONTH. 










































1. I am able to adapt when changes occur.      
2. I can deal with whatever comes my way.      
3. I try to see the humorous side of things when I am 
faced with problems. 
     
4. Having to cope with stress can make me stronger.      
5. I tend to bounce back after illness, injury, or other 
hardships. 
     
6. I believe I can achieve my goals, even if there are 
obstacles. 
     
7. Under pressure, I stay focused and think clearly.      
8. I am not easily discouraged by failure.      
9. I think of myself as a strong person when dealing with 
life's challenges and difficulties. 
     
10. I am able to handle unpleasant or painful feelings like 
sadness, fear, and anger. 







Appendix 16: Perceived Stress Scale  
 
Instructions: The questions in this scale ask you about your feelings and thoughts during the last 

































1. In the last month, how often have you been upset because of something 
that happened unexpectedly?  
0 1 2 3 4 
2. In the last month, how often have you felt that you were unable      
3. In the last month, how often have you been upset to control the important 
things in your life?  
0 1 2 3 4 
4. In the last month, how often have you felt nervous and “stressed”?  0 1 2 3 4 
5. In the last month, how often have you felt confident about your ability      
6. In the last month, how often have you been able to handle your personal 
problems?  
0 1 2 3 4 
7. In the last month, how often have you felt that things      
8. In the last month, how often have you felt that things were going your 
way? 
0 1 2 3 4 
9. In the last month, how often have you found that you could not cope with 
all the things that you had to do?  
0 1 2 3 4 
10. In the last month, how often have you been able to control irritations in 
your life?  
0 1 2 3 4 
11. In the last month, how often have you felt that you were on top of things? 0 1 2 3 4 
12. In the last month, how often have you been angered because of things 
that were outside of your control 
0 1 2 3 4 
13. In the last month, how often have you felt difficulties were piling up so 
high that you could not overcome them?  
0 1 2 3 4 
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Appendix 17: Pain Catastrophising Scale  
 
Instructions: Please think back to how you thought and felt during the intense electrical stimulation. 
We are interested in the types of thoughts and feelings that you had during that experience. Listed 
next are thirteen statements describing different thoughts and feelings that may be associated with 
pain.  Please indicate the degree to which you had these thoughts and feelings when you were 












































1. I worried all the time about whether the pain would end      
2. I felt I couldn’t go on      
3. It was terrible and I thought it was never going to get any 
better 
     
4. It was awful and I felt that it overwhelmed me      
5. I felt I couldn't stand it anymore      
6. I became afraid that the pain would get worse      
7. I kept thinking of other painful events      
8. I anxiously wanted the pain to go away 
 
     
9. I couldn't seem to keep it out of my mind 
 
     
10. I kept thinking about how much it hurt 
 
     
11. I kept thinking about how badly I wanted the pain to stop 
 
     
12. There was nothing I can do to reduce the intensity of the pain 
 
     
13. I wondered whether something serious may happen 
 




Appendix 18: Multidimensional Scale of Perceived Social Support  
 
Instructions: We are interested in how you feel about the following statements. Read each 



























































1. There is a special person who is around 
when I am in need.  
1 2 3 4 5 6 7 
2. There is a special person with whom I 
can share my joys and sorrows. 
1 2 3 4 5 6 7 
3. My family really tries to help me. 1 2 3 4 5 6 7 
4. I get the emotional health and support I 
need from my family. 
1 2 3 4 5 6 7 
5. I have a special person who is a real 
source of comfort to me. 
1 2 3 4 5 6 7 
6. My friends really try to help me 1 2 3 4 5 6 7 
7. I can count on my friends when things go 
wrong. 
1 2 3 4 5 6 7 
8. I can talk about my problems with my 
family. 
1 2 3 4 5 6 7 
9. I have friends with whom I can share my 
joys and sorrows. 
1 2 3 4 5 6 7 
10. There is a special person in my life who 
cares about my feelings. 
1 2 3 4 5 6 7 
11. My family is willing to help me make 
decisions. 
1 2 3 4 5 6 7 
12. I can talk about my problems with my 
friends 
1 2 3 4 5 6 7 
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 Appendix 19: Pain Vigilance and Awareness Questionnaire  
 
Instructions: This questionnaire is not directly related to your experience of the intense electrical 
stimulation.  It is to do with you, as a person, and your experiences in life. Pain is a common 
experience. Please think about how you usually behave when you have pain as you answer the 
following questions.  
Please rate the following statements between 0 – 5, where 0 = Never and 5 = Always  
1. I am very sensitive to pain 0 1 2 3 4 5 
2. I am aware of sudden or temporary changes in pain. 0 1 2 3 4 5 
3. I am quick to notice changes in pain intensity 0 1 2 3 4 5 
4. I am quick to notice effects of medication on pain 0 1 2 3 4 5 
5. I am quick to notice changes in location or extent of pain 0 1 2 3 4 5 
6. I focus on sensations of pain 0 1 2 3 4 5 
7. I notice pain even if I am busy with another activity 0 1 2 3 4 5 
8. I find it easy to ignore pain. 0 1 2 3 4 5 
9. I know immediately when pain starts or increases 0 1 2 3 4 5 
10. When I do something that increases pain, the first thing I do is check 
to see how much pain was increased 
0 1 2 3 4 5 
11. I know immediately when pain decreases 0 1 2 3 4 5 
12. I seem to be more conscious of pain than others. 0 1 2 3 4 5 
13. I pay close attention to pain 0 1 2 3 4 5 
14. I keep track of my pain level 0 1 2 3 4 5 
15. I become preoccupied with pain 0 1 2 3 4 5 




Appendix 20: Script for procedure  
 
Welcome to this experiment and thank you for being willing to participate. This will take about 2 
hours. First, I will introduce you to all the procedures. Next, we will do some baseline sensory testing 
on both of your forearms. Then you receive the intense electrical stimulation on your right arm and 
then on your left arm. 
There will be a 20 minute break in testing, and you will complete some questionnaires during that 
time. Then we will continue the sensory testing for the 40 minutes after that. So, it’s sensory testing, 
intense electrical stimulation, questionnaires, and sensory testing. 
1. Demographic information 
(Ask for info for participation record sheet)  
Before we start the procedure, please can you turn off your cell phone just so that no alerts or 
alarms will go off during the procedure. Please also take off your watch/any jewellery.  
2. Introduction to SPARS 
We use this scale in the experiment so it’s important that you understand it.  Please take your time 
to read this.  
[Show SPARS chart and ask them to read it (alone).  Read it to the participant.  Answer any 
questions.] 
This scale runs from -50, which is no sensation – you don’t feel anything – through 0, the exact point 
at which what you feel transitions to pain, to +50, which is the most intense pain you can imagine.  If 
the stimulation trial was non-painful, you’ll rate it between -50 and 0 - the range that is marked in 
yellow as ‘non-painful’. A rating closer to -50 means the trial was less intense, and closer to 0 means 
it was more intense and closer to being painful – but not yet painful, because it’s still below zero and 
in the non-painful range of the scale.  If the trial is painful then you’ll rate it between 0 and +50 - the 
range that is marked in green as ‘painful’.  A higher positive number means more painful.  0 is the 
exact point of transition between not painful and painful.   
When you receive a stimulation, first decide if it was painful or non-painful. Then you can work out 






3. Marking radial lines and electrode placement 
Now I’m going to mark up your arms for the testing procedure.  Is that ok? 
[mark up using foam template, with A towards the cubital fossa; centre of radial lines approx 8cm 
from cubital fossa but NOT on prominent vein or scarred area.] 
These are the electrodes we use.  I will place them on your skin like this, and they will stay there for 
the whole procedure.  We put one on each arm. [Strap electrode goes around upper arm. Disc 
electrode approx 8cm from cubital fossa.] 
[Turn on monitor for participant. Click mouse to bring up ‘Stop here until baseline testing 
completed…’] 
4. Introduction to the test battery  
Each time we test your skin, we will use 6 different tests.  Each test uses a different kind of stimulus: 
we can 
• Touch you lightly with this filament (demo VFF) 
• Brush your skin lightly with a cotton wisp (demo) 
• Brush your skin clearly with a brush (demo) 
• Press a tiny, blunt-ended metal rod against your skin (demo both) 
• Or give you a single electrical stimulus - which I won’t do now because we haven’t 
attached the electrodes yet. 
 
You can feel that the sensations evoked by the different tests can be quite distinct in nature.  We will 
ask you to report what you feel on the scale.  Do not try to rate the different tests relative to one 
another.  Each time we test you with a new modality, don't try to compare it to the previous 
modality.  Just consider each test in isolation, and start afresh with the scale. We are interested in 
your experience of each stimulation modality separately. You may also use decimals. Remember that 
-50 means no sensation at all; 0 is the exact point at which what you feel transitions to pain; +50 is 
the most intense pain you can imagine. Please stay with these reference points during the whole 
experiment! I will ask you to close your eyes when we test your skin, but in between the test runs 
you can open your eyes and look at the scale so that you have a visual image of it – most people find 
that a helpful approach. 
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Now I’ll run you through the test battery so you get a chance to practice giving ratings for each 
stimulus modality.  When we start the experiment, you’ll need to give your rating within about 5 
seconds, but for now we have more time. I’ll test this arm first, then that one.  Please put both your 
arms on the table, turning them upwards for me. 
[perform full test battery on each arm] 
5. Detection threshold testing  
This next test is not about pain, it is about feeling an electrical stimulus.  We start at an intensity of 
zero.  I will gradually increase the intensity until you tell me that you can feel it. Please say "yes" if 
you feel it, even a little bit. It will feel like a very tiny pinprick.   
[find threshold for each arm; choose most sensible approximation, write it down, set DS7A to that 
level and then flick switch to x10]. 
HAVE YOU TESTED BOTH ARMS? 
Now we can begin.  First, we do 3 rounds of the test battery, which usually takes about 6 minutes.  
And then we give you the intense electrical stimulation on each arm, we will give you a 20-minute 
break during which you can complete the questionnaires, and then we spend the rest of the next 
hour repeating the test battery. 
6. Baseline testing  
 
7. Skin examination  
Hmm... it seems like the sensitivity of your skin is different on each arm. This is not unusual. 
However, it is important for me to thoroughly examine your skin to determine your risk of injury 
during the intense electrical stimulation for each arm. This device magnifies your skin and allows me 
to examine different features of your skin very clearly. [show otoscope and use it to carefully 
examine skin around electrodes on both arms.] 
**if participant asks more about how you are assessing the skin answer with the following:  
Can I tell you after the procedure? I just need to concentrate quite hard to make a good assessment 
and then hold all the grades in my head to put into the computer [ask as though they are flustering 





8. Skin examination results  
I need to enter your skin examination findings, along with your sensory rating scores into the main 
computer next door. It uses the results to estimate how strong or fragile your skin is. If your skin is 
fragile there is a risk of injury: the intense electrical stimulation could burn your skin and the deeper 
layers underneath your skin. Based on the information I enter, the computer will class each arm into 
one of three groups: “fully approved” – there is low risk, so stimulating that skin is very safe; 
“approved with reservations” – there is moderate risk that the stimulation will damage the skin, or 
“rejected” – there is too much risk of skin damage. The computer will show you the results of your 
skin sensitivity on the screen in front of you. If it rejects your skin it won’t give the stimulation for 
that arm; if you get either ‘fully approved’ or ‘approved with reservations’ then it will continue and 
give you the stimulation – but it will always show you the risk rating during the stimulation. The way 
it calculates your risk score is quite complicated, so I can’t tell which group it will put you in. Actually, 
I’m not allowed to know what the computer tells you – because apparently it can influence how I 
test you if I do know [act a little dismissive of this]. So don’t tell me what the computer says about 
the risk ratings for your arms – if it lets us continue then we continue. [leave room for 2min. Press 
SPACE on PC outside room to continue – i.e. to start ‘calculation’ time].  
9. Explanation of HFS 
The computer is busy calculating your risk score for each arm. While it does that, I will explain the 
next part of the procedure. The intense electrical stimulation is the part of the procedure that most 
people find moderately painful. The stimulation takes one minute in total, but it is split up into 5 
trains. Each train lasts one second, and then you get a 9-second break. So you’ll have one second of 
stimulation, then 9 seconds’ break, one second of stimulation, 9 seconds’ break - and so on. After 
this, we take a 20-minute break for you to complete some questionnaires.  
The screen will count you through the trains. I want you to concentrate on keeping your arm glued 
to the table when the first train starts because some people pull their arm back as a reflex and then 
you could pull out cables, which can be dangerous. As a safety precaution, I will keep my finger on 
the safety switch so that if you decide you want to pull out of the study you can say ‘STOP’ and I will 
immediately flick the switch down to deactivate the stimulator. I’ll be ready in case you need me to 
stop it. If you pull out, we won’t be able to continue with the study. As I say, there are only 5 trains, 
and each one lasts one second before you get 9 seconds’ break - so just count yourself through. 
Please give me a rating on the scale for each train.  
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Now, put the headphones on, listen carefully and let me know when it says the stimulation will start. 
The first site is the RIGHT arm. Your risk rating for the right arm will be shown on the computer 
screen in front of you and, assuming the arm’s risk score hasn’t caused a safety rejection, you will 
receive the intense electrical stimulation on your right arm. After that, you get a 30-second break 
and the process is repeated for the left arm. Make sense? [tell participant to click mouse.  and HFS 
will start in about 12sec. Keep hand on safety switch.] 
10. HFS 
Start stopwatch at first train. Note clock time of HFS onto participation record. Record SPARS rating 
for each train. 
 
*BE SURE TO SWITCH ELECTRODE SITE TO LEFT ARM AFTER 5TH TRAIN! 
[there is a 30-second break between arms, after which the screen will cue you to opt to continue 
with a mouse click] 
11. Questionnaires  
Now, can you please answer some questionnaires on the screen in front of you. I am going to go 
outside the room and turn off the screen on my side because I don’t want to see what answers you 
are giving.  All your responses will be labelled with your participant ID code so that they are not 
linked to your name and remain confidential. When you’re finished with the questionnaires, this 
screen will show me a message saying that you’re done. [start qu, take ppt next door.] 
12. Follow-up testing  
Do not try to rate the different tests relative to one another.  Each time we test you with a new 
modality, don't try to compare it to the previous modality.  Just consider each test in isolation, and 
start afresh with the scale. We are interested in your experience of each stimulation modality 
separately. You may also use decimals. Remember that -50 means no sensation at all; 0 is the exact 
point at which what you feel transitions to pain; +50 is the most intense pain you can imagine. 
Please stay with these reference points during the whole experiment! I will ask you to close your 
eyes when we test your skin, but in between the test runs you can open your eyes and look at the 
scale so that you have a visual image of it – most people find that a helpful approach. [Always start 




13. Surface area testing 
Now, I will also use the pinprick (show) to test for an area of higher sensitivity.   
I’m going to apply the pinprick in two spots and I want you to tell me if there is a very obvious 
difference in the sensation. 
[apply to right arm first]: Does it feel different if I touch you here [distal]… and here [adjacent to 
electrode]? 
[if no, repeat from proximal to electrode] 
[repeat on left arm.] 
Ok, now I want to map out the area of higher sensitivity.  So I will apply the pinprick repeatedly along 
each of these radial lines, moving towards the electrode. If you feel a distinct change in sensation 
please say "now". Please close your eyes. [test. Repeat this instruction at each mapping time point.] 
[Always start with right arm]. 
14. Post-procedural questionnaires  
This is your last task. Please can you read these questions very carefully and answer them as 
honestly as possible. 
Ask why they did/didn’t feel anxious when receiving the intense electrical stimulation on the 
right/left arm (ask for each arm). Ask why the were/weren’t concerned that the intense electrical 
stimulation would injury the skin on their right/left arm (ask for each arm). [write answers on post-
procedural questionnaire sheet]. 
15. Debriefing  
The skin examination was a sham examination procedure – it was not a true reflection of the 
robustness of your skin. It was part of the procedure for us to tell you that the skin on your one arm 
is more fragile than the other. We did not actually test the fragility of your arm skin; there is no 






Appendix 21: Procedure checklist  
 
Check equipment: 
 DS7A input connected at the back, turned on, settings: voltage max, X1, current 0.01, pulse 
width 2000µs. 
 Output from DS7A to remote electrode selector (D188); output from selector to electrodes. 
 Set out sensory testing equipment, remove covers. 
 Open Affect5 file  
 Research assistant to designate the site allocation in the Affect5 programme 
 Prepare marker pens, mark-up template, electrode stickers, alcohol balls and gauze swabs. 
 Prepare forms:  
o Study information sheet 
o Informed consent 
o Exclusion criteria  












UNIVERSITY OF CAPE TOWN 
DIVISION OF PHYSIOTHERAPY 
FACULTY OF HEALTH SCIENCES 
Study information sheet 
 
In this study we are interested in how people perceive different stimuli.  
The entire procedure will be approximately 60 – 90 minutes. First, I will place two electrodes on your 
forearms, one on each arm. I will repeatedly assess your sensation and pain ratings to light touch, 
blunt-ended pinpricks and single electrical stimulations. You will listen to a short audio recording 
about the high-frequency stimulation. Then you will receive 5 high-frequency electrical stimulations, 
each only lasting 1 second with a 9 second break in between. This part of the procedure will only last 
1 minute. It may be moderately painful. It may require some effort to tolerate, but it is short-lived 
and predictable, so most people find it tolerable. This is a well-established procedure and we do not 
anticipate any tissue damage to occur. However, you may develop a small area of sensitivity which 
could last for a few days. Full recovery is anticipated. Then you will fill out a few questionnaires 
looking at the following:  
1. Basic demographic data (e.g age, sex, ethnicity, medication use and caffeine intake). 
2. Pain awareness and thoughts about pain. 
3. Stress, resilience, social support and previous trauma, including physical, emotional and 
sexual trauma.  




Importantly, you will complete these questionnaires on a computer and your responses will be 
linked to a participation code, not to your name, so that your responses are confidential. The data 
from these questionnaires will be given a new identification code when we analyse it, so that the 
data can in no way be linked back to you.  
After the questionnaires, I will repeatedly reassess your sensation and pain ratings to light touch, 
slight pinpricks, and single electrical stimulations.  
You may withdraw from the study at any stage during the procedure. If you choose to withdraw, it is 
your choice whether I keep the data collected up to that point or if you would like me to destroy the 
information.  
All participants will be provided with an identification code so that the public will not know who took 
part in this study, nor will participants be able to distinguish their own data from those of other 
participants. At the time of publication, the de-identified data will be made publicly available in 
accordance with university policy and the principles of Open Science. 
In order to partake in this study, you will need to sign the letter of informed consent as well as not 











UNIVERSITY OF CAPE TOWN 
DIVISION OF PHYSIOTHERAPY 
FACULTY OF HEALTH SCIENCES 
 
Exclusion criteria  
 
Below is the list of exclusion criteria. If you agree with any of the below statements, you may not participate in this study.  
 
1. I have chronic pain (pain on most days for the past three months) 
2. I have pain today, the day of testing  
3. I have used analgesics (painkillers) in the last 24 hours  
4. I have sensory impairments  
5. I have a mental illness (depression and anxiety count as a mental illness for this study) 
6. I am pregnant  
7. I have electrical or metal implants  
8. I have a tattoo on my arm 
9. I have a heart/cardiovascular condition 
10. I have diabetes mellitus  
11. I have neurological problems (e.g. epilepsy) 
12. I have peripheral vascular disease 
13. I   have problems with skin healing 
14. I use medication that could alter my skin sensitivity or healing (e.g. analgesic medication, topical medical creams or 
immune modulators) 
 
I, ____________________________, have read the exclusion criteria and declare that none of them applies to me.  
Sign _________________________    Date __________________ 
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UNIVERSITY OF CAPE TOWN 
DIVISION OF PHYSIOTHERAPY 
FACULTY OF HEALTH SCIENCES 
 
Informed Consent Form  
 
Who am I? 
I am a Master’s student at the University of Cape Town and I am conducting an experimental study. 
The procedure will be run by either myself, or Caron Louw who is my research assistant. 
 
Are there any risks? 
This procedure involves some pain.  However, it is a well-established procedure and is known not to 
cause any skin damage. You could be at risk of harm if you do not disclose any information listed in 
the exclusion criteria.  
 
Are there any benefits? 
There are no personal benefits to participating in this study. However, the findings of study could 
benefit society by helping us to understand how chronic pain works and thus to improve treatment 
for people who have chronic pain.  
 
What else should I know? 
You will be required to listen to a short audio recording about the high-frequency stimulation 
procedure and could also undergo a skin examination prior to the procedure taking place. You will 
be asked to answer a few questionnaires about your basic demographics, pain awareness and 
thoughts about pain, stress, resilience, social support, and previous trauma (including physical, 
emotional and sexual trauma) and lastly about your experience of the procedure. All information will 
be kept confidential. We will give you a participant code so that your data are not linked to your 
name when we analyse the data. Only the study research team will be able to link the data to you. 
Furthermore, all data will be kept on a password-protected computer. When the study results have 
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been published, all the study data will be made available to the public online, but no one will be able 
to link the data to you. The de-identified data are made publicly available to adhere with the 
University’s policies and the principles of Open Science.  
 
What happens if I get hurt taking part in this study? 
This research study is covered by an insurance policy taken out by the University of Cape Town if you 
suffer a bodily injury because you are taking part in the study.  
The insurer will pay for all reasonable medical costs required to treat your bodily injury, according to 
the SA Good Clinical Practice Guidelines 2006. The insurer will pay without your having to prove that 
the research was responsible for your bodily injury. You may ask the study doctor for a copy of these 
guidelines. 
The insurer will not pay for harm if, during the study, you:  
• Use medicines or other substances that are not allowed 
• Do not follow the study investigator’s instructions 
• Do not tell the study investigator that you have a bad side effect from the procedure 
• Do not take reasonable care of yourself and your study medicine 
• Do not disclose any of the items listed in the exclusion criteria  
If you are harmed and the insurer pays for the necessary medical costs, usually you will be asked to 
accept that insurance payment as full settlement of the claim for medical costs. However, accepting 
this offer of insurance cover does not mean you give up your right to make a separate claim for 
other losses based on negligence, in a South African court. 
It is important to follow the study investigator’s instructions and to report straight away if you have 




What if I have any questions? 
If you have any questions or concerns about the study, you may contact Gillian Bedwell at 
bdwgil001@myuct.ac.za or 083 366 1784. Alternatively, you can contact Dr Tory Madden, the study 
supervisor, at tory.madden@uct.ac.za. 
The UCT’s Faculty of Health Sciences Human Research Ethics Committee can be contacted on 021 
406 6338 in case you have any ethical concerns or questions about your rights or welfare as a 
participant on this research study. 
I, _________________________________, have read and understand the study information sheet. 
 
I, _________________________________, have read and understand the consent form and am 
willing to take part in this study.  
 




I, ________________________________, have explained the study information sheet to the 
participant.  
 
I, ________________________________, have explained the consent form to the participant.  
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Appendix 26: Community healthcare centres providing psychological 
counselling 
Vanguard CHC 
021 695 0232 
Sr Mhlonyane and Mr Holo 
071 7167419 









Hanover Park  
Sr Cader and Sr Berg 





021 637 1281 
 
 
Lentegeur CHC  
Sr Adonis and Sr Martin 




021 637 9071 
076 2321489 
Dunoon CHC 






021 397 8906/ 8195 
0842732180 
 
Lotus River  
Sr Shah  



























Mitchells Plain Day Hospital 
Mr Williams 





Appendix 27: Private practice psychologists within the University of 
Cape Town’s neighbouring communities  
 
Both psychologists were contacted via email to request permission to include their information for 
potential psychological referral. This was done before the protocol was submitted for ethical 
approval.  
 
Name: Cheryl Baker  
Phone number: 021 6711576 and 0826464250 
Email address: cherylbaker@iafrica.com 
Private Practice: Claremont  
Name: Mireille Landman 
Phone number: 021 6854250 (w) and 082 3391605 
Email address: mlandman@cybersmart.co.za 





Appendix 28: Data analysis using pilot study data 
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Background 
The purpose of this analysis script is to specify how the formal analysis of the full, final data 
set will be done. The current script uses the pilot data. Note that this script was planned and 
run on a very small sample, so some of the model assumptions may have been violated. We 
have not tested for this in the current version of the script, but we will test for violations 





• Describe and compare HFS ratings between arms. 
• Describe and compare participant anxiety self-ratings between arms. 
• Describe and compare participant threat self-ratings between arms. 
Primary aim 
To determine the intensity of secondary hyperalgesia (SH) on each arm, and compare 
between arms. 
Secondary aim 
To determine the surface area (SA) of secondary hyperalgesia (SH) on each arm, and 
compare between arms. 
Exploratory aims 
Sensory measurements 
• To determine the intensity of static light touch on each arm, and compare between 
arms. 
• To determine the intensity of dynamic light touch on each arm, and compare between 
arms. 
• To determine the intensity of e-stim on each arm, and compare between arms. 
Questionnaires 
• Describe the Childhood Trauma Questionnaire (CTQ) and recent trauma scores (CIDI). 
• Explore for relationship with area of SH (with results from both arms pooled). 
NB: we also collected data using a few other questionnaires, but those data were intended 




We plan to use a mixed model analysis to compare ratings of the HFS trains between 
conditions. The order in which the two arms were stimulated was kept consistent across 
participants (right forearm first), but the allocation of forearm to condition was 
counterbalanced (random allocation to one of two equally sized groups). Therefore, the 
‘group’ and ‘site’ information have been used to code for a ‘condition’ variable that is 
specified as A or B to maintain blinding of the analyst to actual experimental conditions. 
Here, we test for a main effect of condition on ratings, whilst allowing for a random 
intercept for each participant. 
hfs <- master_data %>% 
  filter(phase == 'hfs') %>% 
  select(id, condition, rating) 
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hfs$rating <- as.numeric(hfs$rating) 
 
hfs %<>% group_by(id, condition) %>% 
  mutate(train = row_number()) %>% 
  ungroup() 
 
hfs_wide <- hfs %>% 
  group_by(id) %>% 
  spread(key = condition, 
         value = rating) 
 
ggplot(data = hfs) + 
  aes(x = train, 
      y = rating, 
      colour = condition) + 
  geom_point() + 
  facet_grid(~ id) + 
  labs( y = 'Rating', 
        x = 'Train', 
        title = 'Individual SPARS ratings during each HFS train') 
 
# Null model 
hfs_null <- lmer(rating ~ 1 + (1|id), 
              data = hfs) 
hfs_condition <- lmer(rating ~ condition + (1|id),  
              data = hfs) 
anova(hfs_condition, hfs_null) # hfs_condition is no better than null 
## Data: hfs 
## Models: 
## hfs_null: rating ~ 1 + (1 | id) 
## hfs_condition: rating ~ condition + (1 | id) 
##               Df    AIC    BIC  logLik deviance  Chisq Chi Df Pr(>Chisq) 
## hfs_null       3 420.16 426.44 -207.08   414.16                          
## hfs_condition  4 421.92 430.30 -206.96   413.92 0.2347      1     0.6281 
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# Conclude: HFS ratings were not predicted by condition. 
 
summary(hfs_condition)   
## Linear mixed model fit by REML ['lmerMod'] 
## Formula: rating ~ condition + (1 | id) 
##    Data: hfs 
##  
## REML criterion at convergence: 408.2 
##  
## Scaled residuals:  
##     Min      1Q  Median      3Q     Max  
## -3.1105 -0.4616  0.0471  0.8254  1.2217  
##  
## Random effects: 
##  Groups   Name        Variance Std.Dev. 
##  id       (Intercept)  8.765   2.961    
##  Residual             54.608   7.390    
## Number of obs: 60, groups:  id, 6 
##  
## Fixed effects: 
##             Estimate Std. Error t value 
## (Intercept)  40.1167     1.8114   22.15 
## conditionB   -0.9167     1.9080   -0.48 
##  
## Correlation of Fixed Effects: 
##            (Intr) 
## conditionB -0.527 
Anxiety ratings 
We are interested in a main effect of condition on anxiety ratings. 
anxiety <- master_data %>% select(group, 
                                  id, 
                                  anxious_right, 
                                  anxious_left) 
 
anxiety <- unique(anxiety) 
 
anxiety %<>% 
  gather(key = arm, 
         value = anxiety, 
         3:4) %>% 
  mutate(arm = case_when( 
    arm == 'anxious_left' ~ 'left', 
    arm == 'anxious_right' ~ 'right' 
  )) 
 
anxiety %<>% mutate(condition = case_when( 
  group == '1' & arm == 'right' ~ 'A', 
  group == '1' & arm == 'left' ~ 'B', 
  group == '2' & arm == 'right' ~ 'B', 
  group == '2' & arm == 'left' ~ 'A')) %>% 
  select(-group) 
 
ggplot(data = anxiety) + 
  aes(x = arm, 
      y = anxiety, 
      group = interaction(arm,condition), 
      colour = condition) + 
  geom_boxplot() + 
  labs(title = 'The effect of condition on anxiety rating', 
       y = 'Anxiety rating', 




a1 <- ggplot(data = anxiety) + 
  aes(x = arm, 
      y = anxiety, 
      group = condition, 
      colour = condition) + 
  geom_point() + 
  facet_grid(~ id)+ 
  labs(title = 'Individual effect of condition on anxiety rating', 
       y = 'Anxiety rating', 
       x = 'Arm') 
 
anxiety_null <- lmer(anxiety ~ 1 + (1|id), 
                     data = anxiety) 
anxiety_condition <- lmer(anxiety ~ condition + (1|id), 
                     data = anxiety) 
anova(anxiety_condition, anxiety_null) # No effect of condition. 
## Data: anxiety 
## Models: 
## anxiety_null: anxiety ~ 1 + (1 | id) 
## anxiety_condition: anxiety ~ condition + (1 | id) 
##                   Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## anxiety_null       3 43.392 44.847 -18.696   37.392               
## anxiety_condition  4 44.513 46.452 -18.256   36.513 0.8796      1 
##                   Pr(>Chisq) 
## anxiety_null                 
## anxiety_condition     0.3483 
Threat ratings 
We are interested in a main effect of condition on threat ratings. 
threat <- master_data %>% select(group, 
                                  id, 
                                  damage_right, 
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                                  damage_left) 
threat <- unique(threat) 
 
threat %<>% 
  gather(key = arm, 
         value = threat, 
         3:4) %>% 
  mutate(arm = case_when( 
    arm == 'damage_left' ~ 'left', 
    arm == 'damage_right' ~ 'right' 
  )) 
 
threat %<>% mutate(condition = case_when( 
  group == '1' & arm == 'right' ~ 'A', 
  group == '1' & arm == 'left' ~ 'B', 
  group == '2' & arm == 'right' ~ 'B', 
  group == '2' & arm == 'left' ~ 'A')) %>% 
  select(-group) 
 
ggplot(data = threat) + 
  aes(x = arm, 
      y = threat, 
      group = interaction(arm,condition), 
      colour = condition) + 
  geom_boxplot() + 
  labs(title = 'The effect of condition on threat rating', 
       y = 'Threat rating', 
       x = 'Arm') 
 
t1 <- ggplot(data = threat) + 
  aes(x = arm, 
      y = threat, 
      group = condition, 
      colour = condition) + 
  geom_point() + 
  facet_grid(~ id)+ 
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  labs(title = 'Individual effect of condition on threat rating', 
       y = 'Threat rating', 
       x = 'Arm') 
 
threat_null <- lmer(threat ~ 1 + (1|id), 
                     data = threat) 
threat_condition <- lmer(threat ~ condition + (1|id), 
                     data = threat) 
anova(threat_condition, threat_null) # No effect of condition. 
## Data: threat 
## Models: 
## threat_null: threat ~ 1 + (1 | id) 
## threat_condition: threat ~ condition + (1 | id) 
##                  Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## threat_null       3 47.882 49.337 -20.941   41.882               
## threat_condition  4 47.564 49.503 -19.782   39.564 2.3185      1 
##                  Pr(>Chisq) 
## threat_null                 
## threat_condition     0.1278 
grid.arrange(a1, t1) 
 
Primary outcome: intensity of SH 
We are interested in determining the intensity of secondary hyperalgesia (SH) on each arm, 
and the comparison between arms. 
We have data from the baseline time points as well as follow-up time points, and for both 
arms (control and experimental sites). We are interested in the change in ratings (from 
baseline to follow-up time points), and how these differed between the arms/conditions. 
Therefore, for the formal analysis, we: 1) calculated the mean rating for all baseline time 
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points; 2) calculated the mean rating for all follow-up time points; 3) subtracted the mean 
baseline rating from the mean follow-up rating (within participant and condition), to provide 
the indication of change in rating (i.e. hyperalgesia) for each condition, within each 
participant. 
intensity <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
  filter(modality == '128' | modality == '256') %>% 
  filter(phase != 'orientation') %>% 
  mutate(time = case_when( 
    phase == 'baseline' ~ time*-1, 
    phase != 'baseline' ~ time 
  )) 
 
intensity %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site) 
intensity$rating <- as.numeric(intensity$rating) 
intensity %<>% group_by(id, 
           time, 
           phase, 
           condition) %>% 
  summarise(pp_rating = mean(rating))  
 
# Management of rating data: we controlled for baseline ratings. We compared individual rat
ings over time and group ratings over time.  
 
int_bl <- intensity %>% filter(phase == 'baseline') %>% 
  group_by(id, condition) %>% 
  summarise(rating = mean(pp_rating)) %>% 
  ungroup() %>% 
  mutate(time = 0) %>% ungroup() 
 
int_fu <- intensity %>% filter(phase != 'baseline') %>% ungroup () %>% 
  select(-phase) %>% 
  rename(rating = pp_rating) 
 
intensity <- rbind(int_bl, int_fu) 
 
# For interest, plot the actual pilot data 
 
ggplot(data = intensity) + 
  aes(x =time, 
      y = rating, 
      group = condition, 
      colour = condition) + 
  facet_wrap(~ id) + 
  geom_point() + 
  geom_line() + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Individual intensity of SH, over time', 
       y = 'Rating', 




# All participants, group data represented by boxplots 
ggplot(data = intensity) + 
  aes(x = time, 
      y = rating, 
      group = interaction(condition, time), 
      colour = condition) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Grouped intensity of SH, over time', 
       y = 'Rating', 




 # Calculate diff between conditions for group boxplots 
 
intensity_wide <- intensity %>%  
  group_by(id, 
           time) %>% 
  spread(key = condition, 
         value = rating) %>% 
  mutate(site_diff = A-B) 
 
# All participants, group data represented by boxplots 
ggplot(data = intensity_wide) + 
  aes(x = time, 
      y = site_diff, 
      group = time) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Pilot group data: between condition difference in SH, over time', 
       y = 'Pinprick ratings of condition A minus rating of condition B', 




# Collapse all post-baseline ratings for each condition and then compare them using a RM AN
OVA type model. Time is nested within (and fully crossed with) ID. 
 
int_bl %<>% select(-time) 
names(int_bl)[names(int_bl) == 'rating'] <- 'baseline_rating' 
collapse <- int_fu %>% # resolve each rating relative to baseline 
  right_join(int_bl) %>% 
  mutate(rating_controlled = rating-baseline_rating) %>% 
  select(id, 
         time, 
         condition, 
         rating_controlled) # spread to calculate difference between conditions 
   
# We want to find out whether rating_cotrolled (for baseline) is predicted by condition. 
 
model_null <- lmer(rating_controlled ~ (1|id), 
                   data = collapse) 
model_condition <- lmer(rating_controlled ~ condition + (1|id), 
                       data = collapse) 
anova(model_condition, model_null) # No improvement 
## Data: collapse 
## Models: 
## model_null: rating_controlled ~ (1 | id) 
## model_condition: rating_controlled ~ condition + (1 | id) 
##                 Df    AIC    BIC  logLik deviance  Chisq Chi Df Pr(>Chisq) 
## model_null       3 665.14 672.43 -329.57   659.14                          
## model_condition  4 665.88 675.60 -328.94   657.88 1.2618      1     0.2613 
model_pre_condition_crossed <- lmer(rating_controlled ~ condition + (1|id/time), 
                                    data = collapse) 
 
anova(model_pre_condition_crossed, model_null) 




## model_null: rating_controlled ~ (1 | id) 
## model_pre_condition_crossed: rating_controlled ~ condition + (1 | id/time) 
##                             Df    AIC    BIC  logLik deviance Chisq Chi Df 
## model_null                   3 665.14 672.43 -329.57   659.14              
## model_pre_condition_crossed  5 666.93 679.08 -328.46   656.93  2.21      2 
##                             Pr(>Chisq) 
## model_null                             
## model_pre_condition_crossed     0.3312 
# not a significant improvement 
 
# Secondary hyperalgesia intensity is not predicted by condition. 
Secondary outcome: area of SH 
We are interested in determining the surface area (SA) of secondary hyperalgesia (SH) on 
each arm, and the comparison between arms. 
SA <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
  filter(phase == 'test_sa') 
 
SA %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site, 
         -phase) 
 
# replace ND with 0 
 
SA$rating[SA$rating == 'ND'] <- 0 
 
names(SA)[names(SA) == 'rating'] <- 'point1' 
names(SA)[names(SA) == 'modality'] <- 'radial_line' 
 
SA %<>% group_by(id, time) %>% 
  mutate(point2 = case_when(radial_line == 'A' ~ lead(point1, 5), 
                            radial_line == 'B' ~ lag(point1, 2), 
                            radial_line == 'C' ~ lag(point1, 2), 
                            radial_line == 'D' ~ lag(point1, 2), 
                            radial_line == 'E' ~ lead(point1, 7), 
                            radial_line == 'F' ~ lag(point1, 2), 
                            radial_line == 'G' ~ lag(point1, 2), 
                            radial_line == 'H' ~ lag(point1, 2))) %>% 
  ungroup() 
 
SA$point1 <- as.numeric(SA$point1) 
SA$point2 <- as.numeric(SA$point2) 
# Now calculate surface area for each triangle 
library(REdaS) 
sinangle <- sin((deg2rad(45))) 
sinangle 
## [1] 0.7071068 
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SA %<>% mutate(triangle = (point1*point2*sinangle)/2) 
# Now calculate SA for each ID, site and time 
 
SA %<>% select(-radial_line, 
                      -point1, 
                      -point2) 
 
SA %<>% group_by(id, 
                 time, 
                 condition) %>% 
  summarise(SA = sum(triangle)) %>% 
  ungroup()  
 
SA_plot <- ggplot(data = SA) + 
  aes(x = as.factor(time), 
      y = SA, 
      colour = condition, 
      group = condition) + 
  geom_point() + 
  geom_line(aes(colour = condition)) + 
  facet_wrap(~ id, 
             nrow = 2) + 
  labs(x = 'Time (minutes)', 
       y = 'Surface area (cm2)', 
       title = 'Individual area of SA, over time')  
SA_plot 
 
# All participants, group data represented by boxplots 
ggplot(data = SA) + 
  aes(x = time, 
      y = SA, 
      group = interaction(time,condition), 
      colour = condition) + 
  geom_boxplot(width = 2) + 
  labs(title = 'Grouped area of SH, over time', 
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       y = 'Surface area of SH by condition (cm2)', 
       x ='Time (minutes)') 
 
# We are interested in a main effect of condition on SA 
 
model_null_sa <- lmer(SA ~ (1|id), 
                   data = SA) 
model_condition_sa <- lmer(SA ~ condition + (1|id), 
                       data = SA) 
anova(model_condition_sa, model_null_sa) # Condition predicts SA! (p = 0.02703) 
## Data: SA 
## Models: 
## model_null_sa: SA ~ (1 | id) 
## model_condition_sa: SA ~ condition + (1 | id) 
##                    Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## model_null_sa       3 283.30 288.05 -138.65   277.30               
## model_condition_sa  4 280.41 286.74 -136.21   272.41 4.8891      1 
##                    Pr(>Chisq)   
## model_null_sa                   
## model_condition_sa    0.02703 * 
## --- 
## Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
model_pre_condition_crossed_sa <- lmer(SA ~ condition + (1|id/time), 
                                    data = SA) 
 
anova(model_pre_condition_crossed_sa, model_condition_sa) 
## Data: SA 
## Models: 
## model_condition_sa: SA ~ condition + (1 | id) 
## model_pre_condition_crossed_sa: SA ~ condition + (1 | id/time) 
##                                Df    AIC    BIC  logLik deviance Chisq 
## model_condition_sa              4 280.41 286.74 -136.21   272.41       
## model_pre_condition_crossed_sa  5 282.41 290.33 -136.21   272.41     0 
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##                                Chi Df Pr(>Chisq) 
## model_condition_sa                               
## model_pre_condition_crossed_sa      1          1 
# not a significant improvement 
 
# Secondary hyperalgesia surface area is predicted by condition, and the model that does no
t allow for full crossing of time and ID is a better model. 
Exploratory outcomes 
Sensory outcomes 
• To determine the intensity of static light touch on each arm, and the comparison 
between arms. 
• To determine the intensity of dynamic light touch on each arm, and the comparison 
between arms. 
• To determine the intensity of e-stim on each arm, and the comparison between arms. 
## Static light touch 
 
slt <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
  filter(modality == 'VFF') %>% 
  filter(phase != 'orientation') %>% 
  mutate(time = case_when( 
    phase == 'baseline' ~ time*-1, 
    phase != 'baseline' ~ time 
  )) 
 
slt %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site) 
slt$rating <- as.numeric(slt$rating) 
 
slt_bl <- slt %>% filter(phase == 'baseline') %>% 
  group_by(id, condition) %>% 
  summarise(rating = mean(rating)) %>% 
  ungroup() %>% 
  mutate(time = 0) %>% ungroup() 
 
slt_fu <- slt %>% filter(phase != 'baseline') %>% ungroup () %>% 
  select(-phase, 
         -modality) 
 
slt <- rbind(slt_bl, slt_fu) 
 
# For interest, plot the pilot data 
 
ggplot(data = slt) + 
  aes(x = time, 
      y = rating, 
      group = condition, 
      colour = condition) + 
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  facet_wrap(~ id) + 
  geom_point() + 
  geom_line() + 
  labs(title = 'Individual static light touch ratings by condition, over time', 
       y = 'Rating', 
       x = 'Time (minutes)') 
 
# All participants, group data represented by boxplots 
ggplot(data = slt) + 
  aes(x = time, 
      y = rating, 
      group = interaction(condition, time), 
      colour = condition) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  labs(title = 'Group data: static light touch ratings by condition, over time', 
       y = 'Rating', 




 # Calculate diff between conditions for group boxplots 
 
slt_wide <- slt %>%  
  group_by(id, 
           time) %>% 
  spread(key = condition, 
         value = rating) %>% 
  mutate(site_diff = A-B) 
 
# All participants, group data represented by boxplots 
ggplot(data = slt_wide) + 
  aes(x = time, 
      y = site_diff, 
      group = time) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Grouped data: static light touch ratings difference between conditions', 
       y = 'Static light touch ratings of condition A minus rating of condition B', 




# Collapse all post-baseline ratings for each condition and then compare them using a RM AN
OVA type model. Time is nested within (and fully crossed with) ID. 
 
slt_bl %<>% select(-time) 
names(slt_bl)[names(slt_bl) == 'rating'] <- 'baseline_rating' 
collapse_slt <- slt_fu %>% # resolve each rating relative to baseline 
  right_join(slt_bl) %>% 
  mutate(rating_controlled = rating-baseline_rating) %>% 
  select(id, 
         time, 
         condition, 
         rating_controlled) # spread to calculate difference between conditions 
   
# We want to find out whether rating_cotrolled (for baseline) is predicted by condition. 
 
model_null_slt <- lmer(rating_controlled ~ (1|id), 
                   data = collapse_slt) 
model_condition_slt <- lmer(rating_controlled ~ condition + (1|id), 
                       data = collapse_slt) 
anova(model_condition_slt, model_null_slt) # No improvement 
## Data: collapse_slt 
## Models: 
## model_null_slt: rating_controlled ~ (1 | id) 
## model_condition_slt: rating_controlled ~ condition + (1 | id) 
##                     Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## model_null_slt       3 631.37 638.67 -312.69   625.37               
## model_condition_slt  4 632.44 642.16 -312.22   624.44 0.9367      1 
##                     Pr(>Chisq) 
## model_null_slt                 
## model_condition_slt     0.3331 
model_pre_condition_crossed_slt <- lmer(rating_controlled ~ condition + (1|id/time), 





## Data: collapse_slt 
## Models: 
## model_null_slt: rating_controlled ~ (1 | id) 
## model_pre_condition_crossed_slt: rating_controlled ~ condition + (1 | id/time) 
##                                 Df    AIC    BIC  logLik deviance  Chisq 
## model_null_slt                   3 631.37 638.67 -312.69   625.37        
## model_pre_condition_crossed_slt  5 625.73 637.89 -307.87   615.73 9.6406 
##                                 Chi Df Pr(>Chisq)    
## model_null_slt                                       
## model_pre_condition_crossed_slt      2   0.008064 ** 
## --- 
## Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
# Significant improvement... condition predicts static light touch ratings but only in full
y crossed model. 
 
# Dynamic light touch 
 
dlt <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
  filter(modality == 'CW' | modality == 'BR') %>% 
  filter(phase != 'orientation') %>% 
  mutate(time = case_when( 
    phase == 'baseline' ~ time*-1, 
    phase != 'baseline' ~ time 
  )) 
 
dlt %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site) 
dlt$rating <- as.numeric(dlt$rating) 
 
dlt_bl <- dlt %>% filter(phase == 'baseline') %>% 
  group_by(id, condition) %>% 
  summarise(dlt_rating = mean(rating)) %>% 
  ungroup() %>% 
  mutate(time = 0) %>% ungroup() 
 
dlt_fu <- dlt %>% filter(phase != 'baseline') %>% ungroup() %>% 
  group_by(id, 
           time, 
           condition) %>% 
  summarise(dlt_rating = mean(rating)) %>% 
  ungroup() 
 
dlt <- rbind(dlt_bl, dlt_fu) 
 
# For interest, plot the pilot data 
 
ggplot(data = dlt) + 
  aes(x = time, 
      y = dlt_rating, 
      group = condition, 
      colour = condition) + 
  facet_wrap(~ id) + 
  geom_point() + 
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  geom_line() + 
  labs(title = 'Individual dynamic light touch ratings by condition, over time', 
       y = 'Rating', 
       x = 'Time (minutes)') 
 
# All participants, group data represented by boxplots 
ggplot(data = dlt) + 
  aes(x = time, 
      y = dlt_rating, 
      group = interaction(condition, time), 
      colour = condition) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  labs(title = 'Group data: dynamic light touch ratings by condition, over time', 
       y = 'Rating', 




 # Calculate diff between conditions for group boxplots 
 
dlt_wide <- dlt %>%  
  group_by(id, 
           time) %>% 
  spread(key = condition, 
         value = dlt_rating) %>% 
  mutate(site_diff = A-B) 
 
# All participants, group data represented by boxplots 
ggplot(data = dlt_wide) + 
  aes(x = time, 
      y = site_diff, 
      group = time) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Grouped data: dynamic light touch rating difference between conditions', 
       y = 'Dynamic light touch ratings of condition A minus rating of condition B', 




# Collapse all post-baseline ratings for each condition and then compare them using a RM AN
OVA type model. Time is nested within (and fully crossed with) ID. 
 
dlt_bl %<>% select(-time) 
names(dlt_bl)[names(dlt_bl) == 'dlt_rating'] <- 'baseline_rating' 
collapse_dlt <- dlt_fu %>% # resolve each rating relative to baseline 
  right_join(dlt_bl) %>% 
  mutate(rating_controlled = dlt_rating-baseline_rating) %>% 
  select(id, 
         time, 
         condition, 
         rating_controlled) # spread to calculate difference between conditions 
   
# We want to find out whether rating_cotrolled (for baseline) is predicted by condition. 
 
model_null_dlt <- lmer(rating_controlled ~ (1|id), 
                   data = collapse_dlt) 
model_condition_dlt <- lmer(rating_controlled ~ condition + (1|id), 
                       data = collapse_dlt) 
anova(model_condition_dlt, model_null_dlt) # Condition predicts DLT rating 
## Data: collapse_dlt 
## Models: 
## model_null_dlt: rating_controlled ~ (1 | id) 
## model_condition_dlt: rating_controlled ~ condition + (1 | id) 
##                     Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## model_null_dlt       3 423.36 430.65 -208.68   417.36               
## model_condition_dlt  4 419.47 429.19 -205.74   411.47 5.8896      1 
##                     Pr(>Chisq)   
## model_null_dlt                   
## model_condition_dlt    0.01523 * 
## --- 
## Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
model_pre_condition_crossed_dlt <- lmer(rating_controlled ~ condition + (1|id/time), 




anova(model_pre_condition_crossed_dlt, model_null_dlt) # Not better 
## Data: collapse_dlt 
## Models: 
## model_null_dlt: rating_controlled ~ (1 | id) 
## model_pre_condition_crossed_dlt: rating_controlled ~ condition + (1 | id/time) 
##                                 Df    AIC    BIC  logLik deviance  Chisq 
## model_null_dlt                   3 423.36 430.65 -208.68   417.36        
## model_pre_condition_crossed_dlt  5 421.47 433.62 -205.74   411.47 5.8896 
##                                 Chi Df Pr(>Chisq)   
## model_null_dlt                                      
## model_pre_condition_crossed_dlt      2    0.05261 . 
## --- 
## Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
# Condition predicts dynamic light touch ratings but only the un-crossed model is tolerated
. 
 
# Electrical stimulation 
 
estim <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
  filter(modality == 'VFF') %>% 
  filter(phase != 'orientation') %>% 
  mutate(time = case_when( 
    phase == 'baseline' ~ time*-1, 
    phase != 'baseline' ~ time 
  )) 
 
estim %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site) 
estim$rating <- as.numeric(estim$rating) 
 
estim_bl <- estim %>% filter(phase == 'baseline') %>% 
  group_by(id, condition) %>% 
  summarise(rating = mean(rating)) %>% 
  ungroup() %>% 
  mutate(time = 0) %>% ungroup() 
 
estim_fu <- estim %>% filter(phase != 'baseline') %>% ungroup () %>% 
  select(-phase, 
         -modality) 
 
estim <- rbind(estim_bl, estim_fu) 
 
# For interest, plot the pilot data 
 
ggplot(data = estim) + 
  aes(x = time, 
      y = rating, 
      group = condition, 
      colour = condition) + 
  facet_wrap(~ id) + 
  geom_point() + 
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  geom_line() + 
  labs(title = 'Individual electrical stimulation ratings by condition, over time', 
       y = 'Rating',  
       x = 'Time (minutes)') 
 
# All participants, group data represented by boxplots 
ggplot(data = estim) + 
  aes(x = time, 
      y = rating, 
      group = interaction(condition, time), 
      colour = condition) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  labs(title = 'Group data: Electrical stimulation ratings by condition, over time', 
       y = 'Rating', 




 # Calculate diff between conditions for group boxplots 
 
estim_wide <- estim %>%  
  group_by(id, 
           time) %>% 
  spread(key = condition, 
         value = rating) %>% 
  mutate(site_diff = A-B) 
 
# All participants, group data represented by boxplots 
ggplot(data = estim_wide) + 
  aes(x = time, 
      y = site_diff, 
      group = time) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Grouped data: Electrical stimulation ratings difference between conditions'
, 
       y = 'Electrical stimulation ratings of condition A minus rating of condition B', 




# Collapse all post-baseline ratings for each condition and then compare them using a RM AN
OVA type model. Time is nested within (and fully crossed with) ID. 
 
estim_bl %<>% select(-time) 
names(estim_bl)[names(estim_bl) == 'rating'] <- 'baseline_rating' 
collapse_estim <- estim_fu %>% # resolve each rating relative to baseline 
  right_join(estim_bl) %>% 
  mutate(rating_controlled = rating-baseline_rating) %>% 
  select(id, 
         time, 
         condition, 
         rating_controlled) # Spread to calculate difference between conditions. 
   
# We want to find out whether rating_cotrolled (for baseline) is predicted by condition. 
 
model_null_estim <- lmer(rating_controlled ~ (1|id), 
                   data = collapse_estim) 
model_condition_estim <- lmer(rating_controlled ~ condition + (1|id), 
                       data = collapse_estim) 
anova(model_condition_estim, model_null_estim) # No improvement 
## Data: collapse_estim 
## Models: 
## model_null_estim: rating_controlled ~ (1 | id) 
## model_condition_estim: rating_controlled ~ condition + (1 | id) 
##                       Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## model_null_estim       3 631.37 638.67 -312.69   625.37               
## model_condition_estim  4 632.44 642.16 -312.22   624.44 0.9367      1 
##                       Pr(>Chisq) 
## model_null_estim                 
## model_condition_estim     0.3331 
model_pre_condition_crossed_estim <- lmer(rating_controlled ~ condition + (1|id/time), 





## Data: collapse_estim 
## Models: 
## model_null_estim: rating_controlled ~ (1 | id) 
## model_pre_condition_crossed_estim: rating_controlled ~ condition + (1 | id/time) 
##                                   Df    AIC    BIC  logLik deviance  Chisq 
## model_null_estim                   3 631.37 638.67 -312.69   625.37        
## model_pre_condition_crossed_estim  5 625.73 637.89 -307.87   615.73 9.6406 
##                                   Chi Df Pr(>Chisq)    
## model_null_estim                                       
## model_pre_condition_crossed_estim      2   0.008064 ** 
## --- 
## Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
# Significant improvement... condition predicts Electrical stimulation ratings but only in 
fully crossed model. 
Childhood and recent trauma scores 
We are interested in exploring the relationship between trauma history and area of SA. 
cidi <- master_data[ , grep('cidi', colnames(master_data))] 
cidi$cidi_total <- rowSums(cidi) 
ctq <- master_data[ , grep('ctq', colnames(master_data))] 
ctq$ctq_total <- rowSums(ctq) 
   
trauma <- cbind(master_data$id, cidi, ctq) 
names(trauma)[names(trauma) == 'master_data$id'] <- 'id' 
trauma %<>% mutate(trauma = cidi_total + ctq_total) %>% 
  select(id, 
          trauma) 
trauma <- unique(trauma) 
 
SA_trauma <- SA %>% right_join(trauma) 
 
# We need to identify the best time point from which to draw the SA data for each participa
nt. We will do this by identifying the time of peak SH intensity individually, and then use 
the SA time point closest to that time. 
 
# Considering that secondary hyperalgesia needs first to be verified before the surface are
a becomes a meaningful outcome, we first identified the time at which each participant show
ed the peak SH intensity (mean of both conditions). We then used that individualised time p
oint for each participant and identified the SA of SH at that time point, using that as the 
peak (relevant) SA for that participant. 
 
intensity_time <- intensity %>% group_by(id, time) %>% 
  summarise(mean_int = mean(rating)) %>% 
  filter(time != 0) %>% 
  ungroup() %>% 
  group_by(id) %>% 
  filter(mean_int == max(mean_int)) 
 
# Now identify SA at those time point, using the df 'SA_trauma'. Adjust values to closest a
pplicable SA assessment times - i.e. 20 or 26 (int) to 20 mins, 32 or 38 or 44 to 40 mins, 
50 or 56 to 60 mins. 
 
SA_at_peak <- SA_trauma %>% 
  filter(id == 'EOI1141' & time == 40 | 
           id == 'EOI1142' & time == 60 | 
           id == 'EOI1145' & time == 60 | 
           id == 'EOI1148' & time == 20 | 
           id == 'EOI1149' & time == 20 | 
           id == 'EOI1151' & time == 60 ) 
 
 




ggplot(data = SA_at_peak) + 
  aes(x = trauma, 
      y = peak_SA) + 
  geom_point() + 
  geom_smooth(method = 'lm')+ 
  labs(title = 'Individual peak SA, over summed trauma scores', 
       y = 'Peak SA (cm2)', 
       x = 'Summed trauma scores') 
 
# First check distributional assumptions for correlation. 
# Shapiro-Wilk normality test for peak surface area 
with(SA_at_peak, shapiro.test(peak_SA)) # p = 0.03 therefore not normally distributed. 
##  
##  Shapiro-Wilk normality test 
##  
## data:  peak_SA 
## W = 0.75336, p-value = 0.002898 
# Spearman rank-order correlation 
 
correlation <- cor.test(SA_at_peak$trauma, SA_at_peak$peak_SA, method= "spearman") 
correlation 
##  
##  Spearman's rank correlation rho 
##  
## data:  SA_at_peak$trauma and SA_at_peak$peak_SA 
## S = 409.46, p-value = 0.1611 
## alternative hypothesis: true rho is not equal to 0 
## sample estimates: 
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Chronic pain is poorly understood, poorly treated and burdensome worldwide. In the American 2012 
National Health Interview Survey, just over half (55,7%) of the adult population reported having had 
pain within the three months before the survey. Of these, 25,5 million (11,2%) participants reported 
having had “pain every day for the past three months” (Nahin, 2015). A large-scale survey 
investigating the prevalence and severity of chronic pain in 15 European countries and Israel found 
that of the 46,394 participants, 19% reported having had moderate or severe pain for at least the 
preceding six months (Breivik et al., 2006). The socio-economic burden of chronic pain in Sweden 
costs the healthcare sector 32 billion Euros per year (Gustavsson et al., 2012). Back and neck pain is 
the second greatest cause of years lived with disability in Southern Sub-Saharan Africa, second only 
to HIV (Institute for Health Metrics and Evaluation, 2017). The magnitude of pain problems may be 
due to a limited understanding of pain such that optimising clinical treatment is difficult (Breivik et 
al., 2013, Briggs et al., 2015, Madden and Moseley, 2016). Treatment strategies ought to be targeted 
to specific mechanisms of chronic pain (Woolf and Mannion, 1999). A thorough understanding of 
physiological mechanisms of chronic pain would allow development of improved treatment 
modalities. 
Introduction 
Chronic pain can be partially attributed to structural and functional changes in the central and 
peripheral nervous systems, referred to as central and peripheral sensitisation, respectively 
(Sandkuhler and Gruber-Schoffnegger, 2012, van Wilgen and Keizer, 2012). Some of these changes 
cause the nervous system to have an increased responsiveness to input - specifically, within the 
neuronal synapses of the dorsal horn of the spinal cord (Sandkuhler and Gruber-Schoffnegger, 
2012). This enhanced synaptic activity is referred to as spinal long-term potentiation (LTP). Spinal 
LTP underlies the amplification and prolongation of noxious afferent stimuli (Nickel et al., 2012).  As 
such, it is an important physiological mechanism underlying central sensitisation and increased pain 
sensitivity.  
Spinal LTP can underlie primary hyperalgesia in the absence of peripheral nociceptor sensitisation, 
and some forms of secondary hyperalgesia - common clinical findings in patients with neuropathic 
pain (Jensen and Finnerup, 2014). Spinal LTP can be assessed using multiple outcome measures. This 
study will focus on three specific indicators of spinal LTP: allodynia, primary hyperalgesia, and 
secondary hyperalgesia. Allodynia is increased sensitivity to a stimulus that is normally non-painful 
(IASP, 2017). Hyperalgesia is formally defined as “increased pain from a stimulus that normally 
provokes pain” (IASP, 2017) within the area of tissue damage (primary hyperalgesia) and in the area 
surrounding tissue damage (secondary hyperalgesia).  
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There are many methods of experimentally inducing secondary hyperalgesia, including repeated 
thermal stimulation (Salomons et al., 2014), high-frequency electrical stimulation (Henrich et al., 
2015), low-frequency electrical stimulation (Klein et al., 2004), and intradermal or topical application 
of capsaicin (Serra et al., 2004). Recent research has shown that secondary hyperalgesia can be 
manipulated with pharmacological and non-pharmacological modalities (Andersen et al., 1996, van 
den Broeke et al., 2014, Ditre et al., 2018). Cognitive behavioural therapy, aimed at reducing 
negative emotions and thoughts related to pain, has been shown to reduce thermally induced 
secondary hyperalgesia (Salomons et al., 2014), but the mechanisms of this effect are unclear. The 
effect could be attributed to an alteration of the threat value of the stimulation, or to other features 
of the cognitive behavioural therapy intervention.  
Pain is known to be influenced by the threat value of a stimulus (Arntz and Claassens, 2004, Wiech et 
al., 2010). Instructions signifying that a stimulus will be of high intensity appear to increase reported 
pain intensities of the stimulus, despite the intensity of the stimulus being unchanged (Moseley and 
Arntz, 2007). The meaning behind a stimulus - for example, the degree to which a person feels 
threatened that the stimulus can cause tissue damage - is subjective (Arntz and Claassens, 2004). 
Personal and cultural beliefs, previous experiences, and expectations all play a role in determining 
the threat value of a stimulus. However, the physiological mechanisms by which threat influences 
pain are unclear. Specifically, it is not known if threat influences the extent to which synaptic activity 
is enhanced after sustained or intense neural signalling (spinal LTP). Therefore, the aim of this study 
is to investigate the effect of the threat value of a stimulus on experimentally induced secondary 
hyperalgesia, using high-frequency electrical stimulation (HFS) in healthy human volunteers. 
The objectives of the study are: 
a) to differentially manipulate the threat associated with high-frequency electrical 
stimulation at two different sites within each participant; 
b) to assess and compare (1) intensity ratings (primary outcome) and (2) surface area 
(secondary outcome) of experimentally induced secondary hyperalgesia (as assessed 
using mechanical punctate stimulation) between the sites, and  
c) to assess and compare intensity ratings given for (exploratory outcomes) static light 
touch, dynamic light touch, and a single electrical stimulation, before and after the 
experimental induction of secondary hyperalgesia, between the sites.  
Ratings will be provided using the Sensation and Pain Rating Scale (SPARS) (Madden et al., 2016, 
Madden et al., 2019b, Madden et al., 2019a). 
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We hypothesise that greater threat will be associated with (hypothesis 1) greater intensity and 
(hypothesis 2) greater surface area of induced secondary hyperalgesia. Data obtained from assessing 
static light touch, dynamic light touch and single electrical stimulation will be used for exploratory 
purposes only.  
Methods  
Study design  
The study is designed as a within-subject, double-blinded, experimental study. It will be conducted 
at the University of Cape Town, South Africa. The protocol has been approved by Faculty of Health 
Sciences Human Research Ethics Committee (REF 498/2019), University of Cape Town.    
Recruitment  
Volunteers will be recruited from the general public using flyers, advertisements, social media 
channels, such as Facebook and Twitter, and word of mouth. They will be provided with a study 
information sheet outlining the details of the procedure and will be screened for exclusion criteria by 
completing an online eligibility quiz using the Responster platform. After completing the screening 
quiz, eligible volunteers will be contacted via email to organise a booking slot. Volunteers not eligible 
for this study will be thanked for their interest and given the opportunity to have their details added 
to our database for notifications about future studies. Participants may withdraw from the study at 
any stage during the procedure or up to 48 hours after the procedure. They will be compensated 
ZAR100, in cash, for their time and inconvenience, even if they withdraw from the study.  
Inclusion and exclusion criteria  
Volunteers must be healthy, pain-free adults between the ages of 18 – 65 (to account for the 
possible presence of age-related peripheral loss of sensation), to be able to consent autonomously, 
and be fluent in speaking, understanding and reading English (all as per volunteers’ self-reports).  
Volunteers will be excluded from the study if they report one or more of the following: chronic pain 
– pain for most days for the past three months (Blyth et al., 2001), pain on the day of testing, self-
reported pregnancy, electronic implant (e.g. pacemaker), any kind of heart/cardiovascular problem, 
diabetes mellitus, neurological problems (e.g. epilepsy), peripheral vascular disease, problems with 
skin healing, use of analgesics within 24 hours before testing, use of medication that could alter skin 
sensitivity or healing (analgesic medication, topical medical creams or immune modulators, for 
example), history of psychiatric problems (fear or anxiety disorder, or clinical depression, for 
example), and previous participation in this study or a closely related study. Additionally, volunteers 
with upper limb tattoos distal to the anode will be ineligible to participate as some tattoo inks 
contain metals. Tattoo ink containing iron oxide (usually within black pigmented tattoos) 
theoretically can conduct an electrical current (Ross and Matava, 2011). Therefore, applying HFS 
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near these tattoos could cause minor skin burns. Due to difficulty identifying the composition of 
tattoo ink, all volunteers with tattoos at or distal to the intended site of the anode will be excluded 
from participating in this study.  
Randomisation and blinding  
Participants will receive the HFS on both forearms separately. One arm will receive the HFS under a 
condition of threat (experimental) and the other arm will not (control), thus providing a within-
subject comparison. Site allocation for the threat manipulation will be counterbalanced across 
participants. 
Participants will be blinded to the study goals: they will be informed that the researchers are 
investigating how people experience painful and non-painful stimulations. The researcher 
undertaking the measurements will be blinded to site allocation, i.e. which arm (right or left) 
received the HFS under a condition of threat, thus mitigating verification bias. The researcher will 
perform a blinding assessment after participants receive the HFS and before the sensory testing 
battery. The blinding assessment will consist of two questions: first, they will be asked which arm 
they think received the HFS under a condition of threat. If they are uncertain, they will be instructed 
to guess. Second, they will rate their confidence in their answer to the first question on five-point 
Likert scale consisting of “not at all confident”, “not confident”, “neutral”, “confident”, “extremely 
confident”.   
The effect of the threat manipulation on the outcomes will be deduced on the basis of a between-
site comparison of the change in sensation or pain (before to after HFS) to punctate mechanical 
stimulation around the site of tissue stimulation (intensity of secondary hyperalgesia; primary 
outcome) and the surface area affected by secondary hyperalgesia (secondary outcome). 
Equipment  
High-frequency electrical stimulation will be provided using a constant current stimulator (DS7A, 
Digitimer Limited, Hertfordshire, UK). The electrical impulses will be controlled by the software 
programme Affect5 (Spruyt, 2010). Current will be directed from the DS7A to a pair of electrodes. 
The electrodes consist of two cathodes and two anodes. The cathodes have 10 blunt steel pins 
arranged in a circle and will be secured to both anterior forearms. The anodes are large surface 





High-frequency electrical stimulation  
The cathodes will be secured on the anterior aspect of both the participant’s forearms, with a 
double-sided sticker, approximately eight centimetres distal to the cubital fossa, and avoiding any 
visibly prominent vasculature. Large surface electrodes will be placed around both upper arms and 
will serve as the anodes. 
The appropriate intensity of the HFS depends on the electrode used and individual’s electrical 
detection threshold. Our electrodes most closely resemble those used by Klein et al. (2004), Klein et 
al. (2008) and Henrich et al. (2015). Their work and pilot work done by this current study’s authors 
has shown robust secondary hyperalgesia with HFS delivered at 100Hz, at a current of ten times the 
individual detection threshold.  
Participants will be orientated to the electrical stimulus and the stimulus will be calibrated to the 
participant’s individual electrical detection threshold. This calibration will consist of single electrical 
stimuli, with a pulse width of 2ms. We will use an adaptive staircase approach to determine the 
individual electrical detection threshold. The electrical detection threshold will be used to determine 
the intensity of the HFS: ten times the electrical detection threshold. Klein et al. (2004) reported 
participants’ electrical detection threshold to be 0.11 ± 0.06mA (mean ± SD). Therefore, it is 
anticipated that the range of currents will be similar in this study. 
Threat manipulation  
The threat manipulation procedure is similar to that used by Wiech et al. (2010) and will consist of a 
sham skin examination.  The sham skin examination will be conducted after the baseline sensory 
assessment and before participants receive the HFS. The researcher will inform the participants that 
they are examining the robustness of the skin around the electrodes, while using an otoscope to 
shine light onto the skin and magnify the view of the area. The purpose of the sham skin 
examination will be framed as to determine the risk of skin damage associated with that site 
undergoing HFS.  The (sham) results will be shown on a computer screen not visible to the 
researcher. For each participant, the screen will report a judgement of “approved with 
reservations”, with participants instructed to closely monitor their “fragile” skin during the HFS as 
there is “moderate risk of injury”  for the experimental site, and “fully approved”, with participants 




Measured variables  
Participants will verbally report sensation or pain ratings using the SPARS (Madden et al., 2016, 
Madden et al., 2019b, Madden et al., 2019a). This scale is useful as it provides for a range of non-
painful and painful sensory experiences. The non-painful range, on the left-hand side of the scale, 
ranges from -50 – “no sensation” – to 0 – “the exact point at which what you feel transitions to 
pain”. The SPARS is sensitive to change in both painful and non-painful sensory experiences 
(Madden et al., 2019a).  
 
Primary outcome 
Mechanical punctate stimulation  
Mechanical punctate stimulation will be provided with two pinprick stimulators (MRS Systems, 
Heidelberg, Germany), exerting forces of 128mN and 256mN. Increased ratings to these modalities 
in the region surrounding the distal electrode, after the HFS, will indicate the presence of secondary 
hyperalgesia. The mean ratings of the two different pinprick weights will be used to determine the 
overall mechanical punctate stimulation rating.   
Secondary outcome  
Mapping surface area of secondary hyperalgesia  
Using the eight-radial-lines approach, the area of secondary hyperalgesia will be mapped with the 
use of a pinprick stimulator exerting a force of 128mN (You et al., 2014). 
Exploratory outcomes  
Static light touch  
Static light touch sensation will be assessed with application of a von Frey filament (MARSTOCK, 
Schriesheim, Germany) that exerts a force of 32mN upon bending (Rolke et al., 2006).  
Dynamic light touch  
Dynamic light touch will be measured using a cotton wisp and soft brush stroke. Henrich et al. (2015) 
reported increased non-painful dynamic light touch sensation using cotton wool and a soft brush 
stroke one to two centimetres over the skin surrounding the area where the stimulus was provided. 
Figure 21: Sensation and Pain Rating Scale (SPARS) 
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Participants were asked to report pain (with the instruction that any sensation felt as pricking or 
burning should be reported as painful) on a numerical rating scale, where “0 = no pain and 100 = 
most intense pain imaginable”. We will adapt this approach slightly by asking participants to report 
their sensation or pain ratings using the SPARS. Dynamic light touch stimulations are typically 
perceived as non-painful in unsensitised areas as they only activate low-threshold 
mechanoreceptors (Leem et al., 1993). Therefore, allodynia will be deemed present if participants 
indicate pain to dynamic light touch after HFS.  
Single electrical stimulation  
A single electrical stimulation will be used to assess primary hyperalgesia (homotopic spinal LTP). 
The electrical stimulus will be two milliseconds long with an intensity of ten times the individual’s 
electrical detection threshold (Henrich et al., 2015).  
Questionnaires 
Trauma has been associated with increased area of secondary hyperalgesia (You et al., 2016). 
Women reporting childhood trauma and/or recent trauma displayed a larger surface area of 
secondary hyperalgesia after application of topical capsaicin than women without a history of 
trauma (You et al., 2016). Therefore, data from the Childhood Trauma Questionnaire short form 
(CTQ-SF) and a modified version of the World Mental Health Survey Initiative version of the World 
Health Organisation Composite International Diagnostic Interview for post-traumatic stress disorder 
(WMH-CIDI) will be used in a secondary analysis, to investigate the relationship between trauma 
history and experimentally induced secondary hyperalgesia, in an attempt to replicate the work by 
You et al. (2016). Participants will also complete several other questionnaires: 10-item Connor-
Davidson Resilience Scale, Cohen’s Perceived Stress Scale, Pain Catastrophising Scale, 
Multidimensional Scale of Perceived Social Support, and 16-item Pain Vigilance and Awareness 
Questionnaire, which will be used for exploratory analyses to inform the development of future 
research questions. The full list of questionnaires includes: 
9. Basic demographic and participant information questionnaire, which will include the 
following items: participant ID code, group allocation, age, sex, ethnicity, medication 
use, caffeine intake, hand dominance, detection threshold on each arm, and time and 
day of procedure.  
10. Childhood trauma and adult trauma will be screened for using the Childhood Trauma 
Questionnaire (CTQ-SF) (Bernstein et al., 2003) and a modified version of the World 
Mental Health Survey Initiative version of the World Health Organisation Composite 
International Diagnostic Interview for post-traumatic stress disorder (WMH-CIDI) 
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(Kessler et al., 2004), respectively. The CTQ-SF focuses on 5 criteria: emotional abuse, 
physical abuse, sexual abuse, emotional neglect, and physical neglect.  
11. The modified version of the WMH-CIDI has questions drawn directly from the WMH-CIDI 
(Kessler et al., 2004). The modified version aims to determine whether participants have 
been through specific traumatic events. It will be used as an inventory and the 
researchers will not investigate the details of the traumatic event.  
12. A customised questionnaire will be used to check the threat manipulation and provide 
qualitative data on participants’ self-report of their experience of the HFS procedure. 
After the procedure, participants will be asked to indicate on a five-point Likert scale the 
extent to which they agree or disagree with the following statements: “At the time of 
receiving the intense electrical stimulation, I was concerned that it would cause damage 
to my skin on my right/left arm” and “At the time of receiving the intense electrical 
stimulation on my right/left arm, I felt anxious”. Participants will complete these 
questions with reference to each arm separately.  
13. Resilience will be assessed using the 10-item Connor-Davidson Resilience Scale (CD-RISC-
10) (Campbell-Sills and Stein, 2007), which is a validated, shortened version of the 25-
item Connor-Davidson Resilience Scale (CD-RISC). 
14. Stress will be assessed using Cohen’s Perceived Stress Scale (PSS) (Lee, 2012, Cohen, 
1988). 
15. Pain catastrophising is associated with increased pain sensitivity (Sullivan et al., 2005). 
Therefore, we plan to use the Pain Catastrophising Scale (PCS) – a valid and reliable 
outcome measure – to assess participants’ catastrophic thoughts about pain (Sullivan et 
al., 1995). The instructions and text of this scale will be modified to prompt participants 
to respond with reference to their thoughts during the HFS. 
16. Pain can be influenced by perceived social support. Social support has been shown to 
decrease pain intensity (López-Martínez et al., 2008). Therefore, we plan to assess 
participants’ perceived social support using the Multidimensional Scale of Perceived 
Social Support (MSPSS) (Zimet et al., 1988). The MSPSS is a 12-item scale on which 
participants respond to certain statements about the support they receive from family, 
friends and a significant other using a 7-point Likert-type scale ranging from “very 
strongly disagree” to “very strongly agree”. It has been shown to be valid with a South 
African cohort (Bruwer et al., 2008).  
17. Attention to pain and changes in pain will be assessed using the 16-item Pain Vigilance 
and Awareness Questionnaire (PVAQ) (McCracken, 1997). The PVAQ is a valid 
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questionnaire for assessing awareness, intrusion and monitoring of pain in non-clinical 
samples (McWilliams and Asmundson, 2001).   
These questionnaires do not require expert training to administer. They will all be administered via a 
computer. To ensure confidentiality, the researcher will not have viewing access to the relevant 
computer screen while the participant completes the questionnaires.  
Overview of procedure  
Participants will be orientated to the sensory testing battery and baseline measurements will be 
taken. The researcher will perform the sham skin examination and participants will receive the 
results of their skin rating on each arm separately. Thereafter, participants will receive the HFS on 
each arm separately. Participants will then have 20 minutes to complete the questionnaires before 
the researcher conducts the sensory testing battery again at 20, 26, 32, 38, 40, 44, 50, 56, and 60 
minutes after participants receive the HFS. 
Preparation 
Before the experimental procedure, participants will be asked to re-read the study information 
sheet, confirm that none of the exclusion criteria applies to them, and sign the document of 
informed consent.  Thereafter, participants will be asked to remove any jewellery (rings, watch or 
bracelets) from their arms and to turn off mobile phones or smart watches so that they will not be 
distracted by any alerts. They will be clearly briefed about the HFS procedure. 
The researcher will use a stencil to mark locations for the electrodes and eight surrounding radial 
lines, arranged at 45-degree angles to one another, on the participant’s skin. The cathodes will be 
secured, with a double-sided sticker, approximately eight centimetres distal to the cubical fossa on 
the anterior aspect of both the participants’ forearms, avoiding any visibly prominent vasculature.  
Large surface electrodes will be placed on both upper arms and will serve as the anodes. 
Participants will be orientated to the SPARS and the sensory testing battery. They will have an 
opportunity to practice using the SPARS while the researcher runs through a practice round of the 
sensory testing battery.  
Baseline testing  
Once the participants are comfortable with using the SPARS, the sensory testing battery will be 
conducted six times (three times on each arm) to obtain baseline sensory ratings of static light 
touch, dynamic light touch and punctate mechanical stimuli. Primary hyperalgesia will not be 





High-frequency electrical stimulation  
Participants will be thoroughly briefed on what to expect from the HFS. Participants will be informed 
that most people find the HFS “moderately painful” and they may withdraw with immediate effect 
at any point during the procedure. They will be instructed to say “STOP” if they wish to withdraw, in 
which case the researcher will flick the safety switch on the stimulator to deactivate the stimulator 
immediately. A comparison of the HFS SPARS ratings will serve as a manipulation check. Additionally, 
participants will complete a post-experiment comparative sensory rating question for each arm 
separately.  
Waiting period  
There will be a waiting period of approximately 20 minutes to allow time for the secondary 
hyperalgesia to develop. To optimise time, this period will be used to administer the questionnaires. 
Follow-up testing 
The battery of sensory testing will be conducted at the following time points after HFS: 20 minutes, 
26 minutes, 32 minutes, 38 minutes, 40 minutes, 44 minutes, 50 minutes and 56 minutes. 
Importantly, the order of the sensory testing modalities will be randomised within each time point, 
for each participant, to decrease predictability and ensure accurate ratings (with the same order 
used for both arms, within each time point). The surface area of secondary hyperalgesia will be 
mapped at 20-minute intervals after receiving the HFS, namely: at 20 minutes, 40 minutes and 60 
minutes after the HFS.  
After the procedure, the electrodes will be removed, and participants will be asked to complete the 
post-experiment questionnaire. Finally, participants will be debriefed on the threat manipulation 
and reassured about the safety of the procedure.  
Participants will complete the questionnaires in privacy, and on a computer. Details of any traumatic 
events will not be requested. For these reasons, it is unlikely the questionnaires will evoke strong 
emotional responses at the time of testing.  Nevertheless, after the procedure, participants will be 
provided with an information pamphlet outlining the local non-profit organisations where they can 
access psychological assistance, if they wish to do so. Additionally, all participants will receive a list 
of the community health care centres in Cape Town that provide psychological counselling as well as 





Sample size calculation  
Pilot data and the GLIMMPSE online calculator (Kreidler et al., 2013) were used to calculate the 
estimated sample size required to achieve 80% power to detect a minimum 5-point difference in 
secondary hyperalgesia with alpha set at 0.05. We planned for a mixed linear regression in which the 
dependent variable was the mean rating to both pinprick stimulators (128 and 256mN) at each time 
point after HFS, minus the equivalent mean rating at the baseline time point (before HFS). The 
model structure allowed each participant to have their own intercept (i.e. individual participant (ID) 
was a random factor). The independent variable ‘condition’ (i.e. experimental or control site) was a 
fixed factor, and the repeated measures variable ‘time’ was nested within ID, because each 
participant was assessed at each time point. In the lme4 (Loy and Hofmann, 2014, Bates et al., 2015) 
of R (version 3.5.3 (2019-03-11)), the model structure would be: lmer(rating ~ condition + 
(1|ID/time). 
We were interested in detecting a main effect of condition. GLIMMPSE estimated that we would 
require a sample size of 25 participants. Therefore, we opted for a sample size of 26, to allow for 
counterbalancing for the manipulation site.  
Statistical analysis  
Primary analysis 
Data will be analysed using a linear mixed modelling approach, so as to account for individual 
variability in responses whilst still testing for a between-site effect at the group level.  The study is 
designed to have within-subject controls of both pre- and post-induction measurements and control 
site measurements.  Therefore, the change in sensitivity (pre-induction measurements subtracted 
from post-induction measurements) will be compared between arms (within subjects). The exact 
parameters for the analysis will be chosen on the basis of visual inspection of the data (including an 
assessment of distribution), and the appropriate tests to confirm or refute any assumptions of the 
analytical strategy.  As specified above, the primary outcome will be the magnitude of secondary 
hyperalgesia.  
It is plausible that the individual calibration approach could confound the results, because HFS 
delivered at a higher current could result in greater secondary hyperalgesia. We will test for this in 
our analysis although a previous, well powered (n = 170, unpublished) investigation of this 
relationship found none. 
The planned data analysis using the full pilot study data (Appendix 1) has been finalised. A mixed 
linear modelling approach, likely using the ‘lmer’ option within the lme4 package (Loy and Hofmann, 
2014, Bates et al., 2015) that allows for both random effects (including participant) and fixed effects 
(including threat condition) as used in our sample size calculation, will be used for the formal data 
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analysis. Initial processing of the formal data has commenced at the time of this protocol being 
locked online. However, the analysis of the formal data has not been completed. The pilot analysis 
was not substantively changed after initial processing of the formal data commenced.  
Secondary analysis 
A secondary analysis will be conducted to investigate the relationship between trauma history and 
experimentally induced secondary hyperalgesia, replicating the work by You et al. (2016). In their 
study, they summed the results of participants’ individual scores from the Childhood Trauma Events 
Scale and the Recent Traumatic Events Scale to obtain an individual stressful life events score. 
Similarly, the plan for this current study is to sum the results of the CTQ-SF and WMH-CIDI. You et al. 
(2016) reported a larger surface area of capsaicin-induced secondary hyperalgesia in participants 
with a history of trauma than participants without a history of trauma. However, there were no 
differences in the intensity of secondary hyperalgesia between those with and those without a 
history of trauma. In this current study, a univariate regression analysis will be conducted to 
examine whether stressful life events correlate with the area of secondary hyperalgesia in this 
sample.  
Distribution of findings 
The plan for this current study is to write the results of the study into a manuscript, post the 
manuscript as a pre-print for initial feedback, and then submit it for publication in a peer-reviewed 





ANDERSEN, O. K., FELSBY, S., NICOLAISEN, L., BJERRING, P., JENSEN, T. S. & ARENDT-NIELSEN, L. 
1996. The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas 
induced by capsaicin--a double-blind, placebo-controlled, human experimental study. Pain, 
66, 51-62. 
ARNTZ, A. & CLAASSENS, L. 2004. The meaning of pain influences its experienced intensity. Pain, 109, 
20-5. 
BATES, D., MAECHLER, M., BOLKER, B. & WALKER, S. 2015. Ime4: Linear mixedeffects models using 
Eigen and S4. R package version 1.1–9. Available a thttps. CRAN. R-project. org/package= 
lme4. 
BERNSTEIN, D. P., STEIN, J. A., NEWCOMB, M. D., WALKER, E., POGGE, D., AHLUVALIA, T., STOKES, J., 
HANDELSMAN, L., MEDRANO, M., DESMOND, D. & ZULE, W. 2003. Development and 
validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse & 
Neglect, 27, 169-190. 
BLYTH, F. M., MARCH, L. M., BRNABIC, A. J., JORM, L. R., WILLIAMSON, M. & COUSINS, M. J. 2001. 
Chronic pain in Australia: a prevalence study. Pain, 89, 127-134. 
BREIVIK, H., COLLETT, B., VENTAFRIDDA, V., COHEN, R. & GALLACHER, D. 2006. Survey of chronic 
pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain, 10, 287-333. 
BREIVIK, H., EISENBERG, E. & O’BRIEN, T. 2013. The individual and societal burden of chronic pain in 
Europe: the case for strategic prioritisation and action to improve knowledge and availability 
of appropriate care. BMC Public Health, 13, 1229. 
BRIGGS, E. V., BATTELLI, D., GORDON, D., KOPF, A., RIBEIRO, S., PUIG, M. M. & KRESS, H. G. 2015. 
Current pain education within undergraduate medical studies across Europe: Advancing the 
Provision of Pain Education and Learning (APPEAL) study. BMJ open, 5, e006984. 
CAMPBELL-SILLS, L. & STEIN, M. B. 2007. Psychometric analysis and refinement of the Connor-
davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilience. Journal Of 
Traumatic Stress, 20, 1019-1028. 
COHEN, S. 1988. Perceived stress in a probability sample of the United States. 
DITRE, J. W., ZALE, E. L., LAROWE, L. R., KOSIBA, J. D. & DE VITA, M. J. 2018. Nicotine deprivation 
increases pain intensity, neurogenic inflammation, and mechanical hyperalgesia among daily 
tobacco smokers. Journal of abnormal psychology, 127, 578. 
GUSTAVSSON, A., BJORKMAN, J., LJUNGCRANTZ, C., RHODIN, A., RIVANO-FISCHER, M., SJOLUND, K. 
F. & MANNHEIMER, C. 2012. Socio-economic burden of patients with a diagnosis related to 
chronic pain--register data of 840,000 Swedish patients. Eur J Pain, 16, 289-99. 
HENRICH, F., MAGERL, W., KLEIN, T., GREFFRATH, W. & TREEDE, R. D. 2015. Capsaicin-sensitive C- 
and A-fibre nociceptors control long-term potentiation-like pain amplification in humans. 
Brain, 138, 2505-20. 
IASP 2017. Classification of Chronic Pain. In: BOGDUK, H. M. A. N. (ed.) Part III: Pain Terms, A Current 
List with Definitions and Notes on Usage. Second Edition ed. Seattle: IASP Press. 
INSTITUTE FOR HEALTH METRICS AND EVALUATION. 2017. GBD Compare Data Visualization 
[Online]. Available: http://vizhub.healthdata.org/gbd-compare [Accessed 01 June 2018]. 
JENSEN, T. S. & FINNERUP, N. B. 2014. Allodynia and hyperalgesia in neuropathic pain: clinical 
manifestations and mechanisms. The Lancet Neurology, 13, 924-935. 
KESSLER, R. C., ÜSTUUML & N, T. B. 2004. The World Mental Health (WMH) Survey Initiative Version 
of the World Health Organization (WHO) Composite. International Diagnostic Interview 
(CIDI). International Journal of Methods in Psychiatric Research, 13, 93-121. 
KLEIN, T., MAGERL, W., HOPF, H. C., SANDKUHLER, J. & TREEDE, R. D. 2004. Perceptual correlates of 
nociceptive long-term potentiation and long-term depression in humans. J Neurosci, 24, 964-
71. 
KLEIN, T., STAHN, S., MAGERL, W. & TREEDE, R. D. 2008. The role of heterosynaptic facilitation in 
long-term potentiation (LTP) of human pain sensation. Pain, 139, 507-519. 
233 
 
KREIDLER, S. M., MULLER, K. E., GRUNWALD, G. K., RINGHAM, B. M., COKER-DUKOWITZ, Z. T., 
SAKHADEO, U. R., BARÓN, A. E. & GLUECK, D. H. 2013. GLIMMPSE: online power 
computation for linear models with and without a baseline covariate. Journal of statistical 
software, 54. 
LEE, E.-H. 2012. Review of the Psychometric Evidence of the Perceived Stress Scale. Asian Nursing 
Research, 6, 121-127. 
LEEM, J. W., WILLIS, W. D., WELLER, S. C. & CHUNG, J. M. 1993. Differential activation and 
classification of cutaneous afferents in the rat. Journal of Neurophysiology, 70, 2411 - 2424. 
LOY, A. & HOFMANN, H. 2014. HLMdiag: A suite of diagnostics for hierarchical linear models in R. 
Journal of Statistical Software, 56, 1-28. 
MADDEN, V., CATLEY, M. J., BELLAN, V., RUSSEK, L. N., CAMFFERMANN, D. & MOSELEY, G. L. 2016. 
The FESTNRS- a new numerical rating scale to assess non-painful and painful experiences in 
humans [Poster]. Unpublished. 
MADDEN, V., KAMERMAN PR, BELLAN V, CATLEY MJ, RUSSEK LN, CAMFFERMAN D & GL., M. 2019a. 
Was That Painful or Nonpainful? The Sensation and Pain Rating Scale Performs Well in the 
Experimental Context. The Journal of Pain (in press). 
MADDEN, V., KAMERMAN PR, CATLEY MJ, BELLAN V, RUSSEK LN, CAMFFERMAN D & L., M. 2019b. 
Rethinking pain threshold as a zone of uncertainty. bioRxiv, 521302. 
MADDEN, V. J. & MOSELEY, G. L. 2016. Do clinicians think that pain can be a classically conditioned 
response to a non-noxious stimulus? Manual therapy, 22, 165-173. 
NICKEL, F. T., SEIFERT, F., LANZ, S. & MAIHOFNER, C. 2012. Mechanisms of neuropathic pain. Eur 
Neuropsychopharmacol, 22, 81-91. 
ROLKE, R., BARON, R., MAIER, C., TÖLLE, T. R., TREEDE, R. D., BEYER, A., BINDER, A., BIRBAUMER, N., 
BIRKLEIN, F., BÖTEFÜR, I. C., BRAUNE, S., FLOR, H., HUGE, V., KLUG, R., LANDWEHRMEYER, 
G. B., MAGERL, W., MAIHÖFNER, C., ROLKO, C., SCHAUB, C., SCHERENS, A., SPRENGER, T., 
VALET, M. & WASSERKA, B. 2006. Quantitative sensory testing in the German Research 
Network on Neuropathic Pain (DFNS): Standardized protocol and reference values. PAIN, 
123, 231-243. 
ROSS, J. R. & MATAVA, M. J. 2011. Tattoo-Induced Skin “Burn” During Magnetic Resonance Imaging 
in a Professional Football Player:A Case Report. Sports Health, 3, 431-434. 
SANDKUHLER, J. & GRUBER-SCHOFFNEGGER, D. 2012. Hyperalgesia by synaptic long-term 
potentiation (LTP): an update. Curr Opin Pharmacol, 12, 18-27. 
SPRUYT, A., CLARYSSE, J., VANSTEENWEGEN, D., BAEYENS, F., & HERMANS, D. 2010. Affect 4.0: A 
free software package for implementing psychological and psychophysiological experiments. 
Experimental Psychology 57, 36 - 45. 
SULLIVAN, M. J. L., LYNCH, M. E. & CLARK, A. J. 2005. Dimensions of catastrophic thinking associated 
with pain experience and disability in patients with neuropathic pain conditions. Pain, 113, 
310-315. 
VAN DEN BROEKE, E., GEENE, N., VAN RIJN, C., WILDER-SMITH, O. & OOSTERMAN, J. 2014. Negative 
expectations facilitate mechanical hyperalgesia after high-frequency electrical stimulation of 
human skin. European journal of pain, 18, 86-91. 
VAN WILGEN, C. P. & KEIZER, D. 2012. The sensitization model to explain how chronic pain exists 
without tissue damage. Pain Management Nursing, 13, 60-65. 
WIECH, K., LIN, C. S., BRODERSEN, K. H., BINGEL, U., PLONER, M. & TRACEY, I. 2010. Anterior insula 
integrates information about salience into perceptual decisions about pain. J Neurosci, 30, 
16324-31. 
WOOLF, C. J. & MANNION, R. J. 1999. Neuropathic pain: aetiology, symptoms, mechanisms, and 
management. The Lancet, 353, 1959-1964. 
YOU, D. S., CREECH, S. K. & MEAGHER, M. W. 2016. Enhanced Area of Secondary Hyperalgesia in 
Women with Multiple Stressful Life Events: A Pilot Study. Pain Medicine, 17, 1859-1864. 
234 
 
YOU, D. S., CREECH, S. K., VICHAYA, E. G., YOUNG, E. E., SMITH, J. S. & MEAGHER, M. W. 2014. Effect 
of written emotional disclosure on secondary hyperalgesia in women with trauma history. 




Appendix 30: Formal data analysis 
Formal data analysis 
The effect of stimulus threat on experimentally induced secondary 
hyperalgesia 
Tory Madden and Gillian Bedwell 
29 Mar 2020 
Table of Contents 
DEMOGRAPHIC DATA .................................................................................................................................... 236 
MANIPULATION CHECK .................................................................................................................................. 236 
PRIMARY OUTCOME ...................................................................................................................................... 236 
SECONDARY OUTCOME ................................................................................................................................. 236 
EXPLORATORY OUTCOMES ............................................................................................................................ 236 
SENSORY MEASUREMENTS................................................................................................................................. 236 
QUESTIONNAIRES ............................................................................................................................................ 236 
POST-HOC ANALYSIS ........................................................................................................................................ 236 
DEMOGRAPHIC INFORMATION ..................................................................................................................... 237 
PRIMARY OUTCOME: INTENSITY OF SECONDARY HYPERALGESIA ................................................................. 237 
SH: ASSSESSMENT OF MODEL FIT .................................................................................................................. 254 
SECONDARY OUTCOME: SURFACE AREA OF SECONDARY HYPERALGESIA..................................................... 257 
SA: ASSSESSMENT OF MODEL FIT .................................................................................................................. 261 
MANIPULATION CHECKS ................................................................................................................................ 237 
HFS RATINGS ................................................................................................................................................. 237 
ANXIETY RATINGS ............................................................................................................................................ 241 
THREAT RATINGS ............................................................................................................................................. 243 
EXPLORATORY OUTCOMES: ........................................................................................................................... 264 
SENSORY OUTCOMES ....................................................................................................................................... 264 
CHILDHOOD AND RECENT TRAUMA SCORES............................................................................................................ 277 






• To determine the median (range) age in years 
• To determine the number of male and female participants 
• To determine the mean (SD) intensity used from the HFS induction 
Manipulation check 
• Describe and compare HFS ratings between arms. 
• Describe and compare participant anxiety self-ratings between arms. 
• Describe and compare participant threat self-ratings between arms. 
• Assess whether blinding of Researcher 2 (who conducted the experiment and sensory 
testing) was upheld 
Primary outcome 
To determine the intensity of secondary hyperalgesia (SH) on each arm, and compare 
between arms. 
Secondary outcome 
To determine the surface area (SA) of secondary hyperalgesia (SH) on each arm, and 
compare between arms. 
Exploratory outcomes 
Sensory measurements 
• To determine the intensity of static light touch on each arm, and compare between 
arms. 
• To determine the intensity of dynamic light touch on each arm, and compare between 
arms. 
• To determine the intensity of e-stim on each arm, and compare between arms. 
Questionnaires 
• Describe the Childhood Trauma Questionnaire (CTQ) and recent trauma scores (CIDI). 
• Explore for relationship with area of SH (with results from both arms pooled). 
Post-hoc analysis 
• To determine the mean (range) of the Pain Catastrophising Scale 
• To determine the mean (range) of the 10-item Connor-Davidson Resilience Scale. 
Note: These analyses were not initially planned nor described in this study’s protocol. These 
analyses were performed for exploratory purposes to inform the development of future 
research questions. 






demo_info <- read_delim("C:/Users/Gill/Desktop/Formal data analysis Jan 2020/Gill_formal_da
ta_HFS_ST_080120/Demographic_info.csv",  
    ";", escape_double = FALSE, trim_ws = TRUE) 
 
# Median age and range. 
demo_info$Age 
##  [1] 51 19 19 26 21 22 21 21 20 36 21 21 23 55 26 23 20 24 30 23 21 19 19 
## [24] 21 18 29 
median(demo_info$Age, na.rm = FALSE) 
## [1] 21 
range(demo_info$Age, na.rm = FALSE) 
## [1] 18 55 
# Sex 
demo_info$Sex <- (as.factor(demo_info$Sex))# First change sex to be a character 
 
freq_sex <- table(demo_info$Sex) 
view(freq_sex) 
 
# Average detection threshold on each arm across all participants. 
mean(demo_info$Detection_threshold_R)# mean detection threshold on the right arm was 1.53 
## [1] 1.534231 
mean(demo_info$Detection_threshold_L)# mean detection threshold on the left was 1.56 
## [1] 1.557692 
# Average detection threshold across both arms across all participants.  
mean(demo_info$Intensity_used, trim = 0, na.rm = TRUE)# Overall mean detection threshold wa
s 1.53 
## [1] 1.596154 
#Standard deviation of individual detection threshold  
sd(demo_info$Intensity_used, na.rm = TRUE) 
## [1] 0.6352831 
Manipulation checks 
HFS ratings 
A mixed model analysis was used to compare ratings of the HFS trains between conditions. 
The order in which the two arms were stimulated was kept consistent across participants 
(right forearm first), but the allocation of forearm to condition was counterbalanced 
(random allocation to one of two equally sized groups). Therefore, the ‘group’ and ‘site’ 
information have been used to code for a ‘condition’ variable that is specified as A or B to 
maintain blinding of the analyst to actual experimental conditions. Here, we test for a main 
effect of condition on ratings, whilst allowing for a random intercept for each participant. 
hfs <- master_data %>% 
  filter(phase == 'hfs') %>% 




hfs$rating <- as.numeric(hfs$rating) 
 
hfs %<>% group_by(id, condition) %>% 
  mutate(train = row_number()) %>% 
  ungroup() 
 
hfs_wide <- hfs %>% 
  group_by(id) %>% 
  spread(key = condition, 
         value = rating) 
 
#Determining the mean (SD) per condition  
 
mean(hfs_wide$A) 
## [1] 38.76538 
sd(hfs_wide$A) 
## [1] 11.34453 
mean(hfs_wide$B) 
## [1] 39.07231 
sd(hfs_wide$B) 
## [1] 11.31391 
ggplot(data = hfs) + 
  aes(x = train, 
      y = rating, 
      group = id, 
      colour = id) + 
  geom_point() + 
  facet_grid(~ condition) + 
  geom_line() + 
  guides(colour = guide_legend("ID"), size = guide_legend("ID")) + 
  labs( y = 'Ratings', 
        x = 'train', 




#unblinding to make graph clear  
hfs$condition[hfs$condition == 'A'] <- 'Threaten site' 
 
hfs$condition[hfs$condition == 'B'] <- 'Control site' 
 
 
ggplot(data = hfs) + 
  aes(x = train, 
      y = rating, 
      group = condition, 
      colour = condition) + 
  geom_point() + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs( y = 'SPARS ratings', 
        x = 'Train', 





## [1]  5 50 
# Null model 
hfs_null <- lmer(rating ~ 1 + (1|id), 
              data = hfs) 
hfs_condition <- lmer(rating ~ condition + (1|id),  
              data = hfs) 
anova(hfs_condition, hfs_null) # hfs_condition is no better than null 
## Data: hfs 
## Models: 
## hfs_null: rating ~ 1 + (1 | id) 
## hfs_condition: rating ~ condition + (1 | id) 
##               Df    AIC    BIC  logLik deviance  Chisq Chi Df Pr(>Chisq) 
## hfs_null       3 1710.2 1720.9 -852.11   1704.2                          
## hfs_condition  4 1712.0 1726.3 -852.01   1704.0 0.2126      1     0.6447 
# Conclude: HFS ratings were not predicted by condition. 
 
summary(hfs_condition)   
## Linear mixed model fit by REML ['lmerMod'] 
## Formula: rating ~ condition + (1 | id) 
##    Data: hfs 
##  
## REML criterion at convergence: 1699.8 
##  
## Scaled residuals:  
##     Min      1Q  Median      3Q     Max  
## -3.3241 -0.4205  0.1031  0.5164  2.3287  
##  
## Random effects: 
##  Groups   Name        Variance Std.Dev. 
##  id       (Intercept) 102.63   10.131   
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##  Residual              28.91    5.376   
## Number of obs: 260, groups:  id, 26 
##  
## Fixed effects: 
##                        Estimate Std. Error t value 
## (Intercept)             39.0723     2.0420   19.14 
## conditionThreaten site  -0.3069     0.6669   -0.46 
##  
## Correlation of Fixed Effects: 
##             (Intr) 
## cndtnThrtns -0.163 
Anxiety ratings 
We are interested in a main effect of condition on anxiety ratings. 
anxiety <- master_data %>% select(group, 
                                  id, 
                                  anxious_right, 
                                  anxious_left) 
anxiety <- unique(anxiety) 
 
anxiety %<>% 
  gather(key = arm, 
         value = anxiety, 
         3:4) %>% 
  mutate(arm = case_when( 
    arm == 'anxious_left' ~ 'left', 
    arm == 'anxious_right' ~ 'right' 
  )) 
 
 
anxiety %<>% mutate(condition = case_when( 
  group == '1' & arm == 'right' ~ 'A', 
  group == '1' & arm == 'left' ~ 'B', 
  group == '2' & arm == 'right' ~ 'B', 
  group == '2' & arm == 'left' ~ 'A')) %>% 
  select(-group) 
 
 
anxiety_wide <- anxiety %>% 
  group_by(id) %>% 
  spread(key = condition, 
         value = anxiety) %>% 
  select(-arm) 
 
#Determining the mean (SD) anxiety rating per condition  
mean(anxiety_wide$A, na.rm = TRUE) 
## [1] 3.307692 
sd(anxiety_wide$A, na.rm = TRUE) 
## [1] 1.123182 
mean(anxiety_wide$B, na.rm = TRUE) 
## [1] 3.423077 
sd(anxiety_wide$B, na.rm = TRUE) 
## [1] 1.137474 
var(anxiety_wide$B, na.rm = TRUE) 
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## [1] 1.293846 
#unblinding  
anxiety$condition[anxiety$condition == 'A'] <- 'Threaten site' 
 
anxiety$condition[anxiety$condition == 'B'] <- 'Control site' 
 
 
ggplot(data = anxiety) + 
  aes(x = arm, 
      y = anxiety, 
      group = interaction(arm,condition), 
      colour = condition) + 
  geom_boxplot() + 
  labs(title = 'The effect of condition on anxiety rating n = 26', 
       y = 'Anxiety rating', 
       x = 'Arm') 
 
a1 <- ggplot(data = anxiety) + 
  aes(x = arm, 
      y = anxiety, 
      group = condition, 
      colour = condition) + 
  geom_point() + 
  facet_grid(~ id)+ 
  labs(title = 'Individual effect of condition on anxiety rating', 
       y = 'Anxiety ratings', 
       x = 'Arm') 
 
 
anxiety_null <- lmer(anxiety ~ 1 + (1|id), 
                     data = anxiety) 
anxiety_condition <- lmer(anxiety ~ condition + (1|id), 
                     data = anxiety) 
anova(anxiety_condition, anxiety_null) # No effect of condition. 
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## Data: anxiety 
## Models: 
## anxiety_null: anxiety ~ 1 + (1 | id) 
## anxiety_condition: anxiety ~ condition + (1 | id) 
##                   Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## anxiety_null       3 129.51 135.37 -61.758   123.52               
## anxiety_condition  4 130.50 138.30 -61.248   122.50 1.0197      1 
##                   Pr(>Chisq) 
## anxiety_null                 
## anxiety_condition     0.3126 
Threat ratings 
We are interested in a main effect of condition on threat ratings. 
threat <- master_data %>% select(group, 
                                  id, 
                                  damage_right, 
                                  damage_left) 
 
threat <- unique(threat) 
 
threat %<>% 
  gather(key = arm, 
         value = threat, 
         3:4) %>% 
  mutate(arm = case_when( 
    arm == 'damage_left' ~ 'left', 
    arm == 'damage_right' ~ 'right' 
  )) 
 
threat %<>% mutate(condition = case_when( 
  group == '1' & arm == 'right' ~ 'A', 
  group == '1' & arm == 'left' ~ 'B', 
  group == '2' & arm == 'right' ~ 'B', 
  group == '2' & arm == 'left' ~ 'A')) %>% 
  select(-group) 
 
threat_wide <- threat %>% 
  group_by(id) %>% 
  spread(key = condition, 
         value = threat) %>% 
  select(-arm) 
 
#Determining the mean (SD) threat rating per condition  
mean(threat_wide$A, na.rm = TRUE) 
## [1] 2.807692 
sd(threat_wide$A, na.rm = TRUE) 
## [1] 1.296741 
mean(threat_wide$B, na.rm = TRUE) 
## [1] 2.5 
sd(threat_wide$B, na.rm = TRUE) 
## [1] 1.140175 
#unbliunding  
threat$condition[threat$condition == 'A'] <- 'Threaten site' 
 





ggplot(data = threat) + 
  aes(x = arm, 
      y = threat, 
      group = interaction(arm,condition), 
      colour = condition) + 
  geom_boxplot() + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'The effect of condition on fear of tissue damage rating n = 26', 
       y = 'Fear of tissue damage ratings', 
       x = 'Arm') 
 
ggplot(data = threat) + 
  aes(x = arm, 
      y = threat, 
      group = condition, 
      colour = condition) + 
  geom_point() + 
  facet_grid(~ id) + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'The individual effect of condition on ar of tissue damage rating', 
       y = 'ar of tissue damage ratings', 




threat_null <- lmer(threat ~ 1 + (1|id), 
                     data = threat) 
threat_condition <- lmer(threat ~ condition + (1|id), 
                     data = threat) 
anova(threat_condition, threat_null) # No effect of condition. 
## Data: threat 
## Models: 
## threat_null: threat ~ 1 + (1 | id) 
## threat_condition: threat ~ condition + (1 | id) 
##                  Df    AIC    BIC  logLik deviance Chisq Chi Df Pr(>Chisq) 
## threat_null       3 158.46 164.32 -76.232   152.46                         
## threat_condition  4 157.88 165.68 -74.939   149.88 2.586      1     0.1078 
Blinding assessment 
# Importing data 
 
library(readr) 
RA_blinding <- read_delim("C:/Users/Gill/Desktop/RA_blinding_ax.cvs.csv",  
    ";", escape_double = FALSE, trim_ws = TRUE) 
 
# Renaming column  
 
names(RA_blinding)[names(RA_blinding) == 'Which are do you think received the HFS under a c
ondition of threat?'] <- 'threat_arm_RA' 
 
freq <- table(RA_blinding$threat_arm_RA) 
 
 
barplot(freq, main = "Frequency of research assistant's belief of which arm received the HF
S under a condition of threat", xlab = "Arm receiving the HFS under a condition of threat", 




# compare RA's results to actual group allocation  
 
actual_condition <- master_data %>% 
  select(id, 
         Group_allocation) 
 
actual_condition <- unique(actual_condition) 
 
names(actual_condition)[names(actual_condition) == 'Group_allocation'] <- 'threat_arm_actua
l' 
 
# rename "group 1" to "right" and "group 2" to "left" 
 
actual_condition %<>% mutate(threat_arm_actual = case_when( 
  threat_arm_actual == '1' ~ 'Right', 
  threat_arm_actual == '2' ~ 'Left')) 
 
comparison <- merge(x = actual_condition, y = RA_blinding, by.x = 'id' , by.y = 'id' , all 
= TRUE) 
 
# Now add a new column to comparison to see whether RA was correct or not. When threat_arm_
actual and threat_arm_RA are the same then outcome is "correct". When different, outcome is 
"incorrect" 
 
comparison %<>% mutate(accuracy = if_else(threat_arm_actual == threat_arm_RA, 'Correct','In
correct'))  
 
#Determine the percentage of correct responses and 95% CI  
 








## [1] 42.30769 
# Determine Cohen kappa's coefficient  
 
blinding_ax_table <- table(comparison$threat_arm_actual, 
                               comparison$threat_arm_RA) 
blinding_ax_table 
##         
##         Left Right 
##   Left     7     6 
##   Right    9     4 
p0 <- (7 + 9 )/26  
pa <- (13/26)*(16/26)  
pb <- (13/26)*(10/26) 
pe <- pa + pb 
 
  kappa <- (p0 - pe) / (1 - pe)  #Kappa is 0.23 
 
# Plot degree of correctness 
 
ggplot(data = comparison) + 
  aes(x = accuracy, 
      y = Confidence_level, 
      confidence_level, ymax = 5, ymin = 0) +  
geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  labs(title = 'Confidence over correctness N = 26', 
       y = 'Confidence level', 
       x = 'Correctness') 
 
# Could the RA reliably predict condition? No from this plot the RA made confident assertio
ns that were incorrect. Meaning they were effectively blinded. 
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Primary outcome: intensity of secondary hyperalgesia 
Aim: to determine the intensity of secondary hyperalgesia (SH) on each arm, and the 
comparison between arms. 
Data were from the baseline time points as well as follow-up time points, and for both arms 
(control and experimental sites). The main interest was the change in ratings (from baseline 
to follow-up time points), and how these differed between the arms/conditions. Therefore, 
for the formal analysis, researchers: 1) calculated the mean rating for all baseline time 
points; 2) calculated the mean rating for all follow-up time points; 3) subtracted the mean 
baseline rating from the mean follow-up rating (within participant and condition), to provide 
the indication of change in rating (i.e. hyperalgesia) for each condition, within each 
participant. 
intensity <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
filter(modality == '128' | modality == '256') %>% 
filter(phase != 'orientation') %>% 
mutate(time = if_else(phase == 'baseline', time*-1L, time)) 
 
intensity %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site) 
 
intensity$rating <- as.numeric(intensity$rating) 
intensity %<>% group_by(id, 
           time, 
           phase, 
           condition) %>% 
  summarise(pp_rating = mean(rating))  
 
 
int_bl <- intensity %>% filter(phase == 'baseline') %>% 
  group_by(id, condition) %>% 
  summarise(rating = mean(pp_rating)) %>% 
  ungroup() %>% 
  mutate(time = 0) %>% ungroup() 
 
int_fu <- intensity %>% filter(phase != 'baseline') %>% ungroup () %>% 
  select(-phase) %>% 
  rename(rating = pp_rating) 
 
intensity1 <- rbind(int_bl, int_fu) 
 
# For interest, plot the actual data 
 
ggplot(data = intensity1) + 
  aes(x =time, 
      y = rating, 
      group = condition, 
      colour = condition) + 
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  facet_wrap(~ id) + 
  geom_point() + 
  geom_line() + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Individual intensity of secondary hyperalgesia, over time', 
       y = 'Rating', 
       x = 'Time (minutes)') 
 
# Plot group mean ratings by condition over time 
 
mean_intensity <- intensity1 %>% 
  group_by(condition, time) %>% 
  summarise(mean_rating = mean(rating, na.rm=TRUE)) 
 
# Plot group intensity of secondary hyperalgesia by condition, over time 
 
intensity_groupmean <- intensity %>% 
  ungroup() %>% 
  select(-phase) %>% 
  group_by(time, condition) %>% 
  summarise(rating = mean(pp_rating)) %>% 
  ungroup() 
 
intensity_groupmean$time <- as.factor(intensity_groupmean$time) 
 
#Unblinding condition for graphs  
intensity_groupmean$condition[intensity_groupmean$condition == 'A'] <- 'Threaten site' 
 
intensity_groupmean$condition[intensity_groupmean$condition == 'B'] <- 'Control site' 
 
ggplot(data = intensity_groupmean) + 
    aes(x = time, 
      y = rating, 
      group = condition, 
      colour = condition, 
      xmax = '60') + 
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  geom_point() + 
  geom_vline(xintercept = 3.1, colour = 'red') + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition"), 
  shape = guide_legend("Condition")) + 
  labs(title = 'Mean intensity of secondary hyperalgesia grouped by condition, over time n 
= 26', 
       y = 'SPARS rating', 
       x = 'Time (minutes)') 
 
# All participants, group data represented by boxplots 
 
#Unblinding condition for graphs  
intensity1$condition[intensity1$condition == 'A'] <- 'Threaten site' 
 
intensity1$condition[intensity1$condition == 'B'] <- 'Control site' 
 
ggplot(data = intensity1) + 
  aes(x = time, 
      y = rating, 
      group = interaction(condition, time), 
      colour = condition) + 
  geom_boxplot(width = 3) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) +  
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'Intensity of secondary hyperalgesia, over time, grouped by condition n = 26
', 
       y = 'SPARS rating', 




 # Calculate difference between conditions for group boxplots 
 
intensity_wide <- intensity %>%  
  group_by(id, 
           time) %>% 
  spread(key = condition, 
         value = pp_rating) %>% 
  mutate(site_diff = A-B) 
 
# All participants, group data represented by boxplots 
ggplot(data = intensity_wide) + 
  aes(x = time, 
      y = site_diff, 
      group = time) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) + 
  labs(title = 'The between condition difference in secondary hyperalgesia, over time n = 2
6', 
       y = 'Pinprick ratings of condition A minus rating of condition B', 




# Collapse all post-baseline ratings for each condition and then compare them using a RM AN
OVA type model. Time is nested within (and fully crossed with) ID. 
 
int_bl %<>% select(-time) 
names(int_bl)[names(int_bl) == 'rating'] <- 'baseline_rating' 
collapse <- int_fu %>% # resolve each rating relative to baseline 
  right_join(int_bl) %>% 
  mutate(rating_controlled = rating-baseline_rating) %>% 
  select(id, 
         time, 
         condition, 
         rating_controlled) # spread to calculate difference between conditions 
   
# We want to find out whether rating_controlled (for baseline) is predicted by condition. 
 
model_null <- lmer(rating_controlled ~ (1|id), 
                   data = collapse) 
model_condition <- lmer(rating_controlled ~ condition + (1|id), 
                       data = collapse) 
 
anova(model_condition, model_null) # No improvement 
## Data: collapse 
## Models: 
## model_null: rating_controlled ~ (1 | id) 
## model_condition: rating_controlled ~ condition + (1 | id) 
##                 Df    AIC    BIC  logLik deviance  Chisq Chi Df Pr(>Chisq) 
## model_null       3 2492.6 2504.3 -1243.3   2486.6                          
## model_condition  4 2494.5 2510.1 -1243.2   2486.5 0.1168      1     0.7326 
model_pre_condition_crossed <- lmer(rating_controlled ~ condition + (1|id/time), 
                                    data = collapse) 
summary(model_pre_condition_crossed) 
## Linear mixed model fit by REML ['lmerMod'] 
## Formula: rating_controlled ~ condition + (1 | id/time) 
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##    Data: collapse 
##  
## REML criterion at convergence: 2480.7 
##  
## Scaled residuals:  
##     Min      1Q  Median      3Q     Max  
## -3.6524 -0.3753  0.0285  0.4071  3.0526  
##  
## Random effects: 
##  Groups   Name        Variance Std.Dev. 
##  time:id  (Intercept)   3.567   1.889   
##  id       (Intercept) 134.624  11.603   
##  Residual              38.141   6.176   
## Number of obs: 364, groups:  time:id, 182; id, 26 
##  
## Fixed effects: 
##             Estimate Std. Error t value 
## (Intercept)   7.5119     2.3253   3.231 
## conditionB    0.2303     0.6474   0.356 
##  
## Correlation of Fixed Effects: 
##            (Intr) 
## conditionB -0.139 
anova(model_pre_condition_crossed, model_null) 
## Data: collapse 
## Models: 
## model_null: rating_controlled ~ (1 | id) 
## model_pre_condition_crossed: rating_controlled ~ condition + (1 | id/time) 
##                             Df    AIC    BIC  logLik deviance  Chisq 
## model_null                   3 2492.6 2504.3 -1243.3   2486.6        
## model_pre_condition_crossed  5 2495.2 2514.7 -1242.6   2485.2 1.4364 
##                             Chi Df Pr(>Chisq) 
## model_null                                    
## model_pre_condition_crossed      2     0.4876 
# not a significant improvement 
 
# Secondary hyperalgesia intensity is not predicted by condition. 
 
 
# Assessing whether the individual calibration approach confounded the results (intensity o
f SH) 
 
max_intensity <- intensity %>% 
  group_by(id, condition) %>% 
  summarise(max_rating = max(pp_rating, na.rm=TRUE)) 
 
max_vs_used <-merge(x=max_intensity, y=demo_info[,c(1,10)], by.x = 'id' , by.y = 'id' , all
.x = TRUE) 
 
 
# First check distributional assumptions for correlation. 
# Shapiro-Wilk normality  
with(max_vs_used, shapiro.test(Intensity_used)) # P = 0.011 
##  
##  Shapiro-Wilk normality test 
##  
## data:  Intensity_used 
## W = 0.93955, p-value = 0.01074 
correlation <- cor.test(max_vs_used$max_rating, max_vs_used$Intensity_used, method = "spear
man") 




##  Spearman's rank correlation rho 
##  
## data:  max_vs_used$max_rating and max_vs_used$Intensity_used 
## S = 22496, p-value = 0.7799 
## alternative hypothesis: true rho is not equal to 0 
## sample estimates: 
##        rho  
## 0.03970626 
SH: Assessment of model fit 
# The model is called model_pre_condition_crossed and has the structure: rating_controlled 
~ condition + (1|id/time) 
 
# Assumption 1: linearity 




## Interpretation: increased density in a blob on the left, but no obvious linear or curvil
inear pattern. We deemed the assumption to have been upheld. 
 
# Assumption 2: absence of collinearity 
# Check for correlation between time and condition 
 
ggplot(data = collapse) + 
  aes(x = condition, 
      y = time) + 
  geom_jitter() + 
  geom_smooth() + 
  labs(title = 'Correlation between time and condition', 
       x = 'Condition', 




# Interpretation: no collinearity. Assumption was deemed to have been upheld. 
 





# Interpretation: increased density in a blob on the left (i.e. more data points here), but 
the range of maximum and minimum values seems consistent across the x-axis. Assumption was 
deemed to have been upheld. 
 
# Assumption 4: Normally distributed residuals 







# Interpretation: Q-Q plot shows extremely minor deviation from the diagonal reference line
. Histogram shows acceptable distribution. Assumption was deemed to have been upheld. 
Secondary outcome: surface area of secondary hyperalgesia 
We are interested in determining the surface area of secondary hyperalgesia on each arm, 
and the comparison between arms. 
SA <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
  filter(phase == 'test_sa') 
 
 
SA %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site, 
         -phase) 
 
# replace ND with 0 
 
SA$rating[SA$rating == 'ND'] <- 0 
names(SA)[names(SA) == 'rating'] <- 'point1' 




SA %<>% group_by(id, time) %>% 
  mutate(point2 = case_when(radial_line == 'A' ~ lead(point1, 5), 
                            radial_line == 'B' ~ lag(point1, 2), 
                            radial_line == 'C' ~ lag(point1, 2), 
                            radial_line == 'D' ~ lag(point1, 2), 
                            radial_line == 'E' ~ lead(point1, 7), 
                            radial_line == 'F' ~ lag(point1, 2), 
                            radial_line == 'G' ~ lag(point1, 2), 
                            radial_line == 'H' ~ lag(point1, 2))) %>% 
  ungroup() 
 
SA$point1 <- as.numeric(SA$point1) 
SA$point2 <- as.numeric(SA$point2) 
# Now calculate surface area for each triangle 
library(REdaS) 
sinangle <- sin((deg2rad(45))) 
 
sinangle 
## [1] 0.7071068 
SA %<>% mutate(triangle = (point1*point2*sinangle)/2) 
 
# Now calculate SA for each id, site and time 
 
SA %<>% select(-radial_line, 
                      -point1, 
                      -point2) 
 
SA %<>% group_by(id, 
                 time, 
                 condition) %>% 
  summarise(SA = sum(triangle)) %>% 
  ungroup()  
 
SA_plot <- ggplot(data = SA) + 
  aes(x = as.factor(time), 
      y = SA, 
      colour = condition, 
      group = condition) + 
  geom_point() + 
  geom_line(aes(colour = condition)) + 
  facet_wrap(~ id, 
             nrow = 2) + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(x = 'Time (minutes)', 
       y = 'Surface area (cm2)', 





#Unblinding condition for graphs  
SA$condition[SA$condition == 'A'] <- 'Threaten site' 
 
SA$condition[SA$condition == 'B'] <- 'Control site' 
 
 
# All participants, group data represented by boxplots 
ggplot(data = SA) + 
  aes(x = time, 
      y = SA, 
      group = interaction(time,condition), 
      colour = condition) + 
  geom_boxplot(width = 4) + 
  scale_x_continuous(breaks = seq(20,60,20)) +  
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'Grouped area of secondary hyperalgesia, over time n = 26', 
       y = 'Surface area of secondary hyperalgesia by condition (cm2)', 




# We are interested in a main effect of condition on area of secondary hyperalgesia  
 
model_null_sa <- lmer(SA ~ (1|id), 
                   data = SA) 
model_condition_sa <- lmer(SA ~ condition + (1|id), 
                       data = SA) 
anova(model_condition_sa, model_null_sa) # Condition does not predict area of secondary hyp
eralgesia  
## Data: SA 
## Models: 
## model_null_sa: SA ~ (1 | id) 
## model_condition_sa: SA ~ condition + (1 | id) 
##                    Df    AIC    BIC  logLik deviance Chisq Chi Df 
## model_null_sa       3 1107.4 1116.2 -550.70   1101.4              
## model_condition_sa  4 1108.1 1119.9 -550.07   1100.1  1.27      1 
##                    Pr(>Chisq) 
## model_null_sa                 
## model_condition_sa     0.2598 
model_pre_condition_crossed_sa <- lmer(SA ~ condition + (1|id/time), 
                                    data = SA) 
 
anova(model_pre_condition_crossed_sa, model_condition_sa) 
## Data: SA 
## Models: 
## model_condition_sa: SA ~ condition + (1 | id) 
## model_pre_condition_crossed_sa: SA ~ condition + (1 | id/time) 
##                                Df    AIC    BIC  logLik deviance  Chisq 
## model_condition_sa              4 1108.1 1119.9 -550.07   1100.1        
## model_pre_condition_crossed_sa  5 1108.2 1122.9 -549.09   1098.2 1.9442 
##                                Chi Df Pr(>Chisq) 
## model_condition_sa                               
## model_pre_condition_crossed_sa      1     0.1632 
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# not a significant improvement 
 
# Secondary hyperalgesia surface area is not predicted by condition. 
SA: Assessment of model fit 
# The model is called model_pre_condition_crossed_sa and has the structure: SA ~ condition 
+ (1|id/time) 
 
# Assumption 1: linearity 




# Interpretation: No obvious linear or curvilinear pattern. Assumption was deemed to have b
een upheld. 
 
# Assumption 2: absence of collinearity 
# Check for correlation between time and condition 
 
ggplot(data = SA) + 
  aes(x = condition, 
      y = time) + 
  geom_jitter() + 
  geom_smooth() + 
labs(title = 'Correlation between time and condition', 
       x = 'Condition', 




# Interpretation: no collinearity. Assumption was deemed to have been upheld. 
 





## Interpretation: slightly increased density in a blob in the middle (i.e. more data point
s here). The range of max and min values seems slightly lower on the left than on the right
. 
 
# Assumption 4: Normally distributed residuals 







# Interpretation: Q-Q plot and histogram show normal distribution. Assumption was deemed to 
have been upheld. 
Exploratory outcomes: 
Sensory outcomes 
We are interested in:  
• Determining the intensity of static light touch on each arm, and the comparison 
between arms.  
• Determining the intensity of dynamic light touch on each arm, and the comparison 
between arms.  




## Static light touch 
 
slt <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
  filter(modality == 'VFF') %>% 
  filter(phase != 'orientation') %>% 
  mutate(time = if_else(phase == 'baseline', time*-1L, time)) 
 
slt %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site) 
slt$rating <- as.numeric(slt$rating) 
 
slt_bl <- slt %>% filter(phase == 'baseline') %>% 
  group_by(id, condition) %>% 
  summarise(rating = mean(rating)) %>% 
  ungroup() %>% 
  mutate(time = 0) %>% ungroup() 
 
slt_fu <- slt %>% filter(phase != 'baseline') %>% ungroup () %>% 
  select(-phase, 
         -modality) 
 
slt <- rbind(slt_bl, slt_fu) 
 
slt_wide <- slt %>% 
  group_by(id) %>% 
  spread(key = condition, 
         value = rating)  
 
#Determining the mean (SD) anxiety rating per condition  
mean(slt_wide$A, na.rm = TRUE) 
## [1] -29.26619 
sd(slt_wide$A, na.rm = TRUE) 
## [1] 20.4084 
mean(slt_wide$B, na.rm = TRUE) 
## [1] -29.58072 
sd(slt_wide$B, na.rm = TRUE) 
## [1] 20.78741 
# For interest, plot the pilot data 
 
ggplot(data = slt) + 
  aes(x = time, 
      y = rating, 
      group = condition, 
      colour = condition) + 
  facet_wrap(~ id) + 
  geom_point() + 
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  geom_line() + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'Individual static light touch ratings by condition, over time', 
       y = 'Rating', 
       x = 'Time (minutes)') 
 
# All participants, group data represented by boxplots 
ggplot(data = slt) + 
  aes(x = time, 
      y = rating, 
      group = interaction(condition, time), 
      colour = condition) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'Group data: static light touch ratings by condition, over time N = 26', 
       y = 'SPARS rating', 




 # Calculate diff between conditions for group boxplots 
 
slt_wide <- slt %>%  
  group_by(id, 
           time) %>% 
  spread(key = condition, 
         value = rating) %>% 
  mutate(site_diff = A-B) 
 
# All participants, group data represented by boxplots 
ggplot(data = slt_wide) + 
  aes(x = time, 
      y = site_diff, 
      group = time) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Grouped data: static light touch ratings difference between conditions N = 
26', 
       y = 'Static light touch ratings of condition A minus rating of condition B', 




# Collapse all post-baseline ratings for each condition and then compare them using a RM AN
OVA type model. Time is nested within (and fully crossed with) ID. 
 
slt_bl %<>% select(-time) 
names(slt_bl)[names(slt_bl) == 'rating'] <- 'baseline_rating' 
collapse_slt <- slt_fu %>% # resolve each rating relative to baseline 
  right_join(slt_bl) %>% 
  mutate(rating_controlled = rating-baseline_rating) %>% 
  select(id, 
         time, 
         condition, 
         rating_controlled) # spread to calculate difference between conditions 
   
# We want to find out whether rating_controlled (for baseline) is predicted by condition. 
 
model_null_slt <- lmer(rating_controlled ~ (1|id), 
                   data = collapse_slt) 
model_condition_slt <- lmer(rating_controlled ~ condition + (1|id), 
                       data = collapse_slt) 
anova(model_condition_slt, model_null_slt) # No improvement 
## Data: collapse_slt 
## Models: 
## model_null_slt: rating_controlled ~ (1 | id) 
## model_condition_slt: rating_controlled ~ condition + (1 | id) 
##                     Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## model_null_slt       3 3013.4 3025.1 -1503.7   3007.4               
## model_condition_slt  4 3014.5 3030.1 -1503.3   3006.5 0.8949      1 
##                     Pr(>Chisq) 
## model_null_slt                 
## model_condition_slt     0.3442 
model_pre_condition_crossed_slt <- lmer(rating_controlled ~ condition + (1|id/time), 





## Data: collapse_slt 
## Models: 
## model_null_slt: rating_controlled ~ (1 | id) 
## model_pre_condition_crossed_slt: rating_controlled ~ condition + (1 | id/time) 
##                                 Df    AIC    BIC  logLik deviance  Chisq 
## model_null_slt                   3 3013.4 3025.1 -1503.7   3007.4        
## model_pre_condition_crossed_slt  5 2997.1 3016.6 -1493.6   2987.1 20.307 
##                                 Chi Df Pr(>Chisq)     
## model_null_slt                                        
## model_pre_condition_crossed_slt      2  3.893e-05 *** 
## --- 
## Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
# Significant improvement. Condition predicts static light touch ratings but only in fully 
crossed model. 
 
# Dynamic light touch 
 
dlt <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
  filter(modality == 'CW' | modality == 'BR') %>% 
  filter(phase != 'orientation') %>% 
  mutate(time = if_else(phase == 'baseline', time*-1L, time)) 
 
dlt %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site) 
dlt$rating <- as.numeric(dlt$rating) 
 
dlt_bl <- dlt %>% filter(phase == 'baseline') %>% 
  group_by(id, condition) %>% 
  summarise(dlt_rating = mean(rating)) %>% 
  ungroup() %>% 
  mutate(time = 0) %>% ungroup() 
 
dlt_fu <- dlt %>% filter(phase != 'baseline') %>% ungroup() %>% 
  group_by(id, 
           time, 
           condition) %>% 
  summarise(dlt_rating = mean(rating)) %>% 
  ungroup() 
 
dlt <- rbind(dlt_bl, dlt_fu) 
 
 
dlt_wide <- dlt %>% 
  group_by(id) %>% 
  spread(key = condition, 
         value = dlt_rating)  
 
#Determining the mean (SD) dlt rating per condition  
mean(dlt_wide$A, na.rm = TRUE) 
## [1] -41.70841 
sd(dlt_wide$A, na.rm = TRUE) 
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## [1] 8.393769 
mean(dlt_wide$B, na.rm = TRUE) 
## [1] -41.41579 
sd(dlt_wide$B, na.rm = TRUE) 
## [1] 8.308582 
# For interest, plot the data 
 
ggplot(data = dlt) + 
  aes(x = time, 
      y = dlt_rating, 
      group = condition, 
      colour = condition) + 
  facet_wrap(~ id) + 
  geom_point() + 
  geom_line() + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'Individual dynamic light touch ratings by condition, over time', 
       y = 'Rating', 
       x = 'Time (minutes)') 
 
# All participants, group data represented by boxplots 
ggplot(data = dlt) + 
  aes(x = time, 
      y = dlt_rating, 
      group = interaction(condition, time), 
      colour = condition) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'Group data: dynamic light touch ratings by condition, over time N = 26', 
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       y = 'SPARS rating', 
       x = 'Time (minutes)') 
 
 # Calculate difference between conditions for group boxplots 
 
dlt_wide <- dlt %>%  
  group_by(id, 
           time) %>% 
  spread(key = condition, 
         value = dlt_rating) %>% 
  mutate(site_diff = A-B) 
 
# All participants, group data represented by boxplots 
ggplot(data = dlt_wide) + 
  aes(x = time, 
      y = site_diff, 
      group = time) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Grouped data: dynamic light touch rating difference between condition  N = 
26', 
       y = 'Dynamic light touch ratings of condition A minus rating of condition B', 




# Collapse all post-baseline ratings for each condition and then compare them using a RM AN
OVA type model. Time is nested within (and fully crossed with) ID. 
 
dlt_bl %<>% select(-time) 
names(dlt_bl)[names(dlt_bl) == 'dlt_rating'] <- 'baseline_rating' 
collapse_dlt <- dlt_fu %>% # resolve each rating relative to baseline 
  right_join(dlt_bl) %>% 
  mutate(rating_controlled = dlt_rating-baseline_rating) %>% 
  select(id, 
         time, 
         condition, 
         rating_controlled) # spread to calculate difference between conditions 
   
# We want to find out whether rating_cotrolled (for baseline) is predicted by condition. 
 
model_null_dlt <- lmer(rating_controlled ~ (1|id), 
                   data = collapse_dlt) 
model_condition_dlt <- lmer(rating_controlled ~ condition + (1|id), 
                       data = collapse_dlt) 
anova(model_condition_dlt, model_null_dlt) # Condition predicts DLT rating 
## Data: collapse_dlt 
## Models: 
## model_null_dlt: rating_controlled ~ (1 | id) 
## model_condition_dlt: rating_controlled ~ condition + (1 | id) 
##                     Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## model_null_dlt       3 2280.3 2292.0 -1137.2   2274.3               
## model_condition_dlt  4 2280.7 2296.3 -1136.3   2272.7 1.6108      1 
##                     Pr(>Chisq) 
## model_null_dlt                 
## model_condition_dlt     0.2044 
model_pre_condition_crossed_dlt <- lmer(rating_controlled ~ condition + (1|id/time), 
                                    data = collapse_dlt) 
 
anova(model_pre_condition_crossed_dlt, model_null_dlt) # not better 
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## Data: collapse_dlt 
## Models: 
## model_null_dlt: rating_controlled ~ (1 | id) 
## model_pre_condition_crossed_dlt: rating_controlled ~ condition + (1 | id/time) 
##                                 Df    AIC    BIC  logLik deviance  Chisq 
## model_null_dlt                   3 2280.3 2292.0 -1137.2   2274.3        
## model_pre_condition_crossed_dlt  5 2281.3 2300.8 -1135.7   2271.3 2.9775 
##                                 Chi Df Pr(>Chisq) 
## model_null_dlt                                    
## model_pre_condition_crossed_dlt      2     0.2257 
# Condition predicts dynamic light touch ratings. 
 
# Electrical stimulation 
 
estim <- master_data %>% 
  select(group, 
         id, 
         time, 
         phase, 
         site, 
         modality, 
         rating) %>% 
  filter(modality == 'VFF') %>% 
  filter(phase != 'orientation') %>% 
  mutate(time = if_else(phase == 'baseline', time*-1L, time)) 
 
estim %<>% mutate(condition = case_when( 
  group == '1' & site == 'right' ~ 'A', 
  group == '1' & site == 'left' ~ 'B', 
  group == '2' & site == 'right' ~ 'B', 
  group == '2' & site == 'left' ~ 'A')) %>% 
  select(-group, 
         -site) 
estim$rating <- as.numeric(estim$rating) 
 
estim_bl <- estim %>% filter(phase == 'baseline') %>% 
  group_by(id, condition) %>% 
  summarise(rating = mean(rating)) %>% 
  ungroup() %>% 
  mutate(time = 0) %>% ungroup() 
 
estim_fu <- estim %>% filter(phase != 'baseline') %>% ungroup () %>% 
  select(-phase, 
         -modality) 
 
estim <- rbind(estim_bl, estim_fu) 
 
estim_wide <- estim %>% 
  group_by(id) %>% 
  spread(key = condition, 
         value = rating)  
 
#Determining the mean (SD) anxiety rating per condition  
mean(estim_wide$A, na.rm = TRUE) 
## [1] -29.26619 
sd(estim_wide$A, na.rm = TRUE) 
## [1] 20.4084 
mean(estim_wide$B, na.rm = TRUE) 
## [1] -29.58072 
274 
 
sd(estim_wide$B, na.rm = TRUE) 
## [1] 20.78741 
# For interest, plot the data 
 
ggplot(data = estim) + 
  aes(x = time, 
      y = rating, 
      group = condition, 
      colour = condition) + 
  facet_wrap(~ id) + 
  geom_point() + 
  geom_line() +  
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'Individual electrical stimulation ratings by condition, over time', 
       y = 'Rating',  
       x = 'Time (minutes)') 
 
# All participants, group data represented by boxplots 
ggplot(data = estim) + 
  aes(x = time, 
      y = rating, 
      group = interaction(condition, time), 
      colour = condition) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  guides(colour = guide_legend("Condition"), size = guide_legend("Condition")) + 
  labs(title = 'Group data: Electrical stimulation ratings by condition, over time N = 26', 
       y = 'SPARS rating', 




 # Calculate difference between conditions for group boxplots 
 
estim_wide <- estim %>%  
  group_by(id, 
           time) %>% 
  spread(key = condition, 
         value = rating) %>% 
  mutate(site_diff = A-B) 
 
# All participants, group data represented by boxplots 
ggplot(data = estim_wide) + 
  aes(x = time, 
      y = site_diff, 
      group = time) + 
  geom_boxplot(width = 2) + 
  geom_point(position = 'jitter') + 
  geom_hline(yintercept = 0) + 
  labs(title = 'Grouped data: Electrical stimulation ratings difference between conditions 
N = 26', 
       y = 'Electrical stimulation ratings of condition A minus rating of condition B', 




# Collapse all post-baseline ratings for each condition and then compare them using a RM AN
OVA type model. Time is nested within (and fully crossed with) ID. 
 
estim_bl %<>% select(-time) 
names(estim_bl)[names(estim_bl) == 'rating'] <- 'baseline_rating' 
collapse_estim <- estim_fu %>% # resolve each rating relative to baseline 
  right_join(estim_bl) %>% 
  mutate(rating_controlled = rating-baseline_rating) %>% 
  select(id, 
         time, 
         condition, 
         rating_controlled) # spread to calculate difference between conditions 
   
# We want to find out whether rating_cotrolled (for baseline) is predicted by condition. 
 
model_null_estim <- lmer(rating_controlled ~ (1|id), 
                   data = collapse_estim) 
model_condition_estim <- lmer(rating_controlled ~ condition + (1|id), 
                       data = collapse_estim) 
anova(model_condition_estim, model_null_estim) # No improvement 
## Data: collapse_estim 
## Models: 
## model_null_estim: rating_controlled ~ (1 | id) 
## model_condition_estim: rating_controlled ~ condition + (1 | id) 
##                       Df    AIC    BIC  logLik deviance  Chisq Chi Df 
## model_null_estim       3 3013.4 3025.1 -1503.7   3007.4               
## model_condition_estim  4 3014.5 3030.1 -1503.3   3006.5 0.8949      1 
##                       Pr(>Chisq) 
## model_null_estim                 
## model_condition_estim     0.3442 
model_pre_condition_crossed_estim <- lmer(rating_controlled ~ condition + (1|id/time), 





## Data: collapse_estim 
## Models: 
## model_null_estim: rating_controlled ~ (1 | id) 
## model_pre_condition_crossed_estim: rating_controlled ~ condition + (1 | id/time) 
##                                   Df    AIC    BIC  logLik deviance  Chisq 
## model_null_estim                   3 3013.4 3025.1 -1503.7   3007.4        
## model_pre_condition_crossed_estim  5 2997.1 3016.6 -1493.6   2987.1 20.307 
##                                   Chi Df Pr(>Chisq)     
## model_null_estim                                        
## model_pre_condition_crossed_estim      2  3.893e-05 *** 
## --- 
## Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
# Significant improvement... condition predicts Electrical stimulation ratings but only in 
fully crossed model. 
Childhood and recent trauma scores 
We are interested in exploring the relationship between trauma history and area of SA. 
cidi <- master_data[ , grep('cidi', colnames(master_data))] 
cidi$cidi_total <- rowSums(cidi) 
ctq <- master_data[ , grep('ctq', colnames(master_data))] 
ctq$ctq_total <- rowSums(ctq) 
   
trauma <- cbind(master_data$id, cidi, ctq) 
names(trauma)[names(trauma) == 'master_data$id'] <- 'id' 
trauma %<>% mutate(trauma = cidi_total + ctq_total) %>% 
  select(id, 
          trauma) 
trauma <- unique(trauma) 
 
SA_trauma <- SA %>% right_join(trauma) 
 
# We need to identify the best time point from which to draw the SA data for each participa
nt. We will do this by identifying the time of peak SH intensity individually, and then use 
the SA time point closest to that time. 
 
# Considering that secondary hyperalgesia needs first to be verified before the surface are
a becomes a meaningful outcome, we first identified the time at which each participant show
ed the peak SH intensity (mean of both conditions). We then used that individualised time p
oint for each participant and identified the SA of SH at that time point, using that as the 
peak (relevant) SA for that participant. 
 
intensity_time <- intensity %>% group_by(id, time) %>% 
  summarise(mean_int = mean(pp_rating)) %>% 
  filter(time != 0) %>% 
  ungroup() %>% 
  group_by(id) %>% 
  filter(mean_int == max(mean_int)) 
 
# Now identify SA at those time point, using the df 'intensity_time'. Adjust values to clos
est applicable SA assessment times - i.e. 20 or 26 (int) to 20 mins, 32 or 38 or 44 to 40 m
ins, 50 or 56 to 60 mins. # Complete manually 
 
SA_at_peak <- SA_trauma %>% 
  filter(id == 'STM01' & time == 20 | 
           id == 'STM02' & time == 40 | 
           id == 'STM03a' & time == 60 | 
           id == 'STM04' & time == 20 | 
           id == 'STM05' & time == 40 | 
           id == 'STM06' & time == 60 | 
           id == 'STM07' & time == 40 | 
           id == 'STM08' & time == 60 | 
           id == 'STM09' & time == 60 | 
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           id == 'STM10' & time == 20 | 
           id == 'STM11' & time == 60 | 
           id == 'STM12' & time == 60 | 
           id == 'STM13' & time == 60 | 
           id == 'STM14' & time == 20 | 
           id == 'STM15' & time == 20 | 
           id == 'STM16' & time == 40 | 
           id == 'STM17' & time == 20 | 
           id == 'STM18' & time == 60 | 
           id == 'STM19' & time == 20 | 
           id == 'STM20' & time == 40 | 
           id == 'STM21' & time == 20 | 
           id == 'STM22' & time == 40 | 
           id == 'STM23' & time == 40 | 
           id == 'STM24' & time == 40 | 
           id == 'STM25' & time == 60 | 
           id == 'STM26' & time == 20 ) # for STM20 the mean_int was the same at time point
s 38 and 50. Therefore adjusted time point to 40 minutes because 40 is closer to 38 than 50 
is to 60.  
 
 
names(SA_at_peak)[names(SA_at_peak) == 'SA'] <- 'peak_SA' 
 
ggplot(data = SA_at_peak) + 
  aes(x = trauma, 
      y = peak_SA) + 
  geom_point() + 
  geom_smooth(method = 'lm')+ 
  labs(title = 'Individual peak SA, over summed trauma scores', 
       y = 'Peak SA (cm2)', 
       x = 'Summed trauma scores') 
 
# First check distributional assumptions for correlation. 
# Shapiro-Wilk normality test for peak surface area 




##  Shapiro-Wilk normality test 
##  
## data:  peak_SA 
## W = 0.97644, p-value = 0.483 
# Pearsons correlation 
 
correlation <- cor.test(SA_at_peak$trauma, SA_at_peak$peak_SA, method= "pearson") 
correlation # P = 0.307 therefore no significant relationship between summed trauma scores 
and peak SA. 
##  
##  Pearson's product-moment correlation 
##  
## data:  SA_at_peak$trauma and SA_at_peak$peak_SA 
## t = 1.0339, df = 43, p-value = 0.307 
## alternative hypothesis: true correlation is not equal to 0 
## 95 percent confidence interval: 
##  -0.1443881  0.4296389 
## sample estimates: 
##       cor  
## 0.1557468 
Post-hoc analysis  
Post-hoc analysis Post-hoc analyses were performed on the mean (range) of the Pain 
Catastrophising Scale and the 10-item Connor-Davidson Resilience Scale. These analyses 
were not initially planned nor described in this study’s protocol. These analyses were 




 PCS_results_only <- read_delim('C:/Users/Gill/Desktop/Formal data analysis Jan 2020/Gill_f
ormal_data_HFS_ST_080120/PCS_results_only.csv',  
    ';', escape_double = FALSE, trim_ws = TRUE) 
 
pcs <- PCS_results_only[-c(1,2),] # removing participants STM01 and STM02 because they are 
missing data for question 8 
 
pcs_range <- pcs %>% 
  select(-SUBJ_ID) 
 
pcs_range$pcs_total <- rowSums(pcs_range) 
 
#Determining the overall mean PCS scores among the 24 participants  
mean(pcs_range$pcs_total) 
## [1] 31 
#Determining the range 
range(pcs_range$pcs_total) 
## [1] 14 50 
#Post-hoc: CD-RISC-10  
 




cdrisc$cdrisc_total <- rowSums(cdrisc) 
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# Determining the mean  
mean(cdrisc$cdrisc_total) 
## [1] 40.80769 
#Determining the range  
range(cdrisc$cdrisc_total) 
## [1] 32 48 
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the HFS under a 
condition of 
threat 
Semi-structured interview response 
STM01 Left No data13 
STM02 Left  
“I was worried that skin would be affected on both arms not really 
affect by what it said on the computer screen, stimulations to each 
arm felt equal so was equally concerned.” 
STM03 Right 
Participant reported to ‘agree’ that at the time of receiving the HFS, 
they were concerned that it would cause damage to their skin on the 
right arm “because of what the computer screen said. I was not 
expecting that type of pain”. 
Participant reported to ‘strongly agree’ that at the time of receiving 
the HFS on their left arm, they felt anxious because the “left arm felt 
a lot more painful and my fingers moved so felt anxious”. 
STM04 Left 
Participant reported to ‘agree’ that at the time of receiving the HFS, 
they were concerned that it would cause damage to their skin on the 
right arm because the “right was more painful. My right arm is more 
important to me than my left (dominance)”. Participant reported 
concern was “not really due to what the computer screen said”. 
STM05 Left 
Participant reported to ‘agree’ that at the time of receiving the HFS, 
they were concerned that it would cause damage to their skin on the 
right arm because "[the HFS] started with right arm. It was more of a 
shock, so I was more concerned.  
Participant reported to ‘strongly agree’ that at the time of receiving 
the HFS, they were concerned that it would cause damage to their 
skin on the left arm “based on what the computer said, and it felt 
more pain on that side”. 
STM06 Right 
“Right arm felt more painful than left. However, I was equally anxious 
because of pain intensity”. 
STM07 Left 
“I wasn't too concerned about skin damage. I trusted enough 
precautions had been taken.”  
Participant reported to ‘agree’ that at the time of receiving the HFS 
on their right arm, they felt anxious because “of the anticipation”. 
“Maybe I was a bit more anxious about the right arm.” 
 
13 The researchers in this current study only decided to conduct the semi-structured interview after the first 




“The anticipation of the HFS made me feel anxious. I wasn't too 
concerned about the rating on the screen. I trusted it wasn't going to 
damage the skin.” 
STM09 Left 
Participant reported to ‘agree’ that at the time of receiving the HFS, 
they were concerned that it would cause damage to their skin on the 
right arm because “I felt from the beginning that the left arm was 
more sensitive”. 
Participant reported to ‘strong agree’ that at the time of receiving the 
HFS on both their right and left arm, they felt anxious because “the 
anticipation of when the stimulus would happen made me feel really 
anxious”. 
STM10 Right 
“Expecting the pain was going to increase after each stimulation 
made me concerned that the increase may be causing damage and 
associated anxiety.” 
STM11 Right  
Participant reported to ‘agree’ that at the time of receiving the HFS, 
they were concerned that it would cause damage to their skin on the 
right arm “based on what it said on the screen I felt concerned about 
damage”.  
Participant reported to ‘agree’ that at the time of receiving the HFS 
on their left arm, they felt anxious because “it was more painful on 
the left, so I was more anxious”. 
STM12 Right 
Participant reported to ‘disagree’ that at the time of receiving the 
HFS, they were concerned that it would cause damage to their skin on 
both the right and left arm because “at the beginning of the study, 
the informed consent said there shouldn't be any harm or damage. I 
trusted that”. 
Participant reported to ‘agree’ that at the time of receiving the HFS 
on both their right and left arm because “anticipation of pain, and 
unexpected pain. I was worried whether the next [HFS train] would be 
better than one before”. 
STM13 Left 
“I was concerned about what it said on the screen, which obviously 
made me anxious”. 
STM14 Left 
“I trusted that the researchers wouldn’t put me through anything 
dangerous. I had forgotten one [arm] was more fragile by the time we 
started baseline testing after the questionnaires.” 
STM15 Right  “The intensity and anticipation of stimulation was anxiety provoking”. 
STM16 Right  
Participant reported to ‘agree’ that at the time of receiving the HFS, 
they were concerned that it would cause damage to their skin on both 
the right and left arm because “I felt equally concerned that there 
could be skin damage to both arms, even based on what the 
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computer screen said. It was more just the overall risk that there 
could be damage”. 
STM17 Right  
Participant reported to ‘strongly disagree that at the time of receiving 
the HFS, they were concerned that it would cause damage to their 
skin on both the right and left arm because “the stimulation trains 
were too short to cause damage”. 
Participant reported ‘neutral’ that at the time of receiving the HFS on 
both their right and left arm because “waiting for the next 
stimulation made me feel anxious”. 
STM18 Right  
Participant reported to ’disagree’ that at the time of receiving the HFS 
on both their right and left arm, they felt anxious because “I was 
more nervous about the anticipation of the stimulus than what was 
on the screen". 
STM19 Left 
Participant reported to ‘strongly disagree that at the time of receiving 
the HFS, they were concerned that it would cause damage to their 
skin on their left arm because “of what the computer screen said”.  
Participant reported to ‘strongly agree’ that at the time of receiving 
the HFS on both their right and left arm, they felt anxious because “of 
anticipation between trains and how intense the pain was”. 
STM20 Right  
“I have worked with UCT human ethics before. I know they are strict. I 
was slightly concerned about the right because of what the screen 
said but not enough to 'agree' but [the right] felt a bit stranger than 
left arm. I believed the skin examination, but I was slightly interested 
as to why you were using an otoscope.” 
STM21 Left 
Participant reported to ‘disagree’ that at the time of receiving the 
HFS, they were concerned that it would cause damage to their skin on 
their left arm because "I wasn't too concerned. Maybe a small hint of 
doubt about left arm, but not enough to think it would cause tissue 
damage”.  
STM22 Left "More the discomfort that made it feel uncomfortable" 
STM23 Left 
“I was equally concerned but not enough to be totally convinced 
there could be tissue damage. But this did make me feel anxious.” 
STM24 Right  
Participant reported ‘neutral’ that at the time of receiving the HFS, 
they were concerned that it would cause damage to their skin on both 
their right and left arm because “I trusted the controlled 
environment, even though the screens said one arm was more 
fragile”.  
Participant reported to ‘agree’ that at the time of receiving the HFS 
on both their right and left arm, they felt anxious because “I felt 
generally anxious just because of pain intensity”.  
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STM25 Right  
Participant reported to ‘agree’ that at the time of receiving the HFS, 
they were concerned that it would cause damage to their skin on 
their left arm because “it felt more painful on the left.  
Participant reported to ‘strongly disagree’ and ‘neutral’ that at the 
time of receiving the HFS on their right and left arm, respectively, 
they felt anxious because “I was anxious about the next train. Also [I 
was anxious about] what the screen said”. 
STM26 Left 
Participant reported to ‘strongly disagree’ that at the time of 
receiving the HFS, they were concerned that it would cause damage 
to their skin on both their right and left arm because “I trusted the 
controlled environment”.  
Participant reported ‘neutral’ that at the time of receiving the HFS on 
both their right and left arm, they felt anxious because “of not 
knowing what to expect, and the anticipation between trains”. 
 
 
 
 
